Positive emotion processing deficits in schizophrenia by Strauss, Gregory P
UNLV Retrospective Theses & Dissertations 
1-1-2008 
Positive emotion processing deficits in schizophrenia 
Gregory P Strauss 
University of Nevada, Las Vegas 
Follow this and additional works at: https://digitalscholarship.unlv.edu/rtds 
Repository Citation 
Strauss, Gregory P, "Positive emotion processing deficits in schizophrenia" (2008). UNLV Retrospective 
Theses & Dissertations. 2817. 
https://digitalscholarship.unlv.edu/rtds/2817 
This Dissertation is protected by copyright and/or related rights. It has been brought to you by Digital 
Scholarship@UNLV with permission from the rights-holder(s). You are free to use this Dissertation in any way that 
is permitted by the copyright and related rights legislation that applies to your use. For other uses you need to 
obtain permission from the rights-holder(s) directly, unless additional rights are indicated by a Creative Commons 
license in the record and/or on the work itself. 
 
This Dissertation has been accepted for inclusion in UNLV Retrospective Theses & Dissertations by an authorized 
administrator of Digital Scholarship@UNLV. For more information, please contact digitalscholarship@unlv.edu. 
POSITIVE EMOTION PROCESSING 
DEFICITS IN SCHIZOPHRENIA
by
Gregory P. Strauss
Master of Arts 
University of Nevada Las Vegas 
2004
Bachelor of Science 
University of Georgia 
2002
A dissertation submitted in partial fulfillment of 
the requirements for the
Doctor of Philosophy Degree in Psychology 
Department of Psychology 
College of Liberal Arts
Graduate College 
University of Nevada, Las Vegas 
August 2008
UMI Number: 3338187
INFORMATION TO USERS
The quality of this reproduction is dependent upon the quality of the copy 
submitted. Broken or indistinct print, colored or poor quality illustrations and 
photographs, print bleed-through, substandard margins, and improper 
alignment can adversely affect reproduction.
In the unlikely event that the author did not send a complete manuscript 
and there are missing pages, these will be noted. Also, if unauthorized 
copyright material had to be removed, a note will indicate the deletion.
UMI
UMI Microform 3338187 
Copyright 2009 by ProQuest LLC.
All rights reserved. This microform edition is protected against 
unauthorized copying under Title 17, United States Code.
ProQuest LLC 
789 E. Eisenhower Parkway 
PC Box 1346 
Ann Arbor, Ml 48106-1346
Copyright by Gregory P. Strauss 2008 
All Rights Reserved
Dissertation Approval
The Graduate College 
University of Nevada, Las Vegas
May 14
.20 07
The Dissertation prepared by 
G regory P a u l S trauss
Entitled
Positive Emotion Processing Deficits in Schizophrenia
is approved in partial fulfillment of the requirements for the degree of 
D o cto r o f  P h ilo so p h y in  Psychology
T /' r '
ExaminMiûn^mnittœ Member
Examination Committee Member
"Aùa.sl£lM^(LYiâùL(
Graduate College Faculty Representative
Examination Committee Chair
Dean of the Graduate College
u
ABSTRACT
Positive Emotion Processing Deficits in 
Schizophrenia
by
Gregory P. Strauss, M.A.
Dr. Daniel N. Allen, Examination Committee Chair 
Associate Professor of Psychology 
University of Nevada Las Vegas
Affective impairments were examined in patients with and without deficit
syndrome schizophrenia. A battery of teste designed to measure emotional
experience, emotional Information processing, and emotional perception were
administered to deficit (n = 15) and non-defidt syndrome (n = 26) schizophrenia
patients classified according to the Schedule for the Deficit Syndrome, and
matched non-patient control subjects (n = 22). As predicted, in comparison to
non-deficit patients and controls, deficit syndrome patients reported less frequent
and intense experience of positive emotion, recalled significantly fewer positive
words, and displayed an impaired ability to accurately identify and judge the
valenœ of pleasant odors. Additionally, deficit patients demonsfi’ated a unique
failure to have their attention captured by positive information, as well as less
accurate and efficient labeling of positive faœs than non-deficit patients or
controls. Abnormalities were also associated with negative emotions, such that
deficit syndrome patients demonstrated impairment at identifying fearful faces, 
were less accurate at judging negative smells, had a bias toward recalling anger 
words, and displayed an elevated attentional lingering effect for negative 
information. These findings indicate that the defidt syndrome is assodated with 
affective disturbances that impact a number of cognitive and sensory domains, 
and provide support for the notion that abnormalities may be most severe in 
relation to the experience and processing of positive emotions. These 
abnormalities may be due to a mood-congruent processing abnormality, and are 
consistent with the notion that frontal and limbic system dysfunction may be core 
to deficit syndrome schizophrenia.
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CHAPTER 1 
INTRODUCTION
For years, schizophrenia was viewed as something of an enigma. It has 
generally been conceptualized as a mental disturbance beyond the reach of 
science, more of a metaphysical problem than a brain disease (Green, 2000). 
However, this is no longer the case. Recent breakthroughs in neuroscience and 
medicine have resulted in the delineation of etiological factors unique to 
schizophrenia. These factors encompass a wide range of areas, including 
structural and functional brain abnormalities, cognitive deficits, and 
neurochemical impairments. Despite significant advances in our understanding of 
schizophrenia, recent treatments protocols have proven ineffective at 
remediating some of the more chronic and debilitating psychotic symptoms 
(Tandon, Jibson, Taylor, & DeQuardo, 1995). This is particularly true regarding 
emotional disturbances that accompany negative psychotic symptoms, such as 
flat affect, curbed interests, and diminished emotional experience (Carpenter, 
Heinrichs, & Wagman, 1988). Although negative symptoms have Ijeen shown to 
be responsive to newer “atypical” antipsychotic medications, it is apparent that 
some patients evidence residual negative symptoms that are unaffected by 
treatment (Carpenter et al., 1995). If further advances are to be made in the
treatment of negative symptoms of schizophrenia, researchers will need to 
investigate its etiology in a fresh new way.
In a recent critique of the field, Seligman and Csikszentmihalyi (2000) 
proposed that Psychology may benefit from adopting a new perspective. They 
suggested that mental health has historically focused on remediating 
psychological symptoms and weaknesses, devoting much of its energy to 
“curing” disorders associated with negative emotions (e.g., anxiety, depression). 
As a result, our knowledge of positive emotions and factors that promote them 
remains largely wanting. Although there are many consequences associated with 
failing to research positive emotions, the fact that we have little understanding of 
disorders that experience and process positive emotion abnormally poses a 
significant problem. This may be particularly true of individuals with 
schizophrenia who demonstrate deficits in experiencing and perceiving positive 
emotions. The failure to investigate schizophrenia as a disorder of aberrant 
positive emotion processing may account for current difficulties in treating chronic 
symptomatology, such as residual negative symptoms. However, without further 
knowledge of cognitive and neural substrates that maintain these abnormalities, 
we are unlikely to remediate unremitting negative symptoms or increase the 
quality of life of persons with schizophrenia. The current study will provide the 
first systematic attempt at delineating positive emotion processing deficits in 
persons with schizophrenia, placing particular emphasis on how such deficits 
contribute to core negative symptoms.
Clinicians have long noted that individuals with schizophrenia evidence 
severe emotional disturbances, particularly related to the experience and 
expression of positive emotion. Original conceptualizations of the disorder 
proposed by Kraepelin (1919) and Bleuler (1911, 1950) posited that 
schizophrenia was essentially the splitting of cognition and affect. These 
conjectures were based upon clinical observations that patients are particularly 
impaired at producing facial expressions of happiness. Although clinicians largely 
agreed that patients were deficient at expressing emotion, there was disparity 
regarding whether difficulties in emotional expression accurately reflected 
patients’ inner-experience of emotion. Both Kraepelin and Bleuler proposed that 
patients were capable of experiencing a wide-range of emotions, despite being 
able to express them. Although these claims were based upon patient self-report, 
other clinicians contended that some patients were still unable to experience 
emotion (Rado, 1953). Rado proposed this to be particularly true of positive 
emotional experience, and described schizophrenia as a disorder characterized 
by an “integrative pleasure deficiency”.
After several decades of empirical investigation, we now know these 
conjectures of each of these sets of early clinicians to be largely true. Recent 
research suggests that individuals with schizophrenia are deficient at both 
expressing and experiencing emotions. Compared to healthy individuals, patients 
exhibit less observable positive facial expressions, and report experiencing 
elevated levels of negative emotion (/^hevli, Blanchard, & Horan, 2003; 
Berenbaum & Oltmanns, 1992; Kring et al., 1993; Kring & Neale, 1996; Earnst &
Kring, 1999). And some patients, namely those exhibiting negative symptoms, 
may also experience significant reductions in experiencing positive emotions 
(Horan & Blanchard, 2003; Suslow et al., 2005). These affective deficits 
significantly differ from healthy individuals, who typically report being in a 
moderately positive mood (e.g., 5.50 on a 7.0-point scale), and demonstrate the 
ability to express positive affect (i.e., smile) from an early age (see Matlin & 
Stang, 1978). Thus, healthy individuals exhibit a Pollyanna tendency (i.e., tend to 
be in a positive mood, express high levels of positive emotion, and process 
positive information accurately and efficiently), while persons with schizophrenia 
may both express and experience positive and negative emotions abnormally.
Several studies investigating the relationship between emotional 
expression and experience provide direct clarification of debates posed by early 
clinicians. Results of multiple studies suggest that the relationship between 
emotional experience and expression may be disjunctive in patients with 
schizophrenia (Aghevli, Blanchard, & Horan, 2003; Berenbaum & Oltmanns, 
1992; Kring et al., 1993; Kring & Neale, 1996; Eamst & Kring, 1999). That is, 
patients are often unable to produce emotional expressions, yet report 
experiencing a wide range of emotions. However, it should be noted that this 
relationship significantly differs among patients meeting the criteria for deficit 
syndrome schizophrenia (Horan & Blanchard, 2003). Individuals meeting criteria 
for this putative schizophrenia subtype evidence a more severe form of negative 
symptoms, characterized by six specific deficit symptoms: restricted affect, 
diminished emotional range, poverty of speech, curbing of interests, diminished
sense of purpose, and diminished social drive (Carpenter et al., 1988). Deficit 
syndrome schizophrenia is characterized by unique etiological, cognitive, and 
neurological abnormalities (Kirkpatrick et al., 2001). These patients also appear 
to be uniquely deficient at experiencing positive emotions (Horan & Blanchard, 
2003), and display significantly less positive facial expressions than non-deficit 
syndrome patients (Eamst & Kring, 1999). When recent research is viewed in 
relation to early clinical theories, it appears that the majority of individuals with 
schizophrenia display emotional disturbance In line witb the views of Kraepelin 
and Bleuler. However, a distinct group of patients, those meeting criteria for the 
deficit syndrome, may conform to Rado’s (1953) notion that schizophrenia is 
characterized by positive emotion deficits. Thus, schizophrenia characterized by 
severe negative symptoms may reflect a more severe form of emotional 
disturbance.
Several studies also suggest that deficit and non-deficit schizophrenia 
patients also differ with regard to the perception of emotional information. The 
recognition of emotional facial expressions has been found to be particularly 
impaired in patients with schizophrenia (see Edwards et al., 2001 for review). 
However, results are inconclusive regarding which emotions are most 
significantly impaired, and whether differences exist between deficit and non­
deficit patients. Several studies conducted on non-deficit schizophrenia reported 
significant impairment in processing happy faces (Archer et al., 1994; Bellack et 
al., 1996; Loughland, Wiliams, & Gordon, 2002a; Loughland, Williams, & 
Gordon, 2002b; Phillips et al., 1998; Sachs et al., 2004; Schneider et al., 1995 ),
while several others reported intact positive emotion identification and significant 
impairment for fear (Gaebel & Wolwer, 1992; Johnson, Emde, Scherer, &
Kilnnert, 1986; Mandai, 1987, 1998; van derGaag & Haensen, 1990; Wolwer et 
al., 1996; ) and sadness (Kohler et al., 2000; Edwards, Pattison, Jackson, & 
Wales, 2001). Only two studies investigated facial affect identification in deficit 
syndrome patients. Although findings from these two studies are mixed, some 
evidence indicates that deficit syndrome patients evidence poorer recognition 
than non-deficit patients, and that these deficits are more severe for positive 
emotions, such as surprise (Bryson et al., 1998).
Deficit syndrome patients have also been shown to evidence more severe 
olfactory perception impairments than non-deficit patients and controls (Goudsmit 
et al., 2004; Malaspina et al., 2001; Secklinger et al., 2002). These smell 
identification impairments have been demonstrated to be correlated with 
neurocognitive tests foought to measure frontal and parietal structures, regions 
that have not been implicated in smell identification abnormalities in non-deficit 
schizophrenia patients (Secklinger et al., 2002). Considering overlap between 
neural circuits involved with emotion processing and olfoction, researchers have 
also attempted to determine whether individuals with schizophrenia are impaired 
at recognizing olfactory valence. Recent investigations have found foat 
individuals with schizophrenia display impaiiment at judging the pleasantness of 
odors (Crespo-Facorro et al., 2001; Hurdy et al., 2002; Moberg et al., 2003), and 
that these impairments are associated with greater negative symptom severity 
(Doop & Park, 2006). These findings have yet to be extend to deficit syndrome
patients: however, it would be important to do so considering that deficit patients 
display the most severe olfactory impairments noted in patients with 
schizophrenia (Goudsmit et al., 2004; Malaspina et al., 2001; Secklinger et al., 
2002), since impaired olfactory hedonic judgment is associated with greater 
severity of negative symptoms, and because frontal and limbic system 
dysfunction thought to underlie general olfactory identification and valence 
judgment are also thought to be core to negative symptoms associated with the 
deficit syndrome (Kirkpatrick et al., 2001).
Individuals with schizophrenia also evidence deficits in the cognitive 
processing of emotional information, and there is some suggestion that these 
impairments may be more severe in patients with negative symptoms. 
Impairments have been noted in patients with schizophrenia in relation to 
emotional memory (Calev, 1996; Calev & Edelist,1993; Exner, Boucsein, Degner, 
Irle, & Weniger, 2004; Koh, Grinker, Marusarz, & Forman, 1981), with the 
majority of studies indicating that deficits are more severe for the recall of 
positive than negative information (Calev, 1996; Calev & Edelist,1993; Exner et 
al., 2004; Koh et al., 1981). A recent investigation also demonstrated that these 
positive emotion memory impairments may be more pronounced in patients 
displaying negative symptoms, particularly anhedonia (Herbener et al., 2007). 
Research also suggests that patients evidence aberrant automatic affective 
processing, and that these deficits may be more prominent for positive 
information (Suslow, Roestel, Droste, & Arolt, 2003) and particularly in patients 
with negative symptoms (Suslow et al., 2005). However, it has also been noted
that schizophrenia patients display an inherent attention bias for threatening 
information (Epstein, Stern, & Silbersweig, 1999; Fear, Sharp, & Healy, 1996), 
suggesting that negative information may also disrupt automatic cognitive 
processes. Thus, several studies suggest that patients exhibiting negative 
symptoms of schizophrenia may display affective disturbances that are more 
severe than patients without negative symptoms, and that these abnormalities 
may be more severe for the processing of positive information. Additionally, 
these positive emotion processing abnormalities appear to be pervasive, 
extending across multiple cognitive domains, including face perception, smell 
perception, memory, and attention, as well as emotional experience and 
expression. However, additional studies are needed to determine whether these 
findings are core to negative symptoms in and of themselves or the result of 
secondary factors, such as medication effects, depression, and anxiety.
The current study attempte to address these issues and provide the first 
comprehensive assessment of affective disturbance in patients with deficit and 
non-deficit syndrome schizophrenia. Several major questions will be examined to 
achieve this purpose. First, we aim to determine whether deficit patients, non­
deficit patiente, and controls differ with regard to emotional experience. 
Specifically, do groups differ with regard to the experience of state and trait 
positive and negative emotions? Second, do patient groups and controls differ 
with regard to the perception and cognitive processing of emotional information? 
More specifically, a) Are deficit syndrome patients more impaired than non-deficit 
patients and controls at identifying and judging the valence of positive odors?, b)
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Do deficit syndrome patients display a selective impairment in processing 
positive faces accurately and quickly?, c) Are deficit patients more impaired than 
non-deficit patients and controls at remembering positive words?, and d) Does 
positive information fail to capture attention in patients with deficit syndrome 
schizophrenia?
Answers to these questions have significant potential to inform us about 
the nature of aberrant neural mechanisms central to emotion processing deficits 
in patients with negative symptoms of schizophrenia, and may contribute to the 
development of novel methods of treatment for patients with core negative 
symptoms, such as those with the deficit syndrome, who tend to tie highly 
treatment resistant.
CHAPTER 2
LITERATURE REVIEW 
In the following sections, literature relevant to the current proposal is 
reviewed. Discussion involves two primary areas; Deficit Syndrome 
Schizophrenia and Affective Impairment in Schizophrenia. The Deficit Syndrome 
Schizophrenia section reviews literature relevant to patients with primary 
negative symptoms of schizophrenia, including: 1) Symptom Heterogeneity, 2) 
Clinical Characteristics and Classification, 3) Course of Illness, 4) Risk Factors, 
and 5) Neuropsychological Impairment. Sections reviewed in the Affective 
Disturbance section include: 1) Affect Expression and Experience, 2) Facial 
Affect Processing, 3) Olfactory Affect Impairment, 4) Memory for Affective 
Information, and 5) Automatic Processing.
Deficit Syndrome Schizophrenia
Symptom Heterogeneity
Schizophrenia is now widely regarded as a disorder characterized by 
substantial heterogeneity, particularly in relation to symptom presentation. The 
symptoms of schizophrenia are commonly classified according to positive and 
negative features. Traits categorized as positive psychotic features are those that 
involve behavioral excess, and typically include symptoms such as
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hallucinations, delusions, and disorganized speech (Andreasen & Olsen, 1982). 
In contrast, negative features are described as behavioral deficiencies, including 
symptoms like anhedonia (inability to experience pleasure), flat affect (No 
outward expression of emotion), asociality (poor social skills), alogia (poverty of 
speech and thought), and avolition (lack of motivation and energy).
Negative symptoms have received significant attention in the research 
literature due to difficulty associated with their treatment. It is clear that some 
patients experience negative symptoms that neither respond to conventional or 
atypical antipsychotic medications (Carpenter et al., 1995). Due to the high 
incidence of residual negative symptoms (Carpenter, Heinrichs, & Wagman,
1988), researchers have attempted to develop classification systems that divide 
symptom profiles into distinct subtypes that are more amenable to treatment.
The most enduring of these classifications is the delineation of primary 
and secondary negative symptoms. Secondary negative symptoms are those 
features that are the result of medication, exacerbation, or psychotic processes 
(Kirkpatrick et al., 1989). In contrast, primary negative symptoms are stable trait­
like features, which persist throughout durations of symptom stability (Carpenter 
et al., 1988). Primary negative symptoms are commonly defined as those 
negative symptoms (e.g., affective disturbance, alogia, anhedonia) that occur 
independent of medication side-effecte (secondary negative symptom), and are 
not attributable to clinical features like depression, anxiety, or paranoia (Kelley, 
van Kammen, & Allen, 1999). Patients who display multiple primary negative
11
symptoms, which are consistently present for greater than 1 year, are classified 
as having “Deficit Syndrome” schizophrenia.
Clinical Characteristics and Classification
The deficit syndrome classification has received considerable attention in 
the research literature, as it has been found to predict a number of outcomes. For 
example, differences have been noted between deficit and non-deficit syndrome 
schizophrenia patients with regard to neurological processes, cognitive 
functioning, emotional disturbance, clinical symptomatology, course of illness, 
risk factors, structural brain abnormalities, and treatment response (See 
Kirkpatrick, 2001 for a review). Differentiation between deficit and non-deficit 
patients provides support for the validity of this classification, and its use in 
clinical and research purposes.
Although there are a number of negative symptoms common to patients 
with schizophrenia, those meeting criteria for the deficit syndrome primarily 
display impairment in relation to volition and emotionality. As detailed by 
Kirkpatrick et al (2001 ; SDS Manual), deficit patients display clinical features that 
are highly similar to individuals meeting criteria for schizoid personality disorder. 
Like schizoid patients, they tend to have little interest in people and things, and 
evidence a lack of emotionality and liveliness. They also display significant 
impairment in behavioral initiation. For instance, despite being capable of doing 
so, they typically initiate thoughts, emotions, and motor behaviors less frequently 
than other individuals. Thus, deficit syndrome patients are unique in that they 
display a lack of liveliness and interest in people and things that is uncommon.
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both in comparison to the general population and individuals with schizophrenia 
alike.
Deficit syndrome status is evaluated in relation to 6 specific negative 
symptoms: Restricted Affect, Diminished Emotional Range, Alogia, Curbed 
Interests, Diminished Sense of Purpose, and Diminished Social Drive. Restricted 
affect refers to a patient’s overt expression of emotion. Relative to other people, 
deficit patients display reduced expression of emotion in facial and vocal 
channels, and in their use of expressive nonverbal cues. In contrast to the 
observable emotional phenomenon rated for Flat Affect, the estimation of 
Diminished Emotional Range reflects a patient’s subjective inner-experience of 
emotion. In comparison to others, deficit patients commonly report experiencing 
less frequent and intense levels of both positive and negative emotions during 
clinical interview. They tend to enjoy less in life, are not as easily upset, and 
seldom experience anger or irritation. Alogia, the third deficit syndrome symptom, 
has also been termed poverty of speech. This item reflects a patient’s proclivity 
to t)oth use fewer words than what would be considered normal, and convey less 
information than what is needed to express an idea fully.
Deficit patients also display significant volitional impairments. One of the 
most core of these symptoms is that of Curbed Interests. In comparison to 
others, deficit patients display little interest in the external world. They may spend 
less time thinking about things, rarely attempt to learn new information, and 
engage in fewer hobbies or activities than what is nomnal. This may be reflected 
both in terms of breath or depth of interest. They also display a significant
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reduction in relation to experiencing drive for goal-directed activity. Kirkpatrick et 
al. (2001; SDS Manual) term this symptom, Diminished Sense of Purpose, to 
reflect a loss in the ability to independently generate goals for one’s life, sustain 
goal-directed activity, and spend time in purposeful activities. Deficit patients 
therefore spend an inordinate amount of time engaging in aimless activity (e.g., 
passively sitting and staring into space, smoking cigarettes on a bench), and 
have little or no desire to improve the daily situation of their lives.
However, a lack of drive to interact with others is perhaps the most core 
feature of deficit syndrome pathology. In comparison to others, deficit patients do 
not want substantial amounts of social contact, and importantly, this is not due to 
anxiety. Unlike Avoidant patients who withdraw from social situations because 
these situations produce anxiety, even though they long for contact with others, 
deficit patients simply do not have the normal drive for affiliation inherent to most 
individuals. Thus, deficit syndrome patients spend less time around others, prefer 
to complete activities alone, and feel no sense of loneliness even when they go 
for long periods of time without significant human contact.
It is important to note that the concept of deficit syndrome schizophrenia 
differs from the traditional view of negative symptoms of schizophrenia in several 
ways. First, negative symptoms seen in deficit syndrome patients are the most 
prominent aspect of their clinical presentation. In other words, negative 
symptoms are the most severe, distressing, and functionally debilitating aspect of 
the patient’s condition. It is not necessarily true that deficit syndrome patients are 
devoid of positive psychotic symptoms, which are in fact required to be present in
14
some combination for patients to meet criteria for schizophrenia. These 
symptoms are simply not as severe or impacting as what is seen in non-deficit 
patients.
Second, negative symptoms manifested by deficit syndrome patients are 
primary. That is, negative symptoms are idiopathic and not secondary to factors 
other than the disease process that are common to schizophrenia. Such 
secondary factors include: anxiety, medication effect, suspicion (and other 
positive psychotic symptoms), mental retardation, and depression. The 
primary/secondary symptom discrimination is often a difficult one considering that 
prominent negative symptoms can result from a variety of factors. For example, 
prominent negative symptoms may be brought on by: behavioral withdrawal from 
the environment, depressive mood, demoralization, antipsychotic medication 
effects, exposure to an understimulating environment, or neurological processes 
core to the disease process of schizophrenia. To determine whether these 
symptoms are caused by primary or secondary fectors, it is common to use 
longitudinal observation or empirical manipulation. It is often necessary to 
examine patient records during periods of medication change or withdrawal to 
identify fluctuations in negative symptoms, to interview family members or 
treatment staff to track the patient’s history of negative symptoms, and assess 
the effects of antiparkinsonian medication use on the manifestation of flat affect.
Third, negative symptoms of the deficit syndrome also differ in that they 
must be enduring. In the deficit syndrome classification, as made using the gold 
standard method of the Schedule for the Deficit Syndrome (Kirkpatrick et al..
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1989), enduring is defined as a period of 12 months prior to interview. Thus,
negative symptoms of the deficit syndrome must be stable throughout a 1 year
period. Such stability reflects that these negative symptoms are core to the
neurological influences of the disease process of schizophrenia in and of itself,
and not other causes, such as those previously discussed. During periods of
symptom remission or psychotic disorganization, it is still usually possible to
diagnose the presence of the deficit syndrome.
Thus, diagnosis of the deficit syndrome of schizophrenia requires the
patient to meet several very specific criteria, which are designed to reduce
heterogeneity of schizophrenia and identify a homogeneous subgroup of patients
with negative symptoms. Specific criteria for the deficit syndrome include (from
Kirkpatrick, Buchanan, Ross, & Carpenter, 2001, p 166):
“1). At least 2 of the following 6 features must be present and of clinically 
significant severity: Restricted affect. Diminished emotional range. Poverty 
of speech. Curbing of interests. Diminished sense of purpose. Diminished 
social drive. 2.) Two or more of these features must have been present for 
the preceding 12 months, and always have been present during periods of 
clinical stability (including chronic psychotic states). These symptoms may 
or may not be detectable during transient episodes of acute psychotic 
disorganization or decompensation. 3.) Two or more of these enduring 
features are also idiopathic (i.e., not secondary to factors other than the 
disease process. Such factors include; Anxiety, Drug effect. 
Suspiciousness, Formal thought disorder. Hallucinations and delusions. 
Mental retardation. Depression. 4.) The patient meets DSM criteria for 
schizophrenia.”
The following sections detail deficit syndrome literature relevant to the current 
investigation.
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Course of Illness
The deficit syndrome has been described as a more severe form of 
schizophrenia, with a distinct and pervasive course of illness. Compared to non­
deficit patients, deficit schizophrenia is characterized by poorer premorbid 
functioning before the onset of positive symptoms, particularly with regard to 
social functioning (Fenton & McGlashan, 1994; Kirkpatrick, Ram, & Bromet,
1996; Kirkpatrick et al., 1996; Buchanan, Kirkpatrick, Heinrichs, & Carpenter,
1990). Some evidence suggests that these premorbid impairments may be 
pervasive, continuing to affect ftinctioning throughout life. Social and 
occupational abnormalities persist into early and middle adulthood, maintaining 
presence over multiple assessments and long-term follow-up (Fenton & 
McGlashan, 1994). However, it has yet to be determined whether the severity of 
these symptoms progresses with age. This would be an important factor to 
assess considering that patients with schizophrenia show differential patterns of 
premorbid impairment throughout adolescence (Allen, Frantom, Strauss, & van 
Kammen, in press).
Risk Factors
Deficit syndrome schizophrenia is also associated with specific risk 
factors, which are not prevalent in simple schizophrenia. Four primary risk factors 
are associated with deficit syndrome schizophrenia; Summer birth, prevalence of 
borna disease virus antibodies, familial history, and male gender.
Seasonality of birth has been associated with the development of several 
psychiatric disorders. For example, winter birth is highly associated with Bipolar
17
disorder and schizoaffective disorder, while spring birth is significantly correlated 
with major depression and autism (Torrey, Miller, Rawlings, & Yolken, 1997). 
Winter birth month has also been repeatedly correlated with development of 
schizophrenia (Torrey et al., 1997); however, the biological substrates governing 
this relationship are not well understood. It has been hypothesized that this 
relationship may exist due to multiple factors, including gene combination effects, 
weather, infectious substances/toxins, and birth complications (Torrey et al., 
1997). Considering that winter birth is a significant risk factor for development of 
schizophrenia, it is of considerable interest that summer birth is highly associated 
with development of the deficit syndrome (Kirkpatrick et al., 1998, 2000, 
2001).The relationship between summer birth and deficit syndrome has been 
reported in several published studies (Kirkpatrick et al., 1998, 2000), and 
confirmed by multiple unpublished investigations reviewed by Kirkpatrick et al. 
(2001). Despite the prevalence of these findings, their biological underpinnings 
are not well delineated. Regardless of the precise cause, summer birth appears 
to be a unique marker for deficit syndrome schizophrenia.
Viral acquisition has also been associated with the development of several 
psychiatric disorder (e.g., dementia of Alzheimer’s type; de la Torre et al.,
1996), including schizophrenia. The deficit syndrome has been specifically linked 
to an immune system depleting virus that results in meningoencephalitis, the 
Borna Dissease Virus (Waltrip et al., 1997). Boma disease virus antibodies have 
been found to be significantly higher in deficit compared to non-deficit patients 
(Iwahashi et al., 1998; Waltrip et al., 1997). This disease is thought to
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significantly affect limbic system regions (e.g., hippocampus, basal ganglia), and 
potentially disrupt neurotransmitter binding in the DA circuit (Solbrig et al., 1994). 
Considering distinct emotional and neurochemical abnormalities that accompany 
the deficit syndrome, it seems plausible that Borna Dissease infection is a unique 
risk factor for the development of schizophrenia with primary negative symptoms.
Familial relation also increases the risk for developing deficit syndrome 
schizophrenia (Dollfus, 1996; Kirkpatrick, Castle, Murray, & Carpenter, 2000). 
Genetic-linkage studies suggest that first-degree relatives of deficit patients are 
at significantly higher risk for developing schizophrenia than relatives of non­
deficit patients (Dollfus, 1996). Kirkpatrick et al. (2000) report the risk of 
developing schizophrenia to be approximately 1.75 times greater in deficit than 
non-deficit probands. When risk for schizophrenia is compared within families, 
results suggest that the diagnosis of deficit schizophrenia in one sibling makes 
the diagnosis of deficit schizophrenia 3 times more likely than developing non­
deficit syndrome in another sibling diagnosed with schizophrenia (Ross et al.,
2000). Additionally, genes associated with the pathophysiology of deficit 
syndrome may uniquely relate to the development of social skill impairments, as 
deficit probands experience significantly more social isolation compared to non­
deficit probands. Social skills abnormalities noted in deficit syndrome relatives do 
not appear to be due to greater incidence of depression. In fact, relatives of 
deficit patients experience significantly less dysphoria than non-deficit relatives 
(Ross et al., 2000). These findings suggest that deficit syndrome schizophrenia
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has a distinct familial relationship, and that genes associated with this subtype 
are highly associated with social dysfunction.
Male gender has also been associated with increased risk for deficit 
syndrome. Roy (2001) conducted a meta-analysis of 23 studies investigating 
deficit and non-deficit syndrome to determine the relative proportion of male- 
female patients. In the 23 studies examined, approximately 29% of individuals 
with schizophrenia met deficit syndrome criteria (Range = 16.5 - 50%). Of those 
29% of participants meeting deficit criteria, 63% were male. Roy concluded that 
the significantly higher proportion of males meeting diagnosis may reflect that 
sex hormones are related to the etiology of deficit syndrome schizophrenia. 
Cognitive Deficits
As previously noted, schizophrenia is characterized by a wide-range of 
cognitive deficits. Although the majority of persons with schizophrenia evidence 
significantly poorer mental abilities than controls, some patients have also been 
reported to appear neuropsychologically normal (Allen et al., 2003). In an attempt 
to reduce this heterogeneity in cognitive performance, researchers have 
attempted to study cognition in relation to distinct subtypes. Investigations of the 
effects of negative symptoms on cognition have revealed significant associations 
with psychomotor speed, verbal memory (O’Leary et al., 2000), executive 
functioning (Bell et al., 1997), and semantic fluency (Chen et al., 1996). Since it 
has been noted that negative symptoms and the deficit syndrome are 
qualitatively different and maintained by distinct etiological factors, researchers 
have also investigated cognitive impairment specific to the deficit syndrome.
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Although schizophrenia is characterized by a wide-range of cognitive 
impairment, deficit syndrome schizophrenia is characterized by several distinct 
deficits. The most consistently reported finding involves deficient executive 
functioning (Bryson, Whelahan, & Bell, 2001 ; Buchanan, Strauss, Kirkpatrick, 
and Holsetin,1994). Bryson et al. (2001) found that deficit patients were 
approximately -1.0 SD below the performance of non-deficit patients on the 
WCST. Similar impairments were noted by Buchanan (1994), using the Stroop 
Color-Word and Trail Making Tests. These impairments suggest that deficit 
patients perform more poorly than non-deficit patients on tests sensitive to firontal 
lobe dysfunction.
Several studies have also reported that deficit patients are impaired in 
tests measuring parietal lobe functioning (Arango et al., 2000; Buchanan et al., 
1994). Like executive functioning, these deficits are significantly more severe 
than those displayed by non-deficit patients; however, parietal dysfunction may 
be a unique marker for the deficit subtype, as non-deficit patients typically do not 
differ from controls on these tasks. Impairment on tasks sensitive to parietal lobe 
functioning may indicate that deficit patients are particularly deficient at 
integrating sensory processes (e.g., visual and motor senses). Deficit patients 
have also been differentiated by attentional impairments, particularly with regard 
to sustained attention (Buchanan et al., 1997), as well as auditory recognition 
(Lahti, 2001). Collectively, these deficits suggest that individuals with deficit 
syndrome have impairment to multiple sensory domains, and that severity of 
performance may be influenced by frontal and parietal lot>e dysfunction.
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Neuropathology
Abnormalities to specific neural mechanisms may also differentiate deficit 
and non-deficit schizophrenia. Results from three separate neuroimaging studies 
suggest that deficit patients evidence significantly less activation in the 
dorsolateral prefrontal cortex (DLPFC), thalamus, and inferior parietal cortex 
(Carpenter et al., 1996; Heckers et al., 1999; Tamminga et al., 1992). 
Additionally, differences between deficit and non-deficit patients in functional 
activation were not noted for other brain regions known to be deficient in 
schizophrenia (e.g., hippocampus; Hecker et al., 1999), suggesting that 
decreased activity in the DLPFC is a unique finding to deficit syndrome, and is 
not simply the result of a more global pattern of decreased activation throughout 
the cerebrum. Structural abnormalities have also been noted in relation to the 
prefrontal cortex, such that deficit patients are known to have significantly lower 
prefrontal white matter volume (Buchanan et al., 1993) and smaller prefrontal 
volume in general (Turetsky et al., 1995). When structural and ftjnctional brain 
abnormalities are viewed together, findings point to a disruption in the 
dorsolateral prefrontal-basal ganglia-thalamocortical circuit (Kirkpatrick et al.,
2001). Impairment to this circuit likely contributes to the significant cognitive (i.e., 
executive functioning and sensory integration) and social skills abnormalities 
(Kirkpatrick et al., 2001) inherent to deficit syndrome patients. Irregular 
communication between structures within this circuit may also explain the fact 
that deficit patients experience significantly less positive affect than healthy 
controls. This is likely to be true considering the importance of the prefrontal
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cortex, basal ganglia, and thalamus in regulating positive emotion (Thorpe,
1983).
Aberrant neurotransmitter systems may also contribute to the cognitive, 
emotional, and social processes related to the deficit syndrome. Although 
schizophrenia is typically characterized by higher levels of DA activity, recent 
evidence suggests that the deficit syndrome may be uniquely infiuenced by lower 
brain DA levels. Lower levels of the DA metabolite, homovanilic acid (HVA), have 
been reported by multiple investigations (Ribeyre et al., 1994; Thibaut et al.,
1998); however, one investigation, Nibuya et al. (1995), reported contradictory 
evidence, indicating that deficit patients evidenced increased HVA levels. It is 
likely that results indicating lower HVA levels (Ribeyre et al., 1994; Thibaut et al.,
1998) provide the most accurate assessment of functioning, as reports of higher 
HVA concentrations (Nibuya et al., 1995) may be biased by inappropriate 
diagnosis of the deficit syndrome (Kirkpatrick et al., 2001). Reduced DA activity 
may provide another compelling explanation for the diminished inner-experience 
of positive emotion noted in deficit syndrome patients. This explanation seems 
plausible considering the relationship between higher DA levels and positive 
affect in healthy individuals (Benninger 1991 ; Phillips, Blaha, Pfaus, & Blackburn,
1992); however, this association has yet to t>e directly tested among deficit 
syndrome patients.
Summary
The deficit syndrome is a putative subtype of schizophrenia. Patients are 
considered to meet criteria for the deficit syndrome if they exhibit a chronic
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presentation of primary negative symptoms that is not due to the effects of 
medication or other psychotic features. The deficit syndrome is characterized by 
a unique etiology not evident in non-deficit patients, as well as specific cognitive 
and neuropsychological deficits. A critical analysis of the emotion processing 
literature also suggests that the deficit syndrome may be uniquely characterized 
by severe positive emotion processing impairments. Unlike non-deficit patients, 
these individuals are typically unable to experience adequate levels of positive 
emotion. They may also demonstrate unique impairments in the perœption of 
positive emotion. Positive emotion processing deficits may be mediated by 
structural and functional brain abnormalities that affect the dorsolateral 
prefrontal-basal ganglia-thalamocortical circuit, as well as hypoactive DA activity. 
Further research is needed to determine whether the deficit syndrome is uniquely 
characterized by pervasive positive emotion processing deficits, and to identify 
the neurological substrates that maintain these impairments.
Affective Impairment in Schizophrenia
Overview
Emotion has been defined in numerous ways throughout the past century. 
Some researchers describe emotion as adaptive fijnctions that have allowed for 
individual survival throughout the evolutionary process (Plutchik, 1980; Izard, 
1971). Others regard emotion as dimensions or states of consciousness 
(Tellegen, 1985), complex interactions of self-concept and the environment 
(Arnold, 1960), products of cognitive arousal and the appraisal of the situation
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that elicited that arousal (Schacter, 1966), and principal motivational systems that 
influence cognition and action (Tomkins, 1962). These views are seen as 
complimentary, with each theory representing different aspects of emotion.
Current theories classify emotion according to either valence-arousal 
(Russell, 1980; Russell & Feldman Barrett, 1999) or discrete basic emotion 
models (Ekman, 1992; Izard, 1991; Turner & Ortony, 1992). The valence-arousal 
school of thought holds that emotions can be plotted as points within a two- 
dimensional space, with axes representing level of arousal (high and low) and 
valence (positive vs. negative affect) (Russell, 1980). The two-dimensional model 
has been replicated in numerous studies using self-report data (Feldman Barrett 
& Russell, 1999), and supported by some neuropsychological investigations (Lee 
et al., 2004). The opposing view suggests that discrete emotions exist within 
broader positive-negative classifications. This basic emotion model posits that a 
set of universally experienced emotions exist, each possessing unique 
physiological arousal patterns, behavioral expressions, and cognitive correlates 
(Ekman, 1992). Researchers have identified both discrete negative (e.g., disgust, 
sadness, fear, anger) (Ekman, 1992; Izzard, 1991) and positive (e.g., joy, 
surprise, love, contentment) (Fredrickson & Branigan, 2001) emotions that meet 
these characteristics.
Regardless of how one defines emotion, the ability to experience, express, 
and perceive emotion is undeniably important. Without the ability to experience 
emotions like happiness, sadness, fear, and guilt, existence would be limited to 
simple instincts and reflexes, mere actions and reactions that would determine
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major life functions. In several psychiatric disorders, emotional experience is 
known to be abnormal, with some disorders evidencing a reactive affective 
experience (e.g., anxiety), and others possibly not even experiencing some or 
any emotions at all (e.g., alexithymia). Although both abnormalities result in 
significant distress, it is the later that is hypothesized to have more severe social 
consequences, which is possibly the case with persons with schizophrenia.
Until recently, relatively little research has investigated cognitive and 
neurobiological bases of affective disturbances in schizophrenia. Recent studies 
have indicated that persons with schizophrenia evidence impairment in 
expressing and experiencing emotion (Berenbaum & Oltmanns, 1992; Dworkin et 
al., 1993; Eamstet al., 1996; Kring & Eamst, 1999; Kring, Kerr, Smith, & Neale,
1993), identifying emotional facial expressions (Archer et al., 1994; Bellack et al., 
1996; Loughland, Williams, & Gordon, 2002a; Loughland, Williams, & Gordon, 
2002b; Sachs et al., 2004; Schneider et al., 1995; Gaebel & Wolwer, 1992; 
Mandai, 1967, 1996; van derGaag & Haenen, 1990; Wolwer et al., 1996; Kohler 
et al., 2000; Edwards, Pattison, Jackson, & Wales, 2001), differentiating affective 
speech productions (Billenber & Johnson, 1965; Bozikas, Kosmidis, Anezoulaki, 
Giannakou, Karavatos, 2004; Edwards et al., 2001; Fricchione, Sedler, & Shukla, 
1966; Jonsson & Sjostedt, 1973; Murphy & Cutting, 1990), integrating audio­
visual emotion productions (de Gelder et al., 2005), judging the pleasantness of 
common odors (Crespo-Facorro et al., 2001; Doop & Park, 2006; Hurdy et al., 
2002; Moberg et al., 2003), recalling emotionally laden information (Calev, 1996; 
Calev & Edelist, 1993; Koh, Grinker, Marusarz, & Forman, 1981; Matthews and
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Barch, 2004), and automatically processing emotional words (Epstein et al.,
1999; Fear et al., 1996; Suslow, Roestel, Droste, & Arolt, 2003). Affect 
impairment has been noted for both positively and negatively valenced material, 
with the majority of research suggesting that deficits are more severe for positive 
emotion processing. Although it is well-documented that certain neurological 
processes are crucial for normal experience of positive emotion (i.e., normal 
dopamine and left hemisphere activity), and that these brain regions are impaired 
in schizophrenia, it is unknown whether neurological impairments result in 
widespread (i.e., experience, expression, perception, cognition) disturbance 
related to positive emotion, and how such abnormalities are associated with 
clinical characteristics of schizophrenia. The current section discusses emotion 
processing impairments in individuals with schizophrenia, and contrasts those 
deficits with performance of healthy individuals. Specific attention is given to 
studies investigating negative symptoms of schizophrenia, particularly those 
making distinctions between deficit and non-deficit schizophrenia.
Affect Expression and Experience
Although schizophrenia has been characterized by positive and negative 
symptoms (Andreasen, 1999), neurocognitive abilities have been more recently 
identified as core features of the disorder (Antonova, Sharma, Morris, & Kumari, 
2004), so much so that some have suggested neurocognitive variables be used 
to develop subtypes of schizophrenia (e.g., Turetsky et al., 2002). Recent 
research has also provided evidence confirming the presence of emotional 
disturbances (Berenbaum & Oltmanns, 1992; Knight & Roff, 1985; Kring, Kerr,
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Smith, & Neale, 1993), leading some to suggest that affective disturbances too 
should be considered core features of the disorder (Kring et al., 1993).
Clinical observations provided the impetus for investigations into the 
affective abnormalities in schizophrenia, as clinicians have historically noted that 
patients evidence an inability to express affect through facial and vocal channels 
(Bleuler, 1950; Kraepelin, 1911). Both Kraepelin (1856-1926) and Bleuler (1857- 
1939) proposed that affective disturbances are central to schizophrenia 
symptomatology, and considered features like delusions and hallucinations 
secondary to emotion processing deficits. Although clinicians and researchers 
alike agree that emotional abnormalities are central to schizophrenia, debate 
exists regarding the nature of these deficits.
Bleuler (1911, 1950) is credited with proposing a model focusing on the 
presence of an expressivity deficit. Through clinical observation, Bleuler noted 
that patients were typically unable to produce adequate displays of affect. 
Although these deficits appeared to be pervasive, affecting both facial and vocal 
expressions, patient’s self-reported descriptions of inner-experience were often 
inconsistent with their observable expressions. That is, although outward facial 
and vocal affective displays were blunted, patients often reported experiencing a 
wide-range of emotions, despite t»eing unable to express them.
In contrast to Kraepelin (1911) and Bleuler (1950), other clinicians 
suggested that deficits in affective expression result from an inability to 
experience emotion (Rado, 1953). In this sense, Rado (1953) suggested that the 
inability to outwardly express emotion accurately reflects the inner-experience of
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persons with schizophrenia. He particularly thought this true of pleasurable 
affective experiences, and posited that the inability to experience positive affect 
(e.g., joy, affection, pride, interest) was a core deficit of the disorder; however, 
the experience of negative affect (e.g., sadness, fear) was proposed to be intact.
Schizophrenia researchers have focused on elucidating affective 
experience and expression deficits both in conjunction and individually. In the 
current section, discussion of both study types is condensed to provide a clearer 
exploration of valence related deficits. In facial affect expression studies, 
participants are typically asked to view a short film clip, while their facial 
movements are recorded using video tape and/or electromyography (EMG). In 
the former technique, facial actions are coded using standardized systems aimed 
at monitoring affect displays, and in the later, electrodes are placed on the 
participant’s face and muscle activity is recorded for relevant sites (e.g., eyes, 
brow, comers of mouth). Studies examining t>oth experience and expression use 
a combination of the aforementioned procedures. In these studies, mood is 
typically induced via emotional film clips or social role-play, and participant inner- 
experience and facial activity are simultaneously monitored using self report 
methods (e.g., questionnaires, arousal while viewing film clip) and facial 
recording techniques (e.g., video-recording, EMG), respectively.
Disturbances in facial affect expression are perhaps the most well- 
delineated emotional impairments evidenced by individuals with schizophrenia. 
Results of multiple studies consistently suggest that individuals with 
schizophrenia are deficient in producing expressions of facial affect, both while
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viewing mood induction stimuli (e.g., film clips) (Berenbaum & Oltmanns, 1992; 
Dworkin et al., 1993; Earnst et al., 1996; Kring & Earnst, 1999; Kring, Kerr,
Smith, & Neale, 1993; Kring & Neale, 1999) and while engaged in social 
interaction (Aghevli, Blanchard, & Horan, 2003; Krause, Steimer, Sanger-Alt, & 
Wagner, 1989; Mattes, Schneider, Heimann, & Birbaumer, 1995). Deficits have 
typically been discussed in relation to overall emotional expression (i.e., 
collapsing both positive and negative emotions); however, a closer look at results 
from previous studies suggests that impairments may be more severe, and 
perhaps selective to, positive emotions.
All studies reporting valence-specific deficits have indicated that patients 
evidence more severe impairments in positive affect expression. These deficits 
may be mediated by distinct physiological abnormalities. For example, patients 
display significantly fewer zygomatic (lower face) facial movements than orbicular 
movements (upper face) while viewing positively valenced film clips. (Kring, Kerr, 
Smith, & Neale, 1993; Eamst et al., 1996) Similar deficits have been reported in 
social contexts, where positive affect expression is related to fewer movements 
of the lower face in comparison to controls (i.e., less zygomatic activity/smiling) 
(Mattes et al., 1995; Aghevli, Horan, & Blancahrd, 2003). These deficits do not 
appear to be due to medication effects, as patient response is reported to be 
equally diminished during medicated and unmedicated states (Eamst et al.,
1996). Additionally, deficits may be unique to positive affect, as patients evidence 
normal or perhaps greater facial activity (particularly around the brow) than 
controls while viewing negative film clips (Mattes et al., 1995). These findings
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may suggest that positive affect expression deficits are a core characteristic of 
schizophrenia.
Deficits in emotional expression are not limited to facial display. Studies 
also suggest that the vocal production of emotion is disrupted in schizophrenia 
(Cohen & Docherty, 2004; Docherty, 1996; Docherty et al., 1994, 1998; Rosen, 
Welkowitz, Sobin, & Borod, 1989). In these studies, participants are typically 
required to produce a speech sample that consists of reading aloud a positively 
or negatively valenced paragraph. During this procedure, vocal recordings are 
made, and later analyzed for the number of communication errors (e.g., 
ambiguous words, errors in reference) produced for differently valenced 
passages, under stressful or nonstressful conditions. Impairment on measures 
of affective reactivity have been noted in several studies of schizophrenia (Cohen 
& Docherty, 2004; Docherty, 1996; Docherty et al., 1994, 1998), suggesting that 
the ability to produce effective verbal communication is impaired when patients 
are asked to read emotionally valenced material aloud. Deficits may be most 
marked for emotionally negative speech, as communication errors are greatest 
during these conditions (Cohen & Docherty, 2004).
Vocal intonation has also been found to be abnormal in patients with 
schizophrenia. Rosen et al. (1989) investigated the speech of patients and 
controls while reading a neutrally valenced passage, and later measured the 
acoustical properties of that speech (e.g., rate, fundamental frequency) to 
determine whether speech patterns differentiated groups based upon 
symptomatology. It was demonstrated that patients evidencing flat affect
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maintain a distinct pattern of speech not found in healthy individuals. While 
reading emotionally neutral material, vocal correlates of flat affect included a 
lower percentage of total talking time, shortened utterances, and lengthened 
pauses. Additionally, these acoustic correlates were predictive of flat affect in 
schizophrenia, but not other clinical groups. These findings implicate the role of 
brain structures known to be associated with negative symptoms in the vocal 
production of flat affect.
Due to the consistency of observed deficits in affect expression, clinicians 
and researchers alike have posed the question: Does diminished emotional 
expression signify that individuals with schizophrenia have diminished emotional 
experience? Several studies have attempted to address this question. Results of 
multiple investigations suggest a disjunctive relationship between affective 
expression and experience in which persons with schizophrenia show equal, or 
perhaps greater, emotional experience than healthy controls, despite producing 
significantly less affective expressions (Aghevli, Blanchard, & Horan, 2003; 
Berenbaum & Oltmanns, 1992; Kring et al., 1993; Kring & Neale, 1996; Earnst & 
Kring, 1999).
When emotional experience is evaluated independently in relation to 
valence, results suggest that pereons with schizophrenia experience emotion 
equally to controls (Aghevli, Blanchard, & Horan, 2003; Berenbaum & Oltmanns, 
1992; Eamst & Kring, 1999; Kring et al., 1993; Kring & Neale, 1996; Mykin- 
Germeys, Delespaul, deVries, 2000). In fact, several studies suggest that 
patients experience negative affect more intensely than controls (Aghveli et al..
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2003; Kring & Neale. 1996; Mykin-Germeys, et al., 2000). Patients also appear to 
experience positive emotions equally to controls (Aghevli, Blanchard, & Horan, 
2003; Berenbaum & Oltmanns, 1992; Kring et al., 1993; Kring & Neale, 1996); 
however several studies suggest that this finding may significantly differ among 
patients experiencing negative psychotic symptoms, as these individuals typically 
experience significantly less positive emotion than controls and patients who are 
not exhibiting severe negative symptomatology (Earnst & Kring, 1999; Horan & 
Blanchard, 2003; Mykin-Germeys, et al., 2000).
Suslow, Roestel, Ohrmann, and Arolt (2003) compared the self-reported 
experience of multiple discrete emotions among patients experiencing negative 
symptoms (flat-affect, anhedonia), patients not experiencing negative symptoms, 
and healthy controls. Results suggest that patients experiencing negative 
symptoms report experiencing significantly less positive emotions (i.e., joy, 
interest, surprise) than controls and patients without negative symptoms. 
Additionally, healthy controls experienced significantly less negative emotions 
(e.g., fear, sadness, contempt, disgust) than patients with schizophrenia, 
regardless of psychotic symptomatology. These findings suggest that 
schizophrenia characterized by negative symptoms may uniquely result in an 
inability to experience positive emotions.
However, studies classifying patients into deficit and non-deficit forms of 
schizophrenia are mixed regarding whether patients with primary negative 
symptoms display a selective impairment in experiencing positive emotion, or 
even a diminished capacity to experience emotion at all. In comparison to non­
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deficit patients, deficit syndrome patients have been found to report lower levels 
of trait positive affect (Horan & Blanchard, 2003) and higher levels of physical 
anhedonia (Kirkpatrick & Buchanan, 1990; Herbener, Harrow, & Hill, 2005; Loas 
et al., 1996). These findings are consistent with a diminished capacity to 
experience positive emotion. However, impairments have also been noted in 
relation to negative emotions, as deficit patients have received less severe 
ratings on clinical scales measuring negative emotions, such as anxiety, guilt, 
and hostility (Kirkpatrick et al., 1993; Subotnik et al., 2000; Tek et al., 2001). 
Subotnik (2000) also found evidence for a diminished capacity to experience 
negative emotions, as indicated by decreased scores for MMPI variables related 
to emotional distress, such as anxiety, suspiciousness, and social distress. 
Additionally, despite significant cognitive, social and occupational impairments, 
deficit patients do not appear to be at higher risk for developing depression 
(Fenton & McGlashan, 1994; Kirkpatrick et al., 1996; Loas et al., 1996). In fact, 
deficit patients are not only at decreased risk for major depression, but also six 
times less likely to have suicidal ideation or behavior than non-deficit patients 
(Fenton & McGlashan, 1994).Experimental paradigms also suggest that deficit 
syndrome patients experience a reduced capacity to experience negative 
emotions, as they have been found to experience lower levels of stress during 
mood induction procedures paradigms (Cohen & Docherty, 2004; Cohen et al.,
2003). Together, these findings appear generally consistent with the notion that 
deficit syndrome patients report a diminished experience of both positive and 
negative emotion. However, contrary findings have been reported, as Earnst and
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Kring (1999) found that deficit patients did not report experiencing less positive or 
negative emotion for film clips. Horan and Blanchard (2003) also failed to find 
differences in trait negative affect using a self-report questionnaire, despite 
finding diminished trait positive affect. Discrepant findings may be due to 
differences in affective measurement. In Earnst and Kring's (1999) study, which 
failed to find diminished experience, affective experience was measured in 
relation to momentary state experience. Studies finding diminished emotional 
experience in deficit patients, as well as Kirkpatrick et al.’s (1989) clinical criterion 
of reduced emotional range for a period of 1-year, point to enduring trait deficits 
in emotional experience. Thus, it is possible that the diminished capacity for 
emotional experience found in deficit syndrome patients may t>e specific to trait 
emotional experience.
Aberrant neurotransmitter systems may also contribute to the diminished 
emotional range reported to occur in the deficit syndrome. In healthy individuals, 
higher dopamine (DA) levels have been associated with greater experience of 
positive affect and reward (see Ashby, Isen, & Turken, 1999 for a review ). 
Although schizophrenia is typically characterized by higher levels of DA activity, 
recent evidence suggests that the deficit syndrome may be uniquely associated 
with lower brain DA levels. Lower levels of the DA metabolite, homovanilic acid 
(HVA), have been reported by multiple investigations (Ribeyre et al., 1994; 
Thibaut et al., 1998); however, one investigation, Nibuya et al. (1995), reported 
contradictory evidence, indicating that deficit patients evidenced increased HVA 
levels. It is likely that results indicating lower HVA levels (Ribeyre et al., 1994;
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Thibaut et al., 1998) provide the most accurate assessment of functioning, as 
reports of higher HVA concentrations (Nibuya et al., 1995) may be biased by 
inappropriate diagnosis of the deficit syndrome (Kirkpatrick et al., 2001).
Reduced DA activity may provide another compelling explanation for the 
diminished inner-experience of positive emotion noted in deficit syndrome 
patients. This explanation seems plausible considering the relationship between 
higher DA levels and positive affect in healthy individuals (Benninger 1991; 
Phillips, Blaha, Pfaus, & Blackburn, 1992); however, this association has yet to 
be directly tested among deficit syndrome patients.
In sum, findings are generally consistent with Kirpatrick et al.’s (1989) original 
conceptualization of the deficit syndrome, which considers diminished emotional 
range to be a core symptom of the condition; however, additional studies are 
needed to determine whether deficit syndrome patients display a generalized 
diminished capacity to experience emotion, or a positive emotion specific 
impairment that is similar to patients with general negative symptoms of 
schizophrenia. It will also be important to determine whether differences exist 
between state and trait experience of positive and negative emotions, 
considering that findings to date are consistent with trait, but not state 
impairments. The current study attempts to fill some of these needs by examining 
both state and trait emotional experience in relation to a range of positive and 
negative emotions.
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Facial Affect Processing
Researchers have also investigated whether affective disturbances extend 
to emotional perception in patients with schizophrenia. The majority of these 
studies have examined the perception of facial affect. In healthy individuals, a set 
of discrete emotional faces have been found to be highly recognizable across 
genders and cultures (Ekman & Friesen, 1975). These universally identified 
emotions typically include; happiness, surprise, sadness, anger, fear, disgust, 
and possibly contempt (Ekman & Friesen, 1975). The ability to discriminate 
among these emotions is present in infancy (Ludemann, 1991; Soken & Pick,
1999), and typically an automatic task for healthy adults. However, facial affect 
identification may differ between genders, and among individual emotions.
Recent research suggests that women are more accurate in perceiving facial 
affect than men, and that both genders are more accurate at identifying 
happiness and surprise faces (i.e., positively valenced faces) than neutral or 
discrete negative emotions (e.g., sadness, anger, disgust) (Hall & Matsumoto, 
2004). Accurate facial affect perception is thought to be critical to the 
development of normal social fanctioning (Leppânen & Hietanen, 2001), and may 
be a core feature of social skills deficits found in several psychiatric disorders 
(Brozgold et al., 1998).
Over 30 published studies have indicated that persons with schizophrenia 
evidence impairment in facial affect recognition, discrimination, or matching (for 
reviews see Kohler & Brennan, 2004; Edwards, Jackson, & Pattison, 2002). 
Results are inconclusive regarding whether perceptual deficifa differ in relation to
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valence, as some studies indicate significant deficits in processing happy faces 
(Archer et al., 1994; Bellack et al., 1996; Loughland, Williams, & Gordon, 2002a; 
Loughland, Williams, & Gordon, 2002b; Phillips et al., 1998; Sachs et al., 2004; 
Schneider et al., 1995 ), while several others report intact positive emotion 
identification and significant impairment for negative faces, especially fear 
(Gaebel & Wolwer, 1992; Johnson, Emde, Scherer, & Kilnnert, 1986; Mandai, 
1987, 1998; van derGaag & Haensen, 1990; Wolwer et al., 1996; ) and sadness 
(Kohler et al., 2000; Loughland, Williams, & Gordon, 2002, 2003; Edwards, 
Pattison, Jackson, & Wales, 2001). Variability in findings may be due to several 
factors, including methodological variables, medication status, and symptom 
profiles (i.e., presence or absence of negative symptoms) (Edwards, Jackson, & 
Pattison, 2002).
Although findings are variable regarding which facial expressions are 
processed abnormally, studies consistently indicate that deficient cognitive 
abilities contribute to affect perception deficits. Several studies have found that 
facial affect impairments are correlated with the cognitive abilities of abstraction- 
flexibility, selective attention, sustained attention, verbal memory, visual 
organization, and language ability (Bryson, Bell, & Lysaker, 1997; Horan & 
Blanchard, 2003; Kohler et al., 2000; Sachs et al., 2004; Schneider, Gur, Gur, & 
Shtasel, 1995; Silver & Shlomo, 2001). Research by Allen, Strauss, Gilbertson, & 
van Kammen (unpublished manuscript) suggests that these relationships may 
differ in relation to the processing of positive and negative faces. Specifically, 
negative affect labeling is predicted by attention switching/executive functioning.
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as well as disorganization, thought disorder, and anergia. Positive affect labeling 
was not found to significantly correlate with neurocognitive or symptomalogical 
variables. These results suggest that cognitive deficits may differentially 
determine the nature of affect perception impairments in individuals with 
schizophrenia.
Recent eye-tracking research also indicates that positive and negative 
affect identification deficits are maintained by separate neurocognitive 
mechanisms. Results from several studies suggest that patients evidence 
differences in visual-scanning for happy and sad faces (Loughland, Williams, & 
Gordon, 2002a; Loughland, Williams, & Gordon, 2002b). Specifically, individuals 
with schizophrenia display a restricted scanning pattern for happy faces, where 
they fixate upon isolated and irrelevant facial regions (e.g., nose, ears, hair), and 
fail to attend to informative aspects of the face (i.e., eyes, mouth, brow). Negative 
affect processing facilitates a much wider visual scanning behavior, as patients 
typically attend to multiple facial regions, including those that are most 
informative. Additionally, in each of the studies conducted by Williams et al. 
(2002ab), patients only differed from controls in their ability to identify positive 
emotions. This may suggest that difficulties in identifying positive faces are 
uniquely associated with a failure to attend to relevant facial features (Williams et 
al., 2002a). As studies investigating visual scanning did not find impairments 
relative to negative emotions, it is possible that alternate cognitive systems 
underlie those deficits.
39
Positive and negative symptoms of schizophrenia may also influence the 
perception of facial affect. Patients with paranoid schizophrenia have been found 
to exhibit better overall facial affect recognition than non-paranoid patients and 
seem particularly good at identifying negative emotions, including anger, fear, 
disgust, and sadness (Kline, Smith, & Ellis, 1992). A small body of evidence also 
suggests that deficit syndrome patients are particularly deficient at perceiving 
emotional faces. Bryson et al. (1998) investigated facial affect identification in a 
sample of deficit and non-deficit patients using video-taped vignettes designed to 
represent 7 basic emotions. Results suggest that deficit patients were 
significantly poorer than non-deficit patients at recognizing the emotions of 
sadness, disgust, surprise, and neutral. Although impairment was noted for both 
positively and negatively valenced faces, deficits noted for recognition of surprise 
are of particular interest, considering that this emotion is typically identified with 
high accuracy among controls and non-deficit patients alike. Contrary findings 
were reported by Horan and Blanchard (2003), who failed to find differences in 
facial affect identification between deficit and non-deficit patient groups; however, 
these findings should be viewed with caution, since emotions in this study were 
collapsed into a general “emotional” category. Such procedures may preclude 
the observation of noticeable differences by compounding variance across 
multiple emotional conditions. These studies suggest that schizophrenia 
characterized by negative symptoms is more strongly associated with facial 
affect recognition deficits compared to schizophrenia characterized by paranoia 
and possibly positive symptoms.
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Collectively, these findings suggest that facial affect identification deficits 
may be mediated by several variables, particularly neurocognition and psychotic 
symptoms. Although valence-specific deficits have been inconsistently found in 
schizophrenia, the identification of positive and negative emotions appears to be 
maintained by separate neural mechanisms. Further research is needed to 
determine the nature of these mechanisms in relation to discrete facial emotion 
identification, and to examine whether individual emotions are differentially 
influenced by symptom presentation.
Olfactory Affect Perception
Adequate olfactory processes are thought to have significant survival value, 
as they are one of our primary windows to the environment (Ache, 1991). That is, 
smell identification allows us to both avoid things that would be harmful to the 
body and consume things that would be beneficial (Scott & Giza, 2000). Although 
the process of assigning an affective label of “pleasant” or “unpleasant” to a smell 
seems relatively straightfonward, it likely involves a complex emotional appraisal 
that calls upon emotional memory networks. Several brain regions are thought to 
underlie complex processes involved in smell perception, including the orbito 
prefrontal cortex, medial-temporal gyrus, and thalamus. Interestingly, these 
regions are also central to normal emotion processing, particularly for positive 
emotions (Thorpe et al., 1983). Given that the aforementioned regions have been 
consistently implicated in the neuropathophysiology of schizophrenia (see 
Antonova et al., 2004), researchers have recently begun investigating the 
relationship between olfaction and emotion (Moberg et al., 2003).
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Several studies have found smell Identification Impairment In persons with 
schizophrenia (Brewer et al., 1996; Good et al., 1994; Hunvltz et al., 1988; Kohler 
et al., 2001; Kopala et al., 1989, 1992, 1994; Malaspina et al., 1994, 2003; 
Moberg et al., 2003; Seldman et al., 1992; Warner et al., 1990). Deficits extend to 
all aspects of olfactory perception. Including quality discrimination, detection 
threshold (I.e., sensitivity), and odor recognition (see Rupp, 2003 for review). 
Impairments do not appear to be due to the Influence of gender (Koapla et al.,
1994), smoking behavior (Moberg et al., 2003), and medication (PInkhas et al.,
1999), nor do they reflect the presence of a general sensory Impairment (Kopala 
et al., 1995). However, researchers have recently found relationships between 
smell Identification deficits (SID) and neurocognltlve functioning. SID In 
schizophrenia have been related to verbal abilities (Malapina & Coleman, 2003), 
executive functioning (Saoud et al., 1998; Stedman & Clair, 1998), and 
attention/processing speed (Goudsmit et al., 2004). Separate relationships have 
been noted In deficit syndrome patients (I.e., patients with severe negative 
symptoms), who tend to evidence more significant Impairments than non-deficit 
patients In smell identification (Goudsmit et al., 2004; Malaspina et al., 2001; 
Seckllnger et al., 2002). Relationships noted in deficit patients Involve 
visuospatlal processes, such as visual-motor processing speed (Goudsmit et al.,
2004), eye movements (Malaspina et al., 2001), and visuomotor organization 
(Seckllnger et al., 2002). This pattern of correlations Is consistent with both a 
frontal and parietal dysfunction within deficit syndrome patients (Seckllnger et al.,
2002).
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Considering overlap between neural circuits involved with emotion processing 
and olfaction, researchers have recently attempted to determine whether 
Individuals with schizophrenia are Impaired at recognizing olfactory valence. In a 
comprehensive assessment of olfactory perception, Hurdy et al. (2002) found 
that patients were more deficient than controls at several olfactory processes, 
Including the assignment of pleasantness ratings. Similarly, Moberg et al. (2003), 
found patients to be Impaired at rating pleasant stimuli, despite being nearly 
Identical to controls with regard to Intensity judgment. These findings were 
supported by Crespo-Facorro et al. (2001) who furthered results of behavioral 
studies by Identifying neural systems Involved with pleasantness judgments 
using positron emission tomography. In this study, patients and healthy 
comparison subjects were not found to differ In Intensity ratings; however, they 
did evidence differences In judging the valence of pleasant smells. These deficits 
were associated with aberrant prefrontal cortex and limbic system activation. 
Doop and Park (2006) also found schizophrenia patients to display abnormal 
pleasantness judgments, and reported that these abnormalities are correlated 
with negative symptoms, such that more severe flat affect was associated with 
more aberrant hedonic judgment.
Although relatively few studies have Investigated the nature of olfactory affect 
perception In schizophrenia, results from initial studies suggest that patients may 
be particularly deficient at processing positively valenced smells and that these 
Impairments may be more severe In patients with negative symptoms. Further 
research Is needed to determine whether positive affect Impairments are more
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pronounced in deficit syndrome patients, who tend to have more severe olfactory 
impairment in general (Goudsmit et al., 2004; Malaspina et al., 2001; Seckllnger 
et al., 2002). The current study attempts to address this need by examining both 
accuracy and valence judgments for pleasant and unpleasant odors In deficit and 
non-deficit schizophrenia.
Memory for Affective Information
Memory processes are critical for normal emotional functioning. A large 
body of research has Investigated recall and recognition memory for affectively 
valenced Information In healthy Individuals. Results from numerous studies have 
shown that healthy Individuals evidence Increased memory performance for 
positive Information In free recall and recognition measures of long-term memory 
(Amster, 1964; Barrett, 1938; Bradley, Greenwald, Retry, & Lang, 1992; 
Colombel, 2000; Hayward & Strongman, 1987; LIbukman, Stabler, & OtanI, 2004; 
Lishman, 1972a; Matlln, Stang, Gawron, Freedman, & Derby, 1979; Phelps,
La Bar, & Spencer, 1997; Rychlak & Salurl, 1973). These findings reflect a 
memory bias for positive Information. Matlln and Stang (1978) termed this 
memory bias the Pollyanna Principle, to reflect a general tendency to select 
pleasant Information over unpleasant information, and descrltied the 
phenomenon as resulting from Increased accuracy and efficiency relative to the 
encoding and retrieval of positive Information. With regard to memory, the 
tendency to remember positive Information not only occurs in studies examining 
experimenter generated lists, but also encompassed the recall of daily 
experiences and participant generated-lists (Matlin & Stang, 1978). This
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suggests that the memory bias inherent to positive information is a pervasive 
phenomenon that extends to virtually all facets of emotional memory.
A significant body of research suggests that memory performance is 
impaired In persons with schizophrenia (Paulsen et al., 1995; Randolph et al.. 
1994; Saykin et al., 1991). However, relatively few studies have Investigated 
memory for emotional Information In schizophrenia. In a study conducted by Koh, 
Grinker, Marusarz, & Forman (1981) patients and healthy controls were required 
to first sort a list of words repeatedly, and then to unexpectedly recall those 
words. Results suggest that healthy controls recalled a greater number of 
positive than negative words (I.e., Pollyanna Principle); however, this finding was 
not evident In patients with schizophrenia. Patients showed an overall reduction 
In memory for emotional words In comparison to controls, and relatively equal 
recall for positive and negative words. In the second experiment of Koh et al. 
(1981), patients and controls were asked to make judgments of whether 
emotional faces were pleasant or unpleasant, and later required to perform a test 
of recognition memory. Results were similar to the verbal memory task, as 
controls recognized a significantly higher number of positive than negative faces, 
and patients recognized significantly fewer positive stimuli than controls. 
Additionally, patients recognized a significantly greater numt>er of negative than 
positive faces, potentially signifying that patients have a bias toward recognizing 
negative Information.
Calev (1996) found similar results for verbal Information, as patients 
recalled significantly less emotional words In general, and recalled a greater
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number of negative than positive words. Calev and Edellst (1993) also found that 
patients recall significantly fewer emotional words than controls, and extended 
previous research by finding that negative emotional words were forgotten less 
rapidly after a 2 day delay period. Thus, results are consistent with the notion that 
emotional memory Is Impaired In schizophrenia; however, contrary findings have 
also been reported, where some studies have failed to find differences In 
emotional memory between patients and controls. A recent study conducted by 
Matthews and Barch (2004) failed to find differences between controls and 
persons with schizophrenia in verbal recall and recognition tasks. In this study, 
patients and controls were asked to rate words based upon arousal, and 
subsequently tested on recall and recognition. Results suggest that patients and 
controls recalled significantly more high-arousal than low arousal words, and 
neither group displayed the Pollyanna effect typically seen In healthy Individuals. 
However, the discrepant findings of Matthews and Barch may be explained by 
methodological factors, as positive and negative words Included likely vary In 
Intensity (but not valence-arousal).
More recently, studies have examined the association between negative 
symptoms and emotional memory impairment, focusing specifically on the 
Influence of anhedonia on recall for emotional events and Information. In a recent 
study conducted by Horan, Green, Kring, and Nuechterlein (2006), patients and 
controls were presented with a series of pleasant and neutral film clips and asked 
to rate their level of emotional experience. After a four hour delay period, they 
were given an unannounced recall task where they were asked to rate how
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pleasant they felt in relation to previously presented stimuli. Results Indicated 
that although substantially anhedonic, patients did not report experiencing less 
positive emotion In the moment, nor did they recall experiencing stimuli as being 
any less pleasant than they did at Initial presentation. These findings appear to 
suggest that positive emotional memory Impairment Is unassociated with 
negative symptoms of schizophrenia. However, somewhat contrary findings have 
been reported by Herbener, Rosen, Khlne, and Sweeney (2007). Herbener et al. 
(2007) presented patients and controls a series of positive, negative, and neutral 
Images, and required participants to Indicate how emotionally Intense each 
Image made them feel. After a 24-hour delay period, an unannounced 
recognition session occurred, where participants Indicated whether they had 
seen each Image on the previous day. By requiring participants to initially focus 
on the Intensity evoked by each stimulus, the paradigm Is thought to assess 
memory consolidation after Initial encoding, and therefore whether pleasant and 
unpleasant emotional experiences have beneficial effects on memory. With 
regard to Initial emotional experience, results Indicated that patients experienced 
both positive and negative Images as being more Intense than controls. 
Recognition findings Indicated that patients were poorest at recognizing positive 
stimuli, whereas controls displayed a bias toward recognizing positive scenes 
more accurately than negative or neutral stimuli. Correlational findings indicated 
that trait anhedonia was significantly correlated with recognition of positive 
images in controls but not schizophrenia patients, suggesting that a failure in the 
memory consolidation process, such that patients are unable to use the
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experience of positive emotion to enhance their memory for emotional 
information. These findings are consistent with the notion that faculty memory 
contributes to symptoms of anhedonia. Contrary findings reported by Herbener et 
al. (2007) and Horan et al. (2006) may be due to several factors. First, Herbener 
et al employed a 24 hour delay, rather than a 4-hour period. It is possible that the 
effects of initial positive emotional experience may only fade in memory after 
significant time delay. Second, Herbener and colleagues used a paradigm that 
examined recognition for emotional information, rather than recall of their initial 
feelings themselves. Thus, differences may indicate that anhedonia is associated 
with reduced memory for positive Information, rather than feelings In and of 
themselves. It Is possible that patients may experience little variability In their 
dally affective lives, and that they subsequently have little difficulty recalling their 
feelings. However, they appear to have difficulty recalling positive Information, 
which may cause higher symptoms of anhedonia by creating difficulty In recalling 
specific events experienced over recent weeks.
Considering that anhedonia has been proposed to be a core symptom of 
deficit syndrome schizophrenia (Kirkpatrick et al., 1996; Loas et al., 2001), it will 
be Important to determine whether faculty memory for positive feelings or 
Information contributes to deficit syndrome symptoms. More specifically, 
considering that deficit patients have been found to display diminished trait 
(Horan & Balnchard, 2003) but not state (Eamst & KrIng, 1999) positive 
emotional experience, studies could examine whether these patients evidence 
Impaired encoding and/or retrieval of positive Information that leads them to
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recall pleasurable experiences as less pleasurable when asked to think back 
over the last few weeks, despite being able to experience normal levels of 
positive emotion In the moment.
Collectively, results from studies Investigating emotional memory In 
schizophrenia suggest that patients 1) remember less emotional Information than 
controls, 2) do not exhibit the same Pollyanna tendency found In healthy 
Individuals, 3) have a bias toward recalling negatively valenced material, and 4) 
have greater Impairment for positive Information when anhedonia Is present. 
However, further research Is needed to determine whether these findings apply 
when patients are presented with multiple discrete emotional categories and 
whether negative symptoms of the deficit syndrome are associated with Impaired 
verbal recall.
Automatic Processing
Recent emotion research has also focused on automatic cognitive 
processes. Cognitive processes are described as automatic when information Is 
processed quickly and without effort (Logan, 1978). The rapid detection of 
emotional Information has been proposed to facilitate survival within the 
environment (Mandler, 1975; Oatley & Johnson-Laird, 1987). Our attentlonal 
system may play a central role In this process, as It has been proposed to 
regulate the process of diverting focus away from goal-directed behavior and 
toward more adaptive functions that promote survival (I.e., fight or flight) during 
times of danger. Several studies have found that threatening Information 
significantly disrupts ongoing cognition In healthy Individuals (McKenna &
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Sharma, 1995, 2004; Myers & McKenna, 1995; Sharma & McKenna, 2001; 
Watts, McKenna, Sharrock, & Trezise, 1986), signifying that human-beings have 
an inherent attentlonal bias for threat.
Interference tasks provide a valid means of assessing disruption caused 
by emotional material. The Emotional Stroop (ES) task has been widely used to 
assess emotional Interference. Similar to Stroop's (1935) original color-naming 
task, the ES task requires participants to Identify the Ink color In which a word Is 
printed, while Ignoring the meaning of a written word. However, rather than 
manipulating color-congruent and Incongruent words, the ES task compares RT 
for emotional and neutral words. The theory behind the ES task states that words 
more related to an Individual’s preoccupations, concerns, or mood state will 
significantly Interfere with the target process (i.e., color-naming), and thereby 
produce longer RTs when compared to neutral words. The ES task has 
consistently demonstrated that healthy Individuals evidence an attention bias for 
threatening Information (McKenna & Sharma, 1995, 2004; Myers & McKenna, 
1995; Sharma & McKenna, 2001; Watts, McKenna, Sharrock, & Trezise, 1986); 
however, several factors may enhance threat detection.
One factor Includes the manipulation of time pressure. It has been 
hypothesized that negative aspects of stimuli are highly Influential during 
situations eliciting time pressure (Wright & Weltz, 1997). McKenna and Sharma 
(2001 ) examined the role of time pressure using an ES task by varying the length 
of Interstimulus Interval (ISI) time (I.e., length of fixation point that separates 
stimuli). Participants were presented with blocks of negative and neutral words at
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ISI lengths of 32, 80, 160, 240, 400, and 1000 ms, to determine whether RT 
differed as a function of ISI length. Results suggest that ISI length (I.e., time 
pressure) Impacted RT, such that Interference effects for negative words were 
significantly greater than for neutral words at the shorter ISI length (e.g., 160 ms). 
Additionally, differences for negative and neutral words were nonsignificant at 
longer ISIs (> 400 ms). These findings have significant Implications for the 
automatic processing of emotional Information, as they suggest that threat stimuli 
presented under time pressure may rapidly redirect attention, potentially enabling 
an organism to prioritize focus and respond more effectively In times of danger 
(Sharma & McKenna, 2001).
Recent research by Strauss and Allen (unpublished manuscrlptc) 
replicated and extended the findings of Sharma and McKenna (2001). Strauss 
and Allen Investigated the Influence of time pressure In relation to multiple 
discrete positive and negative emotions. Results from this study suggest that 
time pressure differentially Impacts discrete emotions. Specifically, negative 
emotions are significantly Interfering only under periods of time pressure, and 
positive emotions only become Interfering In the absence of time pressure. These 
findings suggest that our attentlonal system Is predisposed to automatically 
detect Information that Is most adaptive based upon situational factors. Under 
periods of high time pressure (which ostensibly signifies danger), negative 
emotions are most salient; however, under periods of normal functioning, self­
relevant positive Information grabs attention. Additionally, not all discrete 
negative emotions are Interfering under periods of time pressure. Sadness words
51
produced the most interference under the most time pressure, while anger and 
anxiety words were significantly less interfering than neural words. This may 
suggest that highly threatening information (i.e., anger and anxiety words) by­
passes cortical pathways during processing, and moves quickly to subcortlcal 
structures specialized for threat detection (I.e., amygdala), allowing a faster 
response to the threatening stimuli (LeDoux & Armony, 1999).
Although our Inherent bias for detecting threatening Information may promote 
survival during times of danger, this mechanism may also facilitate psychological 
distress when active in “every-day” situations. Recent research suggests that 
several psychiatric disorders evidence a heightened sensitivity for or 
preoccupation with emotional Information. This heightened awareness Is typically 
referred to as an “attention bias”, and Is proposed to occur in psychiatric 
populations when Individuals encounter environmental Information relevant to 
their unique concerns (Williams, Matthews, & MacLeod, 1996), Attention biases 
have been proposed to occur In several psychiatric conditions. Including: Social 
Phobia (Hope et al., 1990), Obsessive Compulsive Disorder (GOD) (Foa, Hal, 
McCarthy, Shoyer, & Murdock, 1993: Lavy, Oppen, & Van den Hout, 1994),
Panic Disorder (McNally, Amir, Louro, Lukach, Riemann, & Calamari, 1994), 
Mood Disorders (Gotllb & McCann, 1984), and Specific Phobia (Lavy, Van den 
Hout, & Arntz, 1993),
Relatively few studies have examined attention biases In Individuals with 
schizophrenia. Epstein, Stern, and Sllbersweig (1999) presented Individuals with 
schizophrenia with neutral and Inter-personally threatening (e.g., whisper, follow,
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stare) words. Results suggest that interpersonally threatening words significantly 
interfered with color-naming, particularly among paranoid patients. However, 
implications of these findings are limited due to the lack of a control group 
comparison. Since healthy individuals are also known to evidence an attention 
bias for threatening (i.e., general negative) words, interference effects found by 
Epstein et al. (1999) may reflect an attention bias inherent to all individuals; 
however, diagnosis related differences may suggest that paranoid patients are 
uniquely predisposed to detecting threat Findings of Fear, Sharp, & Healy (1996) 
may further delineate the nature of threat detection and symptom profiles. Fear et 
al. (1996) presented individuals with delusional disorder words representing 
sadness, anxiety, and threat in an ES task. Results suggest that individuals with 
delusional disorder evidenced significantly greater interference for threatening 
words in comparison to healthy controls. Additionally, individuals meeting the 
criteria for the non-persecutory delusion subtype showed significantly greater 
interference than controls for sadness and anxiety words. The fact that these 
results were not found in the persecutory delusion group suggests that psychosis 
without paranoid features may also be related to heightened sensitivity for 
sadness and anxiety words
Affective priming tasks provide another means of assessing automatic 
processing. Priming tasks typically require participants to respond to a target 
word that is preceded by a very brief presentation (e.g., 50 ms) of a prime word, 
which is either emotionally congruent or incongruent with the target word. RT for 
the identification of target stimuli serves as the dependent variable. One study
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investigated affective priming for verbal stimuli in schizophrenia (Suslow,
Roestel, Droste, & Arolt, 2003) and found that patients and controls did not 
significantly differ regarding the automatic processing of emotional words. 
However, significant relationships were found between mood state and priming, 
such that priming based upon positive words was positively correlated with 
positive mood, and negatively correlated with negative mood. Based on this 
finding Suslow et al. (2003) suggest that deficits in the automatic processing of 
positive information may contribute to the development of negative emotions in 
schizophrenia In a similar priming paradigm, Suslow et al. (2005) also found that 
negative symptoms were associated with automatic processing impairments for 
positive, but not negatively valenced faces. Thus, findings of Suslow et al. (2003, 
2005) suggest that patients with schizophrenia display significant automatic 
processing impairments, which are associated with both emotional experience 
and negative symptoms.
Research has yet to investigate whether individuals with schizophrenia 
process discrete emotional information abnormally. Considering the high rate of 
depression in schizophrenia (Hegalson, 1990), and significant abnormalities in 
positive emotion processing (Suslow et al., 2003, 2005), it seems relevant to 
investigate attention bias in relation to the processing of multiple discrete 
emotions. Additionally, since negative symptoms of schizophrenia have laeen 
associated with automatic processing abnormalities in relation to positive 
emotions using priming paradigms, additional studies are needed to determine 
whether patients with core, primary negatives symptoms, such as those with the
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deficit syndrome schizophrenia, evidence a failure to have attention automatically 
oriented to emotional information using interference tasks, such as the Emotional
Summary
Normal emotion processing is critical for the development of social skills 
and appropriate social interaction. Clinicians have historically noted that persons 
with schizophrenia evidence an inability to express affect through facial and vocal 
channels. Research suggests that this inability to express emotion may lae most 
severe for the expression of positive affect. However, deficits in expressing 
emotion may not reflect a diminished ability to experience emotion. In fact, 
patients have been shown to experience an equal amount of positive emotion, 
and a significantly greater amount of negative emotion than normal comparison 
samples. Emotional disturbance has also been noted in relation to the perception 
of emotion. Patients are particularly deficient at identifying emotional faces, 
detecting emotional intonation in speech, rememt»ering emotional words, ignoring 
negative emotional information, and integrating audio-visual affective 
productions. Emotional impairments may be most severe for the processing of 
positive emotion. However, deficits have also been noted for negative emotions, 
particularly sadness and fear. A critical analysis of the emotion processing 
literature also suggests that patients with deficit syndrome schizophrenia may be 
uniquely characterized by severe positive emotion impairments. Unlike non­
deficit patients, deficit syndrome patients are typically unable to experience 
adequate levels of emotion in general, and may display a unique impairment in
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experiencing positive emotion. Deficit patients have also been found to 
demonstrate unique impairments in the perception of positive emotion. Several 
additional abnormalities related to the cognitive processing (e.g., attention, 
memory) or perception (e.g., olfaction, face identification), have been associated 
with more severe negative symptoms; however, it has yet to be determined 
whether these impairments also extend to deficit syndrome patients. Positive 
emotion abnormalities may be mediated by structural and functional brain 
abnormalities that affect the dorsolateral prefrontal-basal ganglia-tiialamocortical 
circuit, as well as hypoactive DA activity. Further research is needed to 
determine whether the deficit syndrome is uniquely characterized by pervasive 
positive emotion processing deficits, and to identify the neurological substrates 
that maintain these impairments.
Hypotheses
The current investigation attempts to answer 3 major questions regarding 
affective disturbance in deficit and non-deficit syndrome schizophrenia: 1) Do 
deficit patients, non-deficit patients, and controls differ with regard to emotional 
experience? 2) Do deficit patients, non-deficit patients, and controls differ with 
regard to the perception of emotional information? 3) Do deficit patients, non­
deficit patients, and controls differ with regard to the cognitive processing of 
emotional information?
Based upon previous research indicating that deficit syndrome patients 
experience significantly less positive affect than non-deficit patients and healthy
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controls (Horan & Blanchard, 2003; Suslow et al., 2003), It Is hypothesized that 
deficit and non-deficit syndrome patients will differ with regard to self-reported 
emotional experience. Specifically: 1) individuals meeting criteria for deficit 
syndrome will report experiencing significantly less positive emotion than non­
deficit patients and healthy controls, and 2) deficit syndrome patients will indicate 
experiencing negative emotion equally to non-deficit patients, and significantly 
more than controls.
Based upon previous research indicating that deficit syndrome patients 
are impaired at perceiving facial expressions of surprise (Bryson et al., 1998), it 
is hypothesized that deficit syndrome patients will be more impaired than non­
deficit patients and healthy controls at identifying positive emotional expressions. 
Additionally, healthy controls will conform to the Pollyanna Principle and identify 
positive faces more accurately and efficiently (quickly) than discrete negative 
emotions, and deficit and non-deficit syndrome patients will evidence positive 
emotion processing impairments. However, impairments will be significantly more 
severe among individuals meeting criteria for the deficit syndrome (i.e., slower 
RTs and poorer accuracy).
Consistent with previous research indicating that deficit syndrome patients 
evidence more severe olfactory impairment than non-deficit patients (Goudsmit 
et al., 2004; Malaspina et al., 2001; Seckllnger et al., 2002), it is hypothesized 
that deficit syndrome patients will have poorer smell identification than non-deficit 
patients and healthy controls. Additionally, considering that patient deficits are 
known to be more severe for pleasant smells (Crespo-Facorro et al., 2001; Hurdy
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et al., 2002; Mober et al., 2003), it is hypothesized that deficit and non-deficit 
syndrome patients will t>e poorer than controls at recognizing pleasant smells. 
Furthermore, the recognition of pleasant smells is expected to be more severe 
for deficit than non-deficit patients.
Based upon previous research indicating that individuals with 
schizophrenia evidence impaired memory for positive emotional words (Calev, 
1996; Calev & Edellst, 1993; Koh et al., 1981), it is hypothesized that deficit and 
non-deficit patients will recall significantly less happiness words than healthy 
controls. Impairments in positive emotional memory are expected to l>e more 
pronounced for deficit than non-deficit groups, while healthy controls are 
expected to display a Pollyanna tendency consistent with previous research 
(Matlin & Stang, 1978).
Based upon previous research indicating that persons with schizophrenia 
are impaired at automatically processing positive information (Suslow et al., 
2003), it is hypothesized that deficit syndrome patients will display less of an 
attention bias for happiness than using the Attention Grabbing Task, non-deficit 
patients and controls (i.e., deficit patients will have significantly shorter RTs for 
happiness).
Additionally, consistent with evidence suggesting that individuals with 
schizophrenia have a greater attention bias for threatening material than controls 
(Epstein et al., 1999; Fear et al., 1996), it is hypothesized that both deficit and 
non-deficit patients will display a greater lingering effect for negative words ttian 
controls (i.e., deficit and non-deficit patients will have longer difference scores for
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negative words). Deficit patients are not expected to differ from non-deficit 
patients regarding lingering effects for negative words, as previously research 
indicates that both patient groups experience similar levels of negative emotion, 
which are considerat>ly higher than controls (Earnst & Kring, 1999; Horan & 
Blanchard, 2003). Additionally, no differences are expected among groups with 
regard to lingering effects for positive or category conditions, as research on 
healthy individuals has found these conditions incapable of rendering the 
lingering effect on the attentional system (McKenna & Sharma, 2005).
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CHAPTER 3
METHODOLOGY
Participants
Data was collected from two participant groups; 1) 41 patients meeting 
DSM-IV-TR criteria for schizophrenia, and 2) 22 psychologically and 
neurologically healthy controls. Participants were selected for inclusion in the 
patient group if they met criteria for current Axis-1 diagnosis of schizophrenia. The 
healthy control group consisted of individuals with no lifetime diagnosis of 
schizophrenia, current Axis-1 psychiatric disorder, or history of neurological 
conditions. Exclusionary criteria for individuals with schizophrenia induded: 1) 
English as a second language; 2) history of traumatic brain injury or any other 
medical condition or neurological disease/damage that could cause cognitive 
deficits (e.g., seizure disorder. Parkinson’s disease); 3) history of alcohol or drug 
abuse or dependence diagnosis within the past six months; 4) current DSM-IV 
Axis I condition other than schizophrenia; 5) diagnosis of mental retardation or 
other cognitive dysfunction; 6) use of prescrilaed or over-the-counter medications 
that could produce significant cognitive effects, other than those medications 
used to treat schizophrenia. In addition to the aforementioned criteria, 
exclusionary criteria for the control group also included: 1) current use of 
psychotropic medication, 2) corrected vision greater than 20/50 (determined
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using a standard wall-chart), 3) biological familial relation to an individual with 
diagnosed or suspected psychosis (as determined through standardized 
interview with the control subject).
Deficit syndrome classification was then applied to patients using the 
Schedule for the Deficit Syndrome (SDS) rating scale. This classification resulted 
in identification of 15 deficit and 26 non-deficit syndrome patients. Patient and 
control groups were matched on age and education, as these demographic 
variables are known to effect cognitive functioning. Basic demographic data are 
presented for deficit, non-deficit, and control participants in Table 1.
Considering the importance of establishing that deficit syndrome patients 
included in the current study were similar to those identified in the research 
literature, deficit and non-deficit patients were evaluated on clinical and 
demographic variables that are recommended for comparison by the SDS 
authors. In line with these recommendations, deficit and non-deficit patients did 
not differ on length of illness, age of onset, medication dosage, extrapyramidal 
symptoms (see Table 4), or severity of positive symptoms (see Tables 5 and 7). 
The deficit group also had a higher percentage of male than female participants 
(see Table 1), received lower ratings on BPRS scales for suspicion and 
emotionality (depressed mood, anxiety, guilt, hostility) (see Table 5), had lower 
premorbid IQ estimates (see Table 1), and less frequent prevalence of current or 
previous marriage (see Table 2). Additionally, none of the deficit patients 
manifested marked disorganization (see Table 5), depressive symptoms (see 
Tables 5 and 6 ), or severe sedation due to the effects of medication. These
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clinical and demographic characteristics are very consistent with specifications 
made by the SDS authors (Kirkpatrick et al., 2001; SDS Manual), and provide 
support for the validity of these patients classified as “deficit syndrome” in the 
current study.
Several additional classification procedures were used to account for 
concerns that the SDS authors have raised regarding establishing intergroup 
reliability within deficit syndrome diagnosis. These procedures were based upon 
recommendations published within the SDS administration manual. First, 
following initial SDS interviews performed by one of 3 trained graduate-level 
researchers, consensus SDS interviews were conducted by the first (G.S.) and 
senior authors (D.A.) to ensure accuracy of deficit classification and symptom 
severity ratings. Consensus ratings were performed on all patients initially 
identified as having the deficit syndrome, or who exhibited significant negative 
symptoms. One-hundred percent deficit/non-deficit classification agreement was 
obtained on all consensus interviews, and patients not identified as deficit 
syndrome were consequently eliminated from the group following consensus 
ratings. Second, treatment providers (psychiatrists, counselors, case managers) 
were consulted and psychiatric charts were reviewed to verify stability of 
symptom presentation and accuracy of primary vs. secondary negative symptom 
distinction. Finally, one of the SDS authors (B. Kirkpatrick) was consulted on 
cases where deficit classification was questionable, and relevant clinical, 
demographic, and historical information were reviewed to assist in making deficit 
diagnosis judgments.
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Procedure
Individuals with schizophrenia were recruited from a local community 
outpatient mental health center (Mojave Adult, Child, and Family Services). A 
clear diagnosis of DSM-IV-TR (American Psychiatric Association, 1994) 
schizophrenia was identified by a staff psychiatrist for all patients, and confirmed 
using the Structured Clinical Interview for DSM-IV-TR. To further ensure 
accuracy of diagnosis and suitability for selection criteria, a thorough review was 
conducted on patient medical records and psychiatrist progress notes. All 
patients provided release of medical records for this review, and for medication 
use and dosage at the time of testing to t>e extracted from charts at the time of 
testing. Consistent with the schizophrenia literature, medication data was 
converted to Chlorpromazine equivalent doses using procedures delineated by 
Woods (2003), allowing patient groups to be compared on neuroleptic dose (see 
Table 1).
Healthy controls were recruited from the local community using posted 
flyers and within the UNLV Psychology Department Subject Pool. Participants 
recruited from the Subject Pool received compensation of extra credit points 
and/or partial fulfillment of their course requirements, equivalent to one credit 
hour for each hour of participation. Patient and control participants recruited from 
the community received monetary compensation for participation in the amount 
of $10.00 per hour, with an average total of $60.00 for completion of the entire 
study. Participants who failed to complete all study procedures, and those who
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were excluded based upon selection criteria, were compensated on a pro-rated 
basis (approximately $2.50 for each half-hour of participation).
Total completion time for the current study was approximately 6-8 hours 
for patient groups. All individuals interested in completing the current study first 
underwent an initial screening. Individuals from the patient group that met initial 
selection criteria were scheduled for an appointment and completed study 
procedures in an average of two to three testing sessions lasting approximately 
1-4 hours in length. For individuals with schizophrenia, session one lasted 
approximately 3 hours, and included the administration of demographic and 
medical history questionnaires, SCID-IV interview, clinical symptom interview, 
and self-report emotion measures. Session two consisted of computerized 
emotional and neuropsychological testing. Patients were allotted breaks as 
needed. For control subjects, testing was generally completed in one sitting that 
lasted approximately 4 hours. A 30 minute break was implemented at the 
midpoint of testing and as needed for controls.
Detailed descriptions of all tests and testing procedures are provided in 
the measures section. Measures included in the first testing session were 
administered in the following order: Demographic and medical history 
questionnaire, SCID-IV, Clinical Symptom Interview (used to obtain information 
for SDS, SAPS, SANS, BPRS), Extrapyramidal Symptom Measurement (used to 
otain information for ratings on the EPS, AIMS, Rockland Rating Scale, and 
Barnes Akathisia scales). Participants also typically completed several self-report 
measures of emotional experienœ and well-being during the first session.
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including: Differential Emotions Scale, Positive and Negative Affect Scale, 
Psychological Well-being Scales, Social Well-Being Scale, and the Satisfaction 
with Life Scale. During the second portion of testing participants received a 
battery of emotion processing tasks, the Brief Smell Identification Test, WAIS-II I 
Subtests (Vocabulary, Information, and Block Design), and neuropsychological 
measures. The order of task administration within this portion of testing was 
designed to control for carry-over effects and account for necessary periods of 
verbal and nonverbal testing. Neuropsychological tests were administered as 
part of a larger study and not described here. These tests included: California 
Verbal Learning Test, Wechsler Memory Scale, Third Edition Digit Span and 
Spatial Span subtests (fonward and backward). Trail Making Test (A & B), Finger- 
tapping test, Purdue Pegboard, Controlled Oral-Word Association Test, Visual 
Backward Masking Test, Biber Figure Drawing Test, and Wisconsin Card Sorting 
Test.
All testing was conducted by the primary author and two trained doctoral- 
level graduate students, and occurred in a quiet setting (office within laboratory 
or community mental health center). Time was allotted for questions after the 
examination, and participants were given a debriefing form containing 
experimenter contact information and information regarding the nature of the 
study.
Measures
Measures used in the current study assessed 4 facets of psychological 
functioning: 1) clinical symptomatology, 2) emotional experience, 3) emotional
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information processing, and 4) intellectual functioning. Description of the format 
of each test and its procedures is provided laelow. Psychometric properties of all 
tests are also provided where relevant.
Clinical Symptomatology
Several measures were included to assess clinical symptomatology 
relevant to schizophrenia. Measures included the Structured Clinical Interview for 
DSM-IV-TR (SCID), Schedule for the Deficit Syndrome (SDS), Scale for the 
Assessment of Negative Symptoms (SANS), Scale for the Assessment of 
Positive Symptoms (SAPS), Brief Psychiatric Rating Scale (BPRS), and the 
Calgary Depression Scale for Schizophrenia. The SCID was used to verify DSM- 
IV Axis-1 diagnosis of schizophrenia. The SDS was used to determine deficit 
syndrome classification, while the SANS, SAPS, BPRS, and Calgary Depression 
Scale were included to assess positive and negative psychotic symptoms and 
depression specific to individuals with schizophrenia.
Several measures were also included to assess patient extrapyramidal 
symptoms, including the Rockland Rating Scale (RRS), Abnormal Involuntary 
Movement Scale (AIMS), Extrapyramidal Symptoms Scale (EPS), and the 
Barnes Akathisia scale. These measures are included to assess a broad 
sampling of the physical domains affected by antipsychotic medications (e.g., 
face, neck, extremities).
Stwctured Clinical Interview for ttie DSM-IV-TR.
The Structured Clinical Interview for DSM-IV-TR (SCID) is a structured 
clinical interview designed to determine psychiatric diagnosis and identify clinical
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symptoms. The interview proœss utilizes open-ended questions and “skip- 
structure” procedures that allow the administrator to investigate content areas 
based upon examinee response. Questions are designed to assess Axis I (SCID- 
I) and Axis II disorders (SCID-II), with separate forms for the assessment of 
inpatient (SCID-P), outpatient (SCID-OP), and nonpatient groups (SCID-NP). In 
order to account for the SCID’s lengthy administration time, examiners commonly 
administer modules of primary concern. The SCID-P will be administered in the 
current study.
When assessing schizophrenia, it is important to rule out the presence of 
several other conditions that present symptoms similar to those in psychosis. The 
SCID-I will be used to allow for differential diagnosis of several Axis-1 disorders, 
including schizophreniform disorder, schizoaffective disorder, delusional disorder, 
brief psychotic disorder, substance abuse and dependence, and bipolar disorder. 
Inter-rater reliability of the SCID-I has been shown to be excellent (kappa = .85, 
range = .71 to .97), and diagnostic accuracy, as compared to consensus 
diagnosis, was very accurate (82%) (Ventura et al., 1998). A study conducted by 
Fennig et al., 1994), suggests that the SCID-I is a valid instrument for the 
diagnosis of schizophrenia, as SCID schizophrenia diagnosis displayed good 
sensitivity (.89), specificity (.96), and agreement (.86) when compared to best 
estimate diagnosis made by psychiatrists on first-admission psychotic patients.
Graduate level researchers in the current study were trained in SCID 
administration using standard video-tapes marketed by the SCID developers. 
Reliability assessments were also conducted on standardized SCID reliability
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patient videos from the psychosis and mood disorder modules prior to beginning 
the study. Student raters were able to obtain 100% diagnostic agreement on 
patient case videos from both modules.
Schedule for the Deficit Syndrome (SOS).
The Schedule for the Deficit Syndrome (SDS) (Kirkpatrick et al., 1989) 
was used to classify patients according to deficit/non-deficit status. The SDS is a 
semi-structured clinical interview designed to assess severity of negative 
symptoms in relation to six domains: restricted affect, diminished emotional 
range, poverty of speech, curbed interests, diminished sense of purpose, and 
diminished social drive. Severity ratings are made on a 0 (normal relative to 
characteristic) to 4 (very severe decrease relative to all aspects of characteristic) 
rating scale. For each symptom domain, symptoms are further classified as being 
primary/secondary (i.e., idiopathic, not due to secondary negative symptom 
factors) and stable/unstable (lasting > 1 year). To be classified as a deficit 
syndrome case, patients must: 1) meet DSM criteria for schizophrenia, 2) 
evidence moderate or higher (SDS severity of 2 or >) symptom severity on at 
least two of the six symptom domains, 3) have at least two of these symptoms 
considered primary, and 4) demonstrate a stable symptom presentation during 
periods of relative remission over the past year.
Brief Psychiatric Rating Scale.
The Brief Psychiatric Rating Scale (BPRS) is commonly employed in the 
assessment of clinical symptoms associated with schizophrenia. The original 
BPRS scale consisted of 16 symptom constructs, most of which were derived
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from factor analysis of psychiatric rating data (Overall and Gorham, 1963). The 
current scale consists of 18 items, having added Excitement and Disorganization, 
that are to be rated. Each item includes a symptom description and a severity 
rating that consists of a seven-point Likert scale, ranging from not 
reported/observed (1) to extremely severe (7). Half of the items are rated on the 
basis of observations made during the 15 to 30 minute interview, while the other 
half are rated on the basis of self-report data regarding the client's functioning 
over the past seven days. Items which predominantly reflect observed behavior 
include Motor retardation. Uncooperativeness, and Mannerisms and posturing. 
Items based upon subjective reports from the client include Unusual thought 
content. Conceptual disorganization. Anxiety, Depressive mood, and Blunted 
affect. Based upon the most comprehensive factor-analysis of the BPRS, three 
BPRS syndrome scales were calculated: positive syndrome (grandiosity, 
suspiciousness, unusual thought content, hallucinatory ttehavior), negative 
syndrome (blunted affect, uncooperativeness, emotional withdrawl, motor 
retardation), and disorganized syndrome (tension, disorientation, excitement, 
conceptual disorganization, and odd mannerisms and posturing). For the current 
study, ratings were made in relation to symptoms manifested over the past week.
Scale for the Assessment of Positive Symptoms.
The Scale for the Assessment of Positive Symptoms (SAPS; And reason,
1986)_is designed to assess positive symptoms that occur in schizophrenia. 
Positive symptoms include hallucinations, delusions, bizarre behavior, and 
positive formal thought disorder. Symptoms were rated over the past week on a
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six-point scale, where 0 reflects that the symptom is not at all present and 5 
represents a severe presentation. Global ratings are used to represent overall 
severity within each of these 5 domains, taking into account both the nature and 
severity of all symptoms observed. A total score is also derived by summing all 
SAPS items (range 0 to 170).
Scale for the Assessment of Negative Symptoms.
The Scale for the Assessment of Negative Symptoms (SANS; Andreason, 
1982) is designed to assess negative symptoms of schizophrenia in relation to 5 
core domains; affective flattening, alogia, avolition, anhedonia, and attentional 
impairment. Examiners rate patients on several clinical domains relevant to each 
of these core symptoms, and patients are also rated on their subjective 
evaluation of the symptom as a whole. A global rating is also made for each core 
domain that takes into account the nature and severity of items within that scale. 
Ratings are made on a six-point scale (0 not at al to 5 severe) and a total score is 
also derived by summing all SANS items (range 0 to 150). Ratings were made on 
a 1-week time frame in the current study.
The Calgary Depression Scale for Schizophrenia.
The Calgary Depression Scale for Schizophrenia was designed to assess 
severity of depression in individuals with schizophrenia. The nine item rating 
scale is based upon the Hamilton Depression Rating Scale and the Present State 
Examination, and has been reliably shown to measure depression speciflc to 
individuals with schizophrenia. The scale has been shown to assess depression 
independently of other symptoms present in schizophrenia, in both acute and
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residual phases of the disorder. In the current investigation depression scores 
will serve as a covariate allowing for an assessment of emotion processing 
without the influence of depression.
Each item consists of several questions designed to assess nine content 
areas (depression, hopelessness, self-deprecation, guilty ideas of reference, 
pathological guilt, morning depression, early wakening, suicide, and observed 
depression), that are each rated on a 0 (Absent) to 3 (severe) scale, based upon 
the individual’s subjective report of thought, feeling, and behavior over the past 
two weeks. Global depressive symptomatology is typically evaluated using a total 
severity rating, which is determined by summing each of the nine items.
Simpson-Angus Extrapyramidal Symptom Scale (SAESS).
A modifled version of the Simpson-Angus scale was administered to 
measure extrapyramidal side effects. This modifled version, used by memt>ers of 
our research group in previous studies (Kelley, van Kammen, & Allen, 1999), 
contained 8 of the original 10 Simpson-Angus items, excluding leg 
pendulousness and head dropping, which are not commonly rated. The 8 items 
adopted from ttie original scale included gait, arm dropping, shoulder shaking, 
elbow rigidity, wrist rigidity, glabella tap, tremor, and salivation. Six additional 
items were also added to obtain a more comprehensive assessment of EPS. 
These additional items included spontaneity of speech, use of gestures, dystonia, 
akathisia, akinesia, and cog wheeling. Ratings were made on a 0 to 4 scale, and 
a total score was tabulated from all items (range 0-56).
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Abnormal Involuntary Movement Scale.
The Abnormal Involuntary Movements Scale (AIMS; Guy, 1976) was used 
to assess involuntary movements occurring in facial/oral, extremity, and trunk 
domains. The AIMS consists of 12 individual items, which are summed to 
compute a total score (range = 0 - 42). Higher ratings reflect greater abnormal 
involuntary movements. These symptoms are common to individuals with tardive 
dyskinesia.
Rockland Rating Scale (RRS).
The Rockland Rating Scale (RRS) is a 14 item movement rating scale 
designed to assess extrapyramidal symptoms. Ratings are made on a 1-6 scale 
across 14 domains measuring abnormality relative to facial and oral movements, 
neck and trunk movements, extremity movements, and entire body (i.e., 
akathisia) movements. Scores from the 14 individual items are summed to 
compute a total score (range 0-84).
Emotion Processing
Emotion processing measures assess either self-reported emotional 
experience or cognitive/neuropsychological emotion processing. Tests are 
included to investigate both valence-arousal and discrete basic emotion models, 
and include several positive (e.g., happiness, surprise) and negative (e.g., 
sadness, anger, disgust) emotions to assess a full range of human affect. Self- 
report questionnaires were selected to assess intensity of subjective emotional 
arousal (positive/negative and basic emotions), and global psychological well- 
toeing and positive affect. Cognitive measures are included to assess
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performance in general aspects of cognition, such as auditory, verbal, and visual 
processing, as well as specific domains, including; facial affect identification, 
hemispheric lateralization, auditory recognition memory, verbal recall and 
recognition memory, attention bias, and auditory-visual integration. All measures 
of emotion processing are commonly used in affect assessment, or similar to 
those used in other studies in the case of computerized tasks, and are suitable 
for research purposes. Individual measures are detailed in the following section.
Positive and Negative Affect Scale.
The Positive and Negative Affect Scale (PANAS) (Watson, Clark, & 
Tellegen, 1988) is a self-report measure of subjective emotional experience. 
Participants respond by indicating how intensely they generally experience 20 
distinct emotions. The measure includes 10 positively valenced emotions and 10 
negatively valenced emotions, which comprise Positive Affect (PA) and Negative 
Affect (NA) factors. Positive affect items include emotions such as; interested, 
excited, and strong. Negative affect items include emotions such as; afraid, 
guilty, and nervous.
Analyses of the PANAS’s psychometric properties suggest tiiat the 
measure displays adequate reliability and validity (Watson, Clark, & Tellegen, 
1988). Eight-week test-retest reliability coefficients were found to be reliable for 
both PA (r = .68) and NA (r = .71) scales, suggesting that test scores obtained on 
the PANAS are highly reliable. Principle factor analyses yield two distinct factors, 
which accounted for approximately 63% of the common variance among 
emotionality ratings, indicating that the measure accurately assesses the
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underlying component of emotionality. Additionally, all items have strong primary 
loadings on ttieir designated factors (r = .50 and above for all items), which 
suggests that all items are accurate representations of their intended emotions. 
Validity analyses suggest excellent convergent validity with other emotion 
measures (.90 and above) and low discriminant validity, providing furttier 
evidence that the PANAS is a valid measure of emotion processing. In the 
current investigation, the PANAS will be used to assess trait positive and 
negative affect experience in relation to valence-arousal theories of emotion 
(Russell, 1980).
Differential Emotions Scale.
Tbe Differential Emotions Scale (DES) (DES; Izard, Dougherty, Bloxom, & 
Kotsch, 1974) is a 30 item self-report measure designed to assess the frequency 
with which individuals experience discrete basic emotions in everyday life. The 
questionnaire yields 10 basic emotion scales, with 3 representing positive 
emotions (joy, interest, & surprise) and 7 representing negative emotions 
(sadness, anger, fear, disgust, contempt, guilt, & shame). Examinees are 
required to identify the frequency with which they experience 30 emotional 
terms/adjectives on a 4-point scale (0 = not experienced; 3 = highly 
experienced). DES items were selected to represent verbal labels commonly 
applied to identify facial expressions, as well as current theories of basic 
emotion, which descrit>e emotions in terms of discrete categories (e.g., Izard, 
1971). The 10 DES factors have been found highly stable across multiple factor- 
analytic investigations (Fuenzalida, Emde, Pannabecker, & Strenberg, 1981;
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Kotsch, Gerbing, SSchwartz, 1982), suggesting that the DES adequately 
measures the experience of discrete emotions. In the current study, the DES will 
be applied in its trait form to assess emotional experience on the day of testing. 
Additionally, this measure has t>een used in previous schizophrenia 
investigations, and demonstrated differences in experience among discrete 
emotions (Suslowet al., 2003).
Facial Affect Labeling Task.
The computerized facial affect labeling task designed for the current study 
is based upon previous investigations of facial affect in schizophrenia (Loughland 
et al., 2002). Administration time was approximately 5 minutes. Facial affect 
stimuli were taken from the Matsumoto and Ekman (1988) stimulus set. All 
stimuli are proven to be highly namable by healthy individuals (Matsummoto & 
Ekman, 1988). Stimuli are digitized color images of Caucasian and Asian males 
and females. Emotions represent 8 primary basic emotions of: happiness, 
surprise, sadness, anger, fear, disgust, contempt, and neutral. Eight individual 
stimuli (2 Caucasian males; 2 Asian males; 2 Caucasian females; 2 Asian 
females) were presented once for each of 6 emotions (happiness, surprise, 
sadness, anger, fear, neutral), resulting in a total of 48 experimental stimulus 
presentations. Participants were provided with a list of all 6 possible emotions, 
and asked to identify the emotion perceived for each face by speaking aloud into 
a voice activated microphone. Six practice stimuli were also presented, one 
stimulus from each targeted emotional condition.
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A PC and monitor were used to present all facial affect stimuli, which 
appeared as color images on a grey background. Stimuli will be preceded by a 
fixation point that remained on the computer screen for 1000 ms. Individual facial 
affect presentations were presented until participants indicated the perceived 
emotion by speaking aloud into the voice-activated microphone or until a duration 
of 5000 ms passed, after which a blank screen appeared prompting participant 
response. After participant response triggered the voice-activated microphone, a 
subsequent screen appeared allowing the experimenter to record participant 
accuracy. Dependent variables for the facial affect identification task included 
accuracy (% correct) and RT (ms) for emotional conditions.
Emotional Stroop Task.
In the current study, two E-Stroop task versions are used to isolate distinct 
components of attention. Administration time approximated 5 minutes per task. 
The first version, the Attention Grabbing Task, measures the extent to which 
emotional information disrupts attentional focus relative to neutral information. 
This task is designed to allow for a comparison of the extent to which various 
types of emotional information (happiness, sadness, anger, anxiety) capture or 
fail to capture the attention of patients with schizophrenia. The second task, the 
Lingering Effect task, assesses the extent to which an emotional word has a 
carry-over effect on a string of subsequent neutral words. The lingering effect 
task therefore allows for a comparison of the extent to which various types of 
emotional information continue to linger and disrupt on-going cognitive 
processes, even after they are no longer present.
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similar to J R. Stroop’s (1935) original color-naming task, the E-Stroop task 
as most commonly used, requires participants to identify the color of ink in which 
a word is printed, while ignoring the meaning of a written word. However, unlike 
the Stroop’s original task, which manipulates color-congruent and incongruent 
words, the E-Stroop contrasts emotional and nonemotional (i.e., neutral) words. 
The theory behind the E-Stroop task states that more influential words cause 
longer color naming latencies, due to the interfering qualities of the word, which 
are thought to occur due to an individual’s “attention bias ” for that particular 
emotion (Williams, Matthews, & MacLeod, 1996).
The attention grabbing task was modeled after published studies investigating 
the attention grabbing power of basic emotions (Strauss, Allen, Jorgensen, and 
Cramer, 2005; Strauss & Allen, 2006). A total of 36 stimuli were presented, six 
practice and 30 experimental. Practice stimuli consisted of 6 emotional and 
neutral words not included in the experimental session. In the experimental 
condition, a total of 30 stimuli were presented, with six words taken from each of 
five emotional categories (happiness, sadness, anger, anxiety, and neutral). 
Stimuli were presented via personal computer, and each stimulus appeared on 
the computer screen for five seconds or until a verbal response was given into a 
voice-activated microphone. The interstimulus interval (ISI) was set to 1000 ms 
to ensure that the stimulus onset asynchrony was sufficiently long enough to 
produce the desired attention grabbing effect that occurs within each trial.
Participants were instructed to name one of four ink colors (red, yellow, 
green, blue), while ignoring the meaning of the written word. Stimuli were block
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presented in a semi-random order with the restriction that no two colors could 
appear in consecutive trials. This was done to ensure that response time was not 
biased by the preceding stimulus. All stimuli were presented in uppercase, Arial 
font (regular), size 18 points, and appeared on the computer screen as color- 
words presented against a black background.
Words were taken from normative emotional intensity and categorization data 
developed by Strauss and Allen (in press). All words included evidenced 
categorization ratings of 70% or higher, indicating that all words are highly 
representative of their designated categories. Across all 5 categories, words do 
not statistically differ with regard to emotional intensity, categorization, frequency, 
or word length. Our research group has previously demonstrated that scores 
obtained in this test version have high classical test score test-retest reliability 
(Strauss, et al, 2005).
The commonly employed difference score method is applied to index 
emotional interference (i.e., attention grabbing effect) using the formula: 
emotional condition RT - Neutral condition RT. Using this difference score 
method, higher scores reflect that a given emotional condition has interfered, or 
captured attention, to a greater extent than neutral words.
The lingering effect task was modeled after parameters reported in a study on 
non-patients conducted by McKenna and Sharma (2005). A total of 125 stimuli 
were presented, with 50 practice stimuli consisting of random letter strings, and 
75 experimental presentations. The practice session was repeated in instances 
where participants had difficulty learning button location until a high degree of
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accuracy was achieved. Stimuli were presented using a standard PC and 
responses input using a serial response box that relayed accuracy and RT data 
to an E-prime data-aid software output file. Stimuli appeared as color words on a 
black background, and were presented in red, blue, green, and yellow ink. Four 
response box buttons were covered with colored caps, and a paper overlay was 
attached that extended up from each button of the t)ox to assist participants from 
having to look down under their fingers while learning button location.
Participants were instructed to press the button of the color in which the letter 
string (practice) or emotional/neutral word was printed as quickly and accurately 
as possible, while trying to ignore reading the written word. Each stimulus 
appeared on the computer screen for five seconds or until a verbal response was 
given into a voice-activated microphone. The interstimulus interval (ISI) was set 
to 32 ms to ensure that the stimulus onset asynchrony was sufficiently long 
enough to produce the desired “lingering effect”. This interval was selected as it 
was previously found to produce the lingering effect in McKenna and Sharma 
(2004).
Three blocks (positive, negative, category/neutral) of word stimuli were 
presented in a counterbalanced order within the experimental condition. Each 
block included a total of 25 words, which were presented sequentially in 5 series 
of 5 words. Within each sequence of 5 words, an emotional word was presented 
in the first position, and was followed by 4 subsequent neutral words (positions 
2,3,4,5) that were matched to the emotional word for frequency and length. Thus, 
there were 5 such sequences of an emotional word followed by four consecutive
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neutral words. This presentation resulted in a 3 emotional condition (positive, 
negative, neutral) x 5 serial position (1 through 5) within-subjects factorial design.
The neutral word in position 2 (i.e., the neutral word immediately following the 
emotional word in position 1) serves as the primary target in this task, and is 
used to assess the presence of the lingering effect using a difference score 
method of: neutral word position 2 -  emotional word position 1. Using this 
difference score, higher RTs reflect a greater lingering effect, suggesting that the 
emotional content of the word is capable of disrupting on-going attention, even 
after that stimulus is no longer present.
Positive and negative words included in this task were selected from the 
normative word set developed by Strauss and Allen (in press). Negative words 
selected for inclusion were taken from the blended emotional category within the 
Strauss and Allen norms. This category reflects words that are clearly negative, 
but not highly representative of a single discrete emotional category. General 
negative words were selected to avoid an over-sampling of words from any given 
category, allowing a valid comparison of valence that is not biased by the effects 
of individual basic emotions. Neutral words used in the positive and negative 
blocks were selected from the Francis and Kucera normative word frequency 
manual, and matched to given positive or negative words based upon tx>th length 
and frequency. Additionally, positive and negative words used within position 1 
did not differ with regard to emotional intensity or word frequency, as measured 
through Strauss & Allen intensity ratings and Francis and Kucera word frequency 
ratings, respectively. Intensity ratings were not available for neutral words used
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within position 2-5 in the positive and negative blocks; however, their content is 
clearly neutral, and they thus appear to be a valid neutral comparison.
Similar to procedures used by McKenna and Sharma (2004), a block of 
category/neutral words were also used as a contrast condition to the positive and 
negative blocks, and to ensure that interference effects are not due to 
participants anticipating a target word within the sequence of 5-word 
presentations. In this category/neutral only block, the word selected for position 1 
consisted of a word neutral in emotional content that is semantically related to 
travel. The words in positions 2-5 were also neutral in content, but were 
semantically un-related to travel.
Brief Smell Identification Test.
Olfactory discrimination will be assessed using the University of Pennsylvania 
Brief Smell Identification Test (BSIT) (Doty et al., 1996). The measure has been 
used in schizophrenia investigations (e.g., Goudsmit et al., 2003), and found 
capable of detecting olfactory processing deficits. The BSIT is a standardized 
measure that requires examinees to identify 12 common microencapsulated 
odors by selecting one of 4 multiple-choice answers representing various odor 
names. Smell identification scores are calculated by totaling the number of 
correct responses. Raw scores are compared to age and gender based norms 
(Doty, 1995). Doty et al. (1996) reported that the BSIT has adequate reliability in 
the normative sample (r= .71). The BSIT also has adequate validity, as indicated 
by satisfactory separation of test items, suggesting that the SIT is able to
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distinguish between individuals with average ability and those with moderate 
impairment.
Participants also provided valence ratings for each BSIT item. In a 
procedure similar to that adopted by Doop and Park (2005), odor valence was 
rated on a 7-point scale (1 = extremely pleasant; 4 = neutral; 7 = extremely 
unpleasant).
Emotional Verbal Learning Test.
The Emotional Verbal Learning Test (EVLT) (Strauss & Allen, unpublished 
manuscriptb) is a measure of learning and memory for emotional words. All 
procedures, parameters, and score calculations are modeled after the CVLT-II 
(Delis, 2000), allowing for a direct comparison t>etween learning and memory 
performance for emotional and neutral words. The EVLT is a standardized 
measure with psychometric properties comparable to the CVLT-II (internal 
consistency, r = .88).
The task first requires the experimenter to orally present 16 words (List A) 
over five immediate-recall trials. The list consists of 4 words from each of four 
“basic emotion” categories (Happiness, Sadness, Anger, and Anxiety). Individual 
words of the same category are never presented successively to allow for the 
assessment of semantic clustering. Following the 5 immediate recall 
presentations, a second “interference” list (List B) is presented for a single trial. 
Immediately following List B, a short delay free and category cued recall of List A 
is administered. A 20 minute delay then occurs t>etween the presentation of the 
short-delay and long-delay free recall assessments. Long delay free and cued
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recall Is then assessed. Recognition of List A is measured using a yes-no 
recognition format immediately proceeding the administration of the long delayed 
recall. In the test of recognition, there are 28 distractors consisting of: List B 
emotional words semantically related to List A words, List B emotional words 
semantically unrelated to List A words (disgust words), novel words that are 
prototypical of semantic categories presented in list A, and emotional words 
semantically unrelated to List A words (fear and surprise words).
Administration time is similar to the CVLT-II (Delis et al., 2000), taking 
approximately 30 minutes to complete. Time estimates include a 20 minute delay 
interval in-t>etween short and long-delayed recall sections. Unlike the CVLT-II, 
the EVLT does not contain a Long-delay forced choice recognition test section, 
which subsequently results in a shorter administration time since the 10 minute 
delay interval is not included.
The EVLT measures both recall and recognition of two separate word lists, 
comprised of emotional words, in several short and long-delayed memory trials. 
As such, the test can measure a number of different aspects of learning and 
memory for emotional words, including: total recall and recognition, primacy- 
recency effects in recall, differences in retention after short and long delays, and 
recognition memory. Measurements of emotional word learning can also be 
obtained, including measures of learning strategies (semantic, serial, and 
subjective clustering), emotional learning slope, and the amount of new teaming 
per trial over the first five presentations of List A. Normative data collected on 
the EVLT suggest that psychologically healthy individuals evidence a memory
83
bias for happiness words (Strauss & Allen, unpublished manuscriptb). This 
memory bias is not accounted for by list order, word frequency, word length, or 
emotional prototypicality.
CaUfornia Verbal Learning Test-ll.
The CVLT-II (CVLT-II; Delis et al., 2000) is an individually administered 
clinical instrument designed to quantify various aspects of verbal learning and 
memory. The CVLT-II is an updated version of the first edition of the CVLT (Delis 
et al., 1987), which was one of the first clinical instruments to utilize theories of 
cognitive psychology to measure multiple facets of learning and memory with 
clinical populations. It has been used in studies of numerous clinical disorders, 
including schizophrenia (Paulsen et al., 1994).
The task first requires the experimenter to orally present 16 words (List A) 
over five immediate-recall trials. The list consists of 4 words firom each of four 
categories (furniture, vegetables, ways of traveling, and animals). Individual 
words of the same category are never presented successively, to allow for the 
assessment of semantic clustering, which is regarded as the most efficient 
strategy for learning verbal information. Following administration of the five trials, 
a second 16 word “interference list” (List B) is presented for a single trial. 
Immediately following List B, a short delay free recall trial and a category cued 
recall trial of List A are conducted. Twenty minutes later, long delay free recall, 
category cued recall, and recognition trials occur for List A. Recognition of List A 
is measured using a yes-no recognition format immediately in which List A is 
presented with 28 distractors consisting of: List B words semantically related to
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List A words, List B words semantically unrelated to List A words, novel words 
that are prototypical of semantic categories presented in list A, and novel words 
semantically unrelated to List A words.
Tbe CVLT-II (Delis et al., 2000) was standardized on a sample of 1,087 
individuals between the ages of 16 to 89. Administration time for individuals 
under 60 years is approximately 47 minutes, while administration time for 
individuals over 60 years is approximately 51 minutes. Nine measures of memory 
are selected for analysis in the current study: Trial 1 total recall correct. Trials 1-5 
total recall correct. List A short delay recall correct. List A long delay recall 
correct, Total recognition hits. Trials 1-5 total repetitions, trials 1-5 total 
intrusions, primacy recall correct, and recency recall correct.
Premorbid Intelligence.
Two subtests from the WAIS-III (Wechsler, 1997a), Vocabulary and 
Information, will be used to estimate premorbid intelligence in persons with 
schizophrenia and verbal IQ in healthy controls. These subtests are commonly 
used to estimate premorbid IQ in schizophrenia, as scores do not markedly 
change over time or in the presence of brain insult, and because reliability 
estimates are highest among all WAIS-III verbal composite subtests (Vocabulary 
= .89; Information = .96) (Vanderploeg, Schinka, & Axelrod, 1996).
The Vocabulary subtest from the Wechsler Adult Intelligence Scale III 
(Wechsler, 1997) consists of 33 items that require the subject to provide 
definitions for words of varying degrees of difficulty. Item scores can range from 
0-2, with a two point score indicating a full credit response, one point indicates a
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partial credit response, and 0 points represent an incorrect response or lack of a 
response.
The Information subtest from the Wechsler Adult Intelligence Scale III 
(Wechsler, 1997b) consists of 28 items that require a general knowledge of 
current and historical events. Items are scored as either correct or incorrect and 
the total number of correct items serves as the raw score.
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CHAPTER 4
RESULTS 
Data Entry and Screening 
All data was double scored and entered to ensure accuracy of findings 
reported. Several preliminary analyses were conducted prior to the evaluation of 
main hypotheses. First, raw test data were inspected to ensure that they meet 
the assumptions for ANOVA. Descriptive statistics and box plots were calculated 
for each of the variables, and skewness and kurtosis were examined to ensure 
that all variables were normally distributed. Box plots were used to evaluate the 
presence of outliers. In cases where variables were not normally distributed, 
transformations were used to increase the normality of the distribution. 
Transformations were selected in accordance with the recommendations of 
Tabachnik and Fiddel (2001). For individual tests, scores that were 3.0 standard 
deviations above/below the mean were considered outliers. Score 
transformations are described in the following results section in reiation to 
individual tests and DVs.
Descriptive statistics and box plots were also calculated for raw computerized 
task data in order to eliminate individual RT outliers. In cases where mechanical 
errors were present in computerized tasks (i.e., microphone does not signal upon 
voice onset), these data were eliminated from analyses as invalid data. Individual
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RTs greater than 2.0 SDs above each condition’s mean (calculated per group), 
or less than 150 ms, were considered outliers and eliminated from the data set. 
Once individual RT oultiers and mechanical errors were removed from the data 
set, means were calculated for each level of each independent variable. These 
means were used in all subsequent main analyses conducted on RT data. Outlier 
procedures were adopted from a study conducted by Ratcliff (1993), which 
suggested that statistical power is considerably impacted when outliers are 
ignored in RT data. The SD rule adopted was one of the recommended 
procedures for eliminating outliers in investigations where there is high variability 
among subject responding (which is certainly true for patients with 
schizophrenia). In the simulation, Ratcliff tested cutoffs only up to 1.5 SD from 
the mean. Our elimination of outliers 2.0 SD above the mean is even 
conservative based upon these standards, and was applied to ensure that too 
much data was not discarded by using a liberal outlier rule. Further, the total 
amount of data eliminated approximated 1 % of the raw data, which is what would 
be expected based upon a 2.0 SD cut-off. Although an even more conservative 
3.0 SD rule was considered, this procedure was found to include RTs exceeding 
4 seconds, which is an absolute eon by typical RT standards. Thus, outlier 
procedures adopted provide greater assurance that overall subject means 
exclude individual trials where extraneous conditions, such as momentary 
difficulty focusing on the task, influenced task performance.
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Demographic and Clinical Symptom Analyses
Groups were also evaluated for differences on basic demographic 
variables including age, education, estimated IQ, race, and gender. ANOVA 
(age, education, IQ) and chi-square (race, gender) analyses were used to make 
these comparisons. Means, standard deviations, and statistical test data are 
presented in Table 1. ANOVA indicated that the 3 groups (deficit schizophrenia, 
non-deficit schizophrenia, control) did not significantly differ on age and 
education. As such, age and education were not used as covariates in ttie main 
analyses.
Patient and control groups also did not differ with regard to the proportion 
of right handed individuals within ttie sample. However, groups significantly 
differed with regard to race and education, such that the deficit syndrome group 
had a greater proportion of African-American participants than non-deficit 
patients or controls, and that both patient groups had a significantly higher 
proportion of males than the control group.
Patient and control groups significantly differed in intellectual functioning, 
such that both patient groups were significantly lower than the control group on 
the WAIS-III Vocabulary, Information, and Block Design subtests. Statistically 
significant differences were also found between deficit and non-deficit patients 
with regard to Information and Block Design subtests, but not Vocabulary.
Given these differences IQ was included as a covariate in the analyses of 
the main hypothesis. These analyses were accomplished primarily for 
comparisons purposes, although their significance is questionable as it pertains
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to neurocognitive and emotion processing differences between the schizophrenia 
groups. The reason for this was highlighted recently by Goldstein, Seidman, and 
Tsuang (1999), who suggested that matching diagnostic groups on variables that 
are not independent of the illness being examined can result in a matching 
fallacy, whereby variance directly attributable to the variable of interest is 
removed due to overmatching on a variable, such as IQ. In studying groups like 
patients with schizophrenia, which are known to display significant 
neurodevelopmental abnormalities, where the illness in and of itself effects 
variables such as premorbid IQ would arbitrarily attenuate differences among 
groups. This may be particularly problematic when studying deficit syndrome 
patients, as these individuals are known to display lower premorbid IQ and 
functioning than non-deficit patients. As such, although main hypotheses were 
conducted using IQ as a covariate, covarying out the effects of IQ may be 
inppropriate in this case, as it arbitrarily removes variance natural to the neural 
basis of the deficit syndrome, and results are primarily interpreted without 
regarding the influence of IQ.
Analyses were also conducted on clinical and demographic variables 
recommended for comparison by SDS authors. These comparisons are designed 
to reduce problems related to intergroup reliability, and to ensure that deficit 
syndrome patients reported here validly represent the concept of deficit 
syndrome schizophrenia. Based upon recommendations outlined in the SDS 
manual, analyses were first conducted on clinical characteristics to ensure that 
deficit syndrome validating variables are not confounded by longer length of
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illness, earlier age of onset, higher daily dosage of antipsychotic medication, a 
different frequency of medication use, or severity of extrapyramidal symptoms. 
ANOVA indicated that deficit and non-deficit patients did not differ with regard to 
length of illness, age of onset, daily antipsychotic medication dosage 
(chlorpromazine equivalent dosage; Woods, 2003), or severity of extrapyramidal 
symptoms (see Table 4). Additionally, deficit and non-deficit patients were 
prescribed a similar regiment of conventional, atypical, anti-depressant, mood- 
stabilizer, anti-parksinsonian, and extrapyramidal medications (see table 4).
Second, analyses were conducted on symptom measures for which deficit 
patients are known to significantly differ from non-deficit patients. Based upon the 
literature, it would be expected that deficit patients would display less severe 
symptoms of emotionality, depression, suspicion, and general positive 
symptoms. Deficit patients should also evidence significantly higher scores on 
most negative symptoms, and less or at least equal levels of disorganization. 
ANOVA indicated that deficit patients demonstrated a symptom profile consistent 
with the published literature. In comparison to the non-deficit group, deficit 
patients evidenced significantly lower scores on BPRS scales of emotionality 
(anxiety, depressed mood, guilt, hostility) and suspicion (see Table 5), and the 
SAPS total score (see Table 7). Deficit patients also showed a trend (p = .062) 
toward less global depressive symptoms as indexed by the Calgary Depression 
Scale total score (see Table 6). Additionally, deficit patients received higher 
ratings on BPRS measures of emotional withdrawal and blunted affect, as well as 
the SANS total score (see Tables 5 and 8), suggesting that they evidence higher
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levels of negative symptoms than non-deficit patients, as would be expected. No 
differences were found t)etween deficit and non-deficit groups on the SAPS 
Disorganization Global Rating or the BPRS Disorganization Syndrome Factor, 
although the deficit group received lower ratings on twth scales (see Tables 5 
and 7). These findings are consistent with clinical characteristics reported for 
deficit and non-deficit patients in the published literature.
Third, descriptive statistics were analyzed for basic demographic variables 
known to differentiate deficit and non-deficit patients based upon multi-site 
clinical field studies. Consistent with previous reports, the deficit group displayed 
a higher proportion of male than female subjects, lower estimated IQ (see Tat>le 
1), and less frequent rate of marriage than non-deficit patients and controls (see 
Table 2).
Fourth, diagnostic groups were compared on smoking behavior, as this 
variable may affect olfactory performance (see Table 3). Chi Square and ANOVA 
results indicated that groups did not significantly differ in the proportion of 
smokers within each group or the number of cigarettes smoked per day..
Finally, deficit patients were compared on SDS characteristics to ensure 
that severity ratings, and the relative percentage of patients displaying primary 
and enduring negative symptoms is consistent with patients in the published 
literature (see Table 9). Deficit patients evaluated in the current study displayed 
symptom severity ratings of a similar magnitude to most publistied studies, 
including those conducted by SDS authors. Ttie percentage of deficit patients 
displaying symptoms which are at least moderate in severity was also
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comparable to previous reports, as were the percentage of patients with primary 
and enduring negative symptoms.
Primary Analyses
Emotional Experience
Hypothesis 1.
Three repeated measures ANOVAs were conducted to examine the 
effects of diagnosis on state and trait subjective emotional experience. In the first 
analysis examining trait experience, a repeated measures ANOVA was 
calculated in which diagnostic group served as a between-subjects factor, and 
emotion valence (positive, negative) as a within-subjects factor, in order to 
determine whether there were group differences in trait experience of positive 
and negative emotion. Total trait affect scores from the Positive and Negative 
Affect Scale (PANAS) served as the dependent variable (range 20-100). A 
significant within subjects effect was found for emotion, F  (2,60) = 92.03, p <
.001 (eta square = .63); however, the t)etween-subjects effect for diagnostic 
group was nonsignificant, F (2, 60) = 1.81, p = .17 (eta square = .06). As 
hypothesized, a significant trait emotion X group interaction, F (2, 60) = 3.56, p = 
.04 (eta square = .12) was present, which is presented in Figure 1. One-way 
ANOVAs were conducted to determine the significance of the overall emotion X 
group interaction, and to explore hypothesized differences among deficit and 
non-deficit patients. A statistically significant difference was found for trait 
positive, F (1, 60) = 4.44, p = .016, but not negative experience, F (1, 39) = 0.37,
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p = .691. Post hoc Scheffe analyses indicated that deficit syndrome patients 
reported experiencing significantly less intense positive emotion than non-deficit 
patients and a trend toward less experience than controls (p = .060). Thus, the 
significant emotion X group interaction refiects that deficit patients experience 
less positive emotion than non-deficit patients or controls, and relatively equal 
levels of trait negative emotion. Means, standard deviations, and post hoc results 
are presented in Table 10.
Given the IQ difference present among the groups, the repeated 
measures ANOVA was conducted again, with IQ entered as a covariate, in order 
to determine whether the group differences in trait experience of positive and 
negative emotion were accounted for by IQ differences among the groups. 
Repeated Measures ANCOVA indicated that the emotion X IQ interaction was 
nonsignificant, F  (2, 60) = 0.13, p = .717 (eta square = .002), indicating that IQ 
differences among the groups did not influence the differences in trait emotional 
experience resulting from diagnostic status.
The second analysis examined intensity of state emotional experience. 
Repeated measures ANOVA was conducted with diagnostic group entered as a 
between-subjects factor and emotion valence (positive, negative) as a within- 
subjects factor. Total state affect scores from the Positive and Negative Affect 
Scale (PANAS) served as the dependent variable (range 20-100). Results 
indicated a statistically significant main effect for emotion, F  (2,60) = 123.27, p < 
.001 (eta square = .67) and a significant between-subjects effect for group, F (2, 
60) = 3.32, p = .044 (eta square = .11). These significant findings are presented
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in Figure 1, and reflect that a greater intensity of state affect was experienced for 
positive than negative emotions across groups. Also, controls experienced 
significantly less overall state emotion than both patient groups, and the patient 
groups experienced higher level of state negative affect than controls. Contrary 
to hypotheses, there was only a trend toward a statistically significant state 
emotion x group interaction, F (2,60) = 1.84, p = .17 (eta square = .06).
ANCOVA was conducted to assess the effects of IQ on state emotional 
experience. Results indicated a nonsignificant emotion X IQ interaction, (2, 60) = 
0.13, p = .724 (eta square = .002), indicating that IQ is not accounting for 
differences in state emotional experience.
The third analysis examined frequency of emotional experience in relation 
to basic emotion theories (e.g., Ekman, 1996). Using diagnostic group as a 
tietween-subjects factor, and emotion (12 levels: joy, interest, surprise, sadness, 
anger, fear, disgust, contempt, guilt, shyness, hostility, and shame) as a within- 
subjects factor, a repeated measures ANOVA was calculated to determine 
whether there were group differences in the experience of individual basic 
emotions. The 12 levels of emotion were from the Differential Emotions Scale 
(DES), and the scores obtained for each level served as the dependent variable. 
Mauchly’s Test of Spericity indicated that assumptions of sphericity were 
violated. As such, the GreenHouse-Geisser correction was applied, and 
significance levels reflect this correction. A significant main effect of emotion was 
found, F (11, 60) = 26.72, p < .001 (eta square = .32). However, the between 
subjects effect for group was nonsignificant, F (2, 60) = 1.33, p = .272 (eta
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square = .63). Consistent with the hypothesis, repeated measures ANOVA also 
indicated a statistically significant emotion X group interaction, F  (22, 60) = 2.48, 
p < .001 (eta square = .08), which is presented in Figure 2. As will be noted from 
the Figure, the interaction effect reflects that diagnostic groups largely did not 
differ with regard to the experience of discrete negative emotions, while deficit 
syndrome patients displayed a unique diminished capacity to experience 
individual positive emotions. This significant interaction was followed by 
individual one-way ANOVAs to further determine the nature of these differences. 
Results indicated statistically significant differences in frequency of experience 
for the positive emotions of interest, F (11, 60) = 4.28, p = .019, joy, F (11, 60) = 
6.76, p = .002, and a trend toward a difference in surprise, F (11, 60) = 2.60, p = 
.083. Significant differences were also found for the negative emotion shame, F 
(11, 60) = 3.36, p = .042, and there was a trend toward significant differences in 
reported experience of fear, F (11, 60) = 2.82, p = .068. Differences were 
nonsignificant for all other negative emotions. Post hoc Scheffe analyses were 
conducted for emotions where significant differences were found. Results 
indicated that deficit patients experience both joy and interest significantly less 
than non-deficit patients and controls. Means, standard deviations, and post hoc 
results are presented in Table 10.
An ANCOVA conducted to determine whether IQ influenced the 
experience of discrete emotions was nonsignificant. F (22, 60) = 0.54, p = .877 
(eta square = .01). This indicates that IQ did not account for differences found 
across diagnostic groups with regard to the frequency of experienced emotion.
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Emotional Perception
Hypothesis 2 and 3 were concerned with potential differences in emotion 
perception among the groups. These differences were assessed using two types 
of tasks, a facial affect identification task (Hypothesis 2) and a test of olfaction 
(Hypothesis 3).
Hypothesis 2.
Two separate repeated measures ANOVAs were conducted to assess the 
effects of diagnosis on facial affect perception. For these analyses, performance 
on the facial affect identification task was examined. Using diagnostic group as a 
t»etween-subjects factor and facial affect (6 levels; happiness, surprise, sadness, 
anger, fear, neutral) as a within-subjects factor, a repeated measures ANOVA 
was calculated to determine whether there were group differences in the mean 
accuracy (% correct) for emotional faces. Mauchly’s Test of Spericity indicated 
that assumptions of sphericity were violated. As such, the GreenHouse-Geisser 
correction was applied, and significance levels reflect this correction. The 
ANOVA indicated a significant main effect of emotion, F  (5, 36) = 40.8, p < .001 
(eta square = .41), and a significant between subjects effect for group, F  (2, 36) = 
9.79, p < .001. However, contrary to hypotheses, there was a nonsignificant 
emotion X group interaction, F  (5, 59) = 0.95, p = .487, indicating that all 
diagnostic groups had similar levels of difficulty and accuracy at identifying 
individual emotions. The findings are presented in Figure 3. The significant 
within-subjects effect of emotion and between subjects effect of group can mostly 
be attributed to very high rates of accuracy for happiness and low rates for fear.
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along with deficit patients being generally less accurate on affect identification 
than non-deficit patients, who were in turn less accurate than controls.
An ANCOVA was then conducted with 10 as a covariate. Results 
indicated a nonsignificant emotion X 10 interaction, F  (10, 36) = 1.38, p = .233 
(eta squared = .03), suggesting that 10 does not account for group differences in 
emotion identification.
For the second repeated measures ANOVA, diagnostic group as a 
between-subjects factor and facial affect (6 levels: happiness, surprise, sadness, 
anger, fear, neutral) as a within-subjects factor. However, rather than number 
correct, group differences in the speed with which facial displays of discrete basic 
emotion were used as the dependent variable. For these analyses, only those 
faces where correct responses were obtained were included. Results indicated a 
significant main effect of emotion, F  (5, 36) = 17.03, p < .001 (eta square = .32). 
There was also a significant between subjects effect for group, F  (2, 36) = 24.66, 
p < .001. Consistent with hypotheses, there was also a significant emotion X 
group interaction, F  (10, 36) = 2.13, p = .024 (eta squared = .11), which is 
presented in Figure 4. The significant emotion X group interaction can largely be 
attributed to differences in the processing of positive vs. negative emotions, 
which was particularly apparent for the deficit syndrome group. While all groups 
evinced an increase in processing speed for happy faces (indicated by shorter 
reaction times), this was particularly evident in ttie deficit syndrome group, who 
exhibited much slower processing for negative faces, especially fear and 
sadness. To further examine this interaction, one-way ANOVAs were then
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conducted to determine the nature and significance of these differences among 
the groups, and to explore hypothesized differences among deficit and non­
deficit patients. Results indicated statistically significant differences for all 6 
emotional conditions: Anger = F  (2, 57) = 19.98, p < .001; Fear = F (2,45) = 
27.26, p < .001 ; Happiness = F (2, 59) = 29.87, p < .001 ; Neutral = F (2, 55) = 
33.50, p < .001; Sadness = F(2, 54) = 18.47, p < .001; Surprise = F (2, 59) = 
32.07, p < .001. One-way ANOVAs were followed up by Scheffe post hoc 
comparisons. Results indicated that deficit patients labeled facial affect stimuli, 
for all 6 emotional conditions, significantly more slowly than non-deficit patients 
and controls. Non-deficit patients also processed all 6 facial affect conditions 
significantly more slowly than controls, who were fastest at processing all 
affective conditions. Means, standard deviations, and post hoc results are 
presented in Tat>le 11.
To examine the effects of IQ on facial affect labeling speed, ANCOVA was 
conducted using IQ as a covariate. Results indicated a nonsignificant emotion X 
group interaction, F (10, 36) = 1.15, p = .337 (eta squared = .04), indicating that 
group differences in IQ do not account for ttie observed effects of diagnostic 
group on facial affect labeling time.
Hypothesis 3.
A One-Way ANOVA was conducted to assess the effects of diagnosis on 
smell perception. Smell perception was assessed using the University of 
Pennsylvania Brief Smell Identification Test (SIT). BSIT total recognition scores 
served as the dependent variable (range 0-12). ANOVA indicated statistically
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significant differences in total smell identification accuracy among diagnostic 
groups, F (2, 60) = 14.34, p < .001. Post fioc Sctieffe tests indicated that deficit 
patients performed significantly worse than non-deficit patients and controls; 
however, differences between non-deficit patients and controls were 
nonsignificant (see Figure 5). Total BSIT accuracy means, standard deviations, 
and post hoc data are presented in Table 12.
Two repeated measures ANOVAs were then conducted to examine 
potential differences in accuracy and valence judgment within positive and 
negative odors. Individual items were divided into pleasant and unpleasant 
categories using normative valence ratings published by Doty, Shaman, and 
Dann (1984), which are also available within the 40-item UPSIT manual. Ratings 
for each odor were made on a 5 point scale, with 5 representing extremely 
unpleasant, 3 representing a neutral reference point, and 1 representing 
extremely pleasant. Items included within the pleasant category had mean 
valence ratings that fell toward the pleasant end of the neutral reference point. 
Similarly, items were considered unpleasant if they fell toward the unpleasant 
end of the neutral reference point. This division resulted in 7 positive and 5 
negative items.
Using diagnostic group as a between-subjects factor, and odor valence 
(pleasant, unpleasant) as a within-subjects factor, a repeated measures ANOVA 
was calculated to determine whether there were group differences in the 
identification of pleasant and unpleasant odors. Accuracy per emotional condition 
(% correct) served as the as the dependent variable. Mauchly’s Test of Spericity
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indicated that assumptions of sphericity were violated. As such, the GreenHouse- 
Geisser correction was applied, and significance levels reflect this correction. 
Results indicated that the main effect for emotion was significant, F  (1,60) =
5.81, p = .019 (eta square = .10), which can be attributed to all diagnostic groups 
displaying greater accuracy for pleasant than unpleasant odors. Ttiere was also 
a significant between-subjects effect for group, F (2, 60) = 16.03, p < .001 (eta 
square = .37). This significant effect of diagnostic group reflects that controls 
displayed the highest performance, followed by non-deficit patients, and deficit 
patients (see Figure 6). Contrary to hypotheses, the emotion X group interaction 
was nonsignificant, F (2, 60) = 1.26, p = .292.
To further evaluate the hypothesis, separate one-way ANOVAs were then 
calculated to determine whettier differences existed among groups for both 
pleasant and unpleasant items. Results indicated statistically significant 
differences in the overall magnitude of performance on pleasant item accuracy, F 
(2, 60) = 8.473, p = .001, and unpleasant item accuracy, F (2,60) = 13.53, p < 
.001. Post hoc Scheffe analyses were conducted to determine the nature of 
differences among groups. Results indicated that deficit patients performed 
significantly more poorly than non-deficit patients and controls for both pleasant 
and unpleasant items. However, non-deficit patients and controls did not 
significantly differ on accuracy for either pleasant or unpleasant items. These 
results indicate that deficit patients are significantly less accurate at identifying 
both pleasant and unpleasant odors than non-deficit patients and controls, while 
non-deficit patients do not significantly differ from controls on either pleasant or
101
unpleasant odor Identification. Means, standard deviations, and post hoc data 
are presented per emotional condition in Table 12.
ANCOVA, conducted with IQ as a covariate, was nonsignificant, F  (1, 60) 
= 1.72, p = .195 (eta square = .03), indicating that IQ did not influence group 
differences in positive and negative odor identification.
Analyses were also conducted to examine the effects of diagnostic group 
on judging the valence of pleasant and unpleasant odors. Diagnostic group 
served as a between-subjects factor and odor valence (pleasant, unpleasant) as 
a within-subjects factor. Mean valence judgment ratings per odor condition 
(range 1: extremely pleasant to 7: extremely unpleasant) served as ttie 
dependent variable. Repeated measures ANOVA indicated a significant main 
effect for emotion, F (1,60) = 110.49, p < .001 (eta square = .67) and a 
nonsignificant between subjects effect for group, F (2, 60) = 1.44, p = .245 (eta 
square = .05). As hypothesized, ttiere was also a statistically significant emotion 
X group interaction, F (2, 60) = 4.94, p = .011, which is presented in Figure 7. 
One-way ANOVAs were used to follow-up ttie significant emotion x group 
interaction, and indicated a trend toward significant differences in valence 
judgments of both pleasant, F (2, 60) = 2.58, p = .085, and unpleasant items, F 
(2, 60) = 2.96, p = .06. These analyses suggest that deficit patients rated positive 
items as being significantly more neutral than controls, and that they tended to 
rate pleasant items as tieing somewhat more neutral than non-deficit patients, 
alttiough this was only at a trend level of difference. Deficit patients also 
displayed a trend toward rating unpleasant items as being more neutral than
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controls, but did not significantly differ from non-deficit patients. Additionally, non­
deficit patients do not differ from controls on judging pleasant items, but rate 
unpleasant items as being more neutral than controls. Although only a trend level 
of significance was achieved, the results are generally consistent with the notion 
that both deficit and non-deficit patients judge unpleasant items as tieing more 
neutral than controls. However, deficit patients display a unique impairment in 
judging pleasant items as tieing more neutral than either the non-deficit patients 
or the controls. Valence judgment means, standard deviations, and post hoc 
results are presented per emotional condition in Table 12.
Considering that groups significantly differed on IQ, ANCOVA was 
conducted to determine whether IQ influenced valence ratings across groups. A 
nonsignificant emotion X IQ interaction was present, F  <1, 60) = 0.20, p = .654 
(eta square = .03), indicating that IQ did not account for differences in valence 
ratings found tietween groups.
Cognitive Processing o f Emotion
Hypothesis 4 and 5 were concerned with potential differences in cognitive 
processing of emotional information for the deficit and non-deficit groups. Two 
fundamental processes were examined, memory (Hypothesis 4) and attention 
(Hypothesis 5).
Hypothesis 4.
To evaluate potential differences in learning and memory for emotional 
information among the groups, two separate repeated measures ANOVAs were 
conducted, one examining memory bias and the other examining acquisition of
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>emotional information (learning). The first analyses investigated whether there 
were group differences in emotional word recall for discrete emotional categories 
as measured by the EVLT, with diagnosis serving as a between-subjects factor, 
and emotion as a within-subjects factor (4 levels; happiness, sadness, anger, 
anxiety). For each of the four levels of emotion, separate memory bias scores 
were calculated using the following formula: EVLT Emotion Condition Trials 1-5 
Total Recall/ EVLT Trials 1-5 Total Recall * 100. For each emotion, this memory 
bias score reflects the relative proportion of words recalled out of the total 
number of words recalled across the five learning trials, and therefore provides 
an estimate of the relative bias in recall toward a given emotion. Results of the 
ANOVA indicated a significant main effect for emotion, F  (3,60) = 8.73, p < .001 
(eta square = .13), nonsignificant between-subjects effect for group, F  (2, 60) = 
0.780, p = .463 (eta square = .03), and a significant emotion X group interaction, 
F  (6, 60) = 2.54, p = .022 (eta square = .08), indicating that the pattern of recall 
bias differs across diagnostic groups (see Figure 8). As the figure demonstrates, 
the interaction effect results from the deficit patients’ unique bias toward recalling 
anger, which is not seen in non-deficit patients or controls. Additionally, they do 
not display the memory bias for happiness seen in both non-deficit patient and 
control groups, who consistently have a higher proportion of recall for happiness 
words relative to sadness, anger, and anxiety. Thus, deficit syndrome patients do 
not display a memory bias for positive emotion. For comparison purposes, 
descriptive statistics for the raw data are also presented for total recall across 
trials 1-5 per emotion (i.e., raw recall means per emotional condition) in Figure 9.
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This significant interaction was followed by individual one-way ANOVAs 
and post hoc Scheffe analyses to clarify the nature of differences. One-way 
ANOVA indicated statistically significant differences in memory bias for anger 
between the groups, F (2, 62) = 3.328, p = .043, and a trend toward differences 
in happiness, F (2, 62) = 2.08, p = .134, and anxiety, F (2, 58) = 2.87, p = .065. 
Post Hoc analyses indicate that deficit patients evidence a significantly greater 
memory bias for anger than controls (p = .044); however, differences between 
deficit and non-deficit patients and non-deficit patients and controls were 
nonsignificant.
To determine whether these findings were influenced by significant 
differences in group 10, ANCOVA was conducted using 10 as a covariate.
Results indicated a nonsignificant emotion X 10 interaction, F (3, 60) = 1.31, p = 
.272 (eta square = .02), indicating that 10 did not significantly influence 
differences in emotional memory bias.
The second set of analyses were then conducted to examine group 
differences in emotional and non-emotional word recall in order to determine 
whether emotional memory impairments reflect a diminished capacity for learning 
emotional information in patients with the deficit syndrome. In these analyses 
measures of emotional learning and memory (EVLT) and non-emotional learning 
and memory (CVLT) were included in a two test (CVLT vs. EVLT) X five trial (1 
through 5), X 3 group repeated measures ANOVA. Results are presented in 
Figure 10. Significant main effects were found for test, F (1, 58) = 14.77, p <
.001, and trial, F (4, 58) = 141.91, p < .001. These differences can tie attributed
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to participants evidencing greater recall on the CVLT than EVLT, and the 
expected learning slope occurring across the 5 trials on both tests. A significant 
trial X group interaction was found, F  (8, 58) = 8.57, p < .001, which indicates 
that non-deficit patients and controls demonstrated a typical learning increase 
across each of the 5 trials, on both the EVLT and CVLT, and a subsequent 
failure of deficit syndrome patients to display learning effects on either of the two 
memory tests. A significant test X trial interaction was also found, F  (4, 58) = 
3.35, p = .01. This significant interaction can be attributed to a steeper initial 
learning slope (trials 1 -  3) for the CVLT with a leveling out of performance on 
trials 4 and 5. In contrast, the EVLT demonstrated a gradual increase in learning 
across the five trials. Results also indicated a nonsignificant test X group 
interaction, F (2, 58) = 2.01, p = .14, and a nonsignificant test X trial X group 
interaction, F (8, 60) = 0.95, p = .48. Although these interactions were 
nonsignificant, when diagnostic group is considered, results are consistent with 
the idea that both deficit and non-deficit patients display impaired memory for 
emotional and non-emotional information relative to controls, with deficit patients 
exhibiting even greater impairment than non-deficit patients. Additionally, non­
deficit patients and controls both recalled significantly fewer emotional than 
neutral words, and display increased learning across the five immediate recall 
trials for both emotional and emotional words. These patterns were not found in 
deficit syndrome patients who failed to display superior recall for non-emotional 
words, and were unable to make gains in emotional and non-emotional word 
learning after the 2"“ (EVLT) and third (CVLT) learning trials, respectively. These
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findings suggest that while emotional information impacts memory in similar 
manner for controls and patients with non-deficit schizophrenia such that 
emotional information is more difficulty to learn, this disparity is not present for 
deficit patients. Rather, learning in deficit patients is not affected by the 
emotional content of the word, or put another way, emotional information is not 
salient for them and is processed like neutral information. These findings are 
consistent with an emotion processing abnormality in patients with deficit 
syndrome.
ANCOVA was also conducted, entering IQ as a covariate, to examine the 
effects of IQ differences on emotional and nonemotional word recall. There was a 
significant trial X IQ interaction, F  (4, 58) = 3.27, p = .012, nonsignificant test X IQ 
interaction, F  (1, 58) = 0.00, p = .964, and a significant test X trial X IQ 
interaction, F  (4, 60) = 2.73, p = .03. These results indicate that while IQ does not 
influence global differences in emotional and nonemotional memory, it does have 
impact on general learning, and differentially impacts the rate at which emotional 
and non-emotional information is learned. Estimated marginal means are plotted 
for EVLT and CVLT data across the 5 immediate learning trials in Figure 12 to 
demonstrate the effects of partialing out the influence of IQ on the learning and 
memory measures. As the Figure illustrates, the IQ effects can largely t>e 
attributed to IQ impacting EVLT scores of deficit syndrome patients, causing 
them to drop in later recall trials (particularly 3 and 4), in comparison to 
calculations not accounting for IQ. Thus, IQ appears to tie associated with the 
learning impairments associated with emotional information that are seen in
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deficit syndrome patients. However, it does not moderate the abnormality 
originally noted in which it appeared that emotional information was not salient 
for those with deficit syndrome.
Hypothesis 5.
Two separate repeated measures ANOVAs were conducted to examine 
the effects of diagnosis on attentional processing. In the first analysis, attention 
bias was assessed using the E-Stroop Attention Grabbing Task. E-Stroop 
difference scores calculated for each of the 4 emotional conditions (happiness, 
sadness, anger, anxiety) served as the dependent variable (difference score = 
emotional condition RT -  Neutral condition RT). Results indicated a significant 
main effect of emotion, F  (3, 56) = 2.76, p = .044, indicating that there were 
significant differences in the extent to which individual emotions captured 
attention across participant groups. As can be seen from Figure 12, these 
differences can largely tie attributed to anxiety words capturing attention to a 
greater extent than other emotions, and happiness capturing attention less than 
anger, anxiety, and sadness. The between-subjects effect of group was 
nonsignificant, F (6, 56) = 1.02, p =  .367, indicating that the overall magnitude of 
E-Stroop interference does not differ among groups. Although unexpected, the 
emotion X group interaction was nonsignificant, F (6, 56) = 1.34, p = .242, 
indicating that the pattern of attentional capture for emotional information did not 
significantly differ as a ftjnction of diagnostic group (see Figure 12). ANCOVA 
was also conducted, using IQ as a covariate to assess the influence of group IQ 
differences on attention bias, and indicated a nonsignificant emotion X IQ
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interaction, F  (3, 56) = 0.871, p = .458. Ttiis nonsignificant interaction indicates 
that IQ did not influence group differences in attention bias for emotional 
information.
A one-way ANOVA was also conducted to examine the specific sub­
hypothesis that happiness would fail to grab attention (i.e., a lack of attention 
bias) in deficit syndrome patients. Consistent with hypotheses, results indicated 
that deficit, non-deficit, and control participants significantly differed with regard 
to attention bias for happiness, F (2, 58) = 4.23, p = .019. Post hoc Scheffe 
analyses indicate that these differences can be attributed to deficit patients 
displaying significantly less attention bias for happiness than non-deficit patients 
(p= .021), as well as a trend toward less attention bias for happiness than 
controls (p = .141).
The second series of analyses examined the extent to which emotional 
information continues to disrupt on-going attentional processes, even when it is 
no longer present, using the E-Stroop Lingering Effect task. A lingering effect 
difference score (neutral word position #2 -  emotional or category word position 
#1) served as the DV. Results indicated a significant main effect of emotion, F (2, 
58) = 20.93, p < .001, which is indicative of differences in overall lingering effect 
across groups, such that negative emotion produced the greatest lingering effect, 
while category words and positive words failed to produce a lingering effect. A 
significant between-subjects effect was also found for group, F (2, 58) = 3.23, p = 
.047, which can be attributed to deficit syndrome patients displaying a greater 
lingering effect than non-deficit patients or controls across all word conditions.
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The emotion X group interaction was nonsignificant, F (4, 58) = 1.33, p = .248. 
This lack of significant differences is contrary to the hypothesis and indicates that 
diagnostic groups all display similar lingering effect patterns, such that negative 
emotions produced the greatest and positive emotions the least lingering effect 
for each group. ANCOVA using IQ as a covariate produced a nonsignificant, 
emotion X IQ interaction, F (2, 58) = 1.51, p = .226, indicating that IQ did not 
influence effects reported for the lingering effect task.
Individual One-Way ANOVAs were conducted to examine the specific 
sul>hypothesis that both deficit and non-deficit patients would evidence a 
significantly greater lingering effect for negative emotions than controls, and to 
determine whether differences are unique to negative emotions. Results 
indicated a statistically significant difference among deficit, non-deficit, and 
control groups with regard to the lingering effect resulting from negative words, F 
(2, 58) = 4.26, p = .02, but not positive, F (2, 58) = 1.63, p=  .21, or non­
emotional category words, F (2, 58) = 0.84, p = .92. Scheffe post hoc 
comparisons clarified the nature of these differences by indicating that deficit 
patients experience a significantly greater lingering effect than non-deficit 
patients (p = .02), but not controls (p = .23); however, non-deficit patients did not 
significantly differ from controls (p = .48), suggesting that the lingering effect 
abnormality is specific to deficit syndrome patients. Figure 13 presents E-Stroop 
lingering effect means and standard errors for patients and controls
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CHAPTER 5 
DISCUSSION
Results are discussed in relation to three major aspects of emotional 
functioning; emotional experience, emotion perception, and cognitive processing 
of emotional information. Wittiin these sections, emotion perception is divided 
into facial affect identification and olfactory perception, while the cognitive 
processing section is separated into attention and memory. These 5 separate 
sections correspond with the 5 hypotheses outlined in the literature review.
Emotional Experience 
Prior research has provided evidence that patients with deficit syndrome 
schizophrenia have a diminished capacity to experience emotion, in comparison 
to non-deficit patients, those classified as having the deficit syndrome have tieen 
found to report lower levels of trait positive affect (Horan & Blanchard, 2003) and 
higher levels of physical anhedonia (Kirkpatrick & Buchanan, 1990; Herbener, 
Harrow, & Hill, 2005; Loas et al., 1996). They have also been reported to have 
less severe ratings on clinical scales measuring negative emotions, such as 
anxiety, guilt, and hostility (Kirkpatrick et al., 1993; Subotnik et al., 2000; Tek et 
al., 2001), depression/suicidality (Fenton et al., 1997; Kirkpatrick & Buchanan, 
1990; Loas et al., 1996), and suspicion (Kirkpatrick et al., 1996). Experimental
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paradigms also suggest that deficit patients experience lower levels of induced 
stress (Cohen & Docherty, 2004; Cohen et al., 2003; however, see Earnst & 
Kring, 1999). Together, these previous findings appear to suggest that deficit 
syndrome patients experience diminished levels of both positive and negative 
emotions, and are consistent with the original clinical conceptualization of the 
syndrome (Kirkpatrick et al., 1989).
However, findings from the current study provide mixed support for the idea 
that the deficit syndrome is associated with a diminished capacity to experience 
both positive and negative emotion, by suggesting that there is a greater 
diminishment for the experience of positive emotion alone. More specifically, 
when the frequency of self-reported emotional experience was compared across 
a range of positive and negative emotions, deficit syndrome patients reported 
experiencing significantly less frequent experience for the positive emotions of 
joy, interest, and surprise. In contrast, no differences were found among deficit, 
non-deficit, and control participants with regard to reported experience of discrete 
negative emotions. Additionally, when intensity of emotional experience was 
examined using the Positive and Negative Affect Scale (PANAS), data were also 
consistent with a diminished capacity to experience positive, but not negative 
emotion. These findings provide converging evidence which suggests that deficit 
syndrome patients report a diminished capacity to experience positive emotions, 
whereas the experience of negative emotion may be intact.
However, an important caveat of this finding is that the positive emotion 
impairment was specific to trait experience, as state affect was not diminished. In
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fact, deficit, non-deficit, and control subjects did not significantly differ on state 
measures of either positive affect, as measured by the PANAS, and both patient 
groups reported experiencing higher levels of state negative affect than controls. 
Diminished capacity for trait positive, but not negative affect, is consistent with 
findings reported by Horan and Blanchard (2003) who also noted diminished trait 
positive but not negative affect in their deficit syndrome group. Additionally, 
similar to the current findings, Earnst and Kring, (1999) did not find differences in 
state positive affect between their deficit and non-deficits groups. However, 
results are contrary to findings of Cohen et al. (2005) who failed to find impaired 
experience of positive affect. Cohen et al. and Horan and Blanchard also found 
deficit patients to display heightened experience of negative emotion, as was 
found to occur in the current study. Contradictory findings regarding positive 
emotion may be due to differences in measurement, as previous studies used 
different self-report questionnaires than those administered in the current study. 
In this regard, findings from the current study were most consistent with those of 
Horan and Blanchard, who used a measure similar to the one employed that 
required participants to provide emotional intensity ratings across a variety of 
positive and negative affective states. Previous studies also did not examine 
differences in trait and state experience, using measures selective to one time 
frame or another. The current findings may therefore reflect differences in the 
time frame in which patients are asked to rate their subjective level of 
experience. Also, the current findings are consistent with a larger body of 
literature in patients with schizophrenia that documents association among
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negative symptom and diminished positive but not negative emotions (Suslow et 
al., 2005). Thus, while not wholly consistent with prior studies of deficit syndrome 
schizophrenia, the present findings are interpreted as valid in that some of the 
inconsistency seems to be accounted for by methodological variation from one 
study to the next, and they are more generally consistent with the literature 
examining negative symptoms in schizophrenia.
While the cause of this impairment in positive emotional experience is not 
fully understood, deficit syndrome patients may report experiencing significantly 
less positive emotion when measured in trait, but not state form for several 
reasons. As previously suggested, one potential explanation for the trait vs. state 
discrepancy relates to differences in measurement. It is possible that interview- 
based clinical rating scales, self-report questionnaires, and experimental mood 
induction paradigms yield divergent findings due to measuring different 
components of emotional experience. Thus, conclusions made regarding the 
diminished capacity to experience positive emotion may be specific to self-report 
questionnaire measurement. It is possible that use of an alternative method, such 
as inner-experience sampling, or on-line assessment of hedonic capacity in 
relation to mood induction techniques (e.g., film clips, food, etc.) might produce 
different results. Future studies are needed that compare multiple measurement 
methods of emotional experience in deficit and non-deficit patient, considering 
that self-report questionnaires examined in the current study may require use of 
other cognitive factors in addition to experience in and of itself, such as appraisal 
or complex emotion knowledge, and that evidence for reduced positive emotional
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experience may be better accounted for by these factors, and not a diminished 
capacity per se.
Another possibility is that deficit syndrome patients may have poor memory 
for previously experienced positive feelings or events. Recent findings by Horan 
et al. (2006) and Herbener et al. (2007) provide further insight into how emotional 
memory may play a role in diminished positive emotional experience. Horan et al. 
investigated the possibility that anhedonia in schizophrenia occurs due to poor 
encoding, retention, or retrieval of positive feelings using an experimental mood 
induction paradigm. Although patients reported significant levels of anhedonia, 
they did not have impairment in immediate or delayed recall for their feelings 
during mood induction. However, Herbener et al. (2007) utilized an experimental 
paradigm and found that patients with schizophrenia evidenced impaired memory 
for positive information after a 24 hour delay period, potentially reflecting an 
impaired ability to integrate positive experience in the memory consolidation 
process. These discrepant findings may reflect that patients with schizophrenia 
are able to adequately recall their general feelings, potentially because there is 
little variation in positive experience, yet fail to accurately recall positive 
information after a significant amount of time. Thus, there is some suggestion 
that anhedonia in schizophrenia may be associated with a failure to accurately 
recall positive information. The inability to recall positive information after 
substantial delay (e.g., 24 hours) may explain why patients with the deficit 
syndrome exhibit trait decreases in positive emotion. In other words, because 
they are unable to appropriately consolidate positive events in memory, deficit
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patients may be less accurate at rating their emotional experience when asked to 
think back over the past few weeks, even though they have the capacity to 
experience positive emotions in the moment in a manner that is similar to that of 
healthy individuals. Alternatively, poor consolidation of positive information may 
render positive events unavailable in episodic memory, and thus cannot be 
recalled to create a positive perception or more general increase in positive 
mood, both of which are present in normal individuals.
Finally, it is also important to note that the specificity of trait impairment for 
positive emotion is consistent with the assertion that consummatory pleasure 
(i.e., pleasure derived from momentary experience; Depue & lacono, 1989) is 
unimpaired in schizophrenia (Germans & Kring, 2000). Thus, although unable to 
express emotions, patients with schizophrenia, including those with the deficit 
syndrome, appear to be able to experience positive and negative emotions in the 
moment at a normal level.
Considering that frequent experience of positive emotion has been found to 
precede and cause a number of desirable functional outcomes (e.g., social, 
occupational, health) (Lyubomirsky, King, & Diener, 2005), it is likely that 
diminished positive emotional experience contributes at least in part to symptoms 
and functional impairments seen in deficit patients. For example, deficit patients 
may fail to develop interest in people and things or the drive to socialize, because 
they do not experience positive emotion frequently enough for these activities to 
become rewarding (or perhaps to be remembered as rewarding). Symptoms and 
functional impairments may therefore develop because of a lack of positive
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emotional experience needed for behavioral activation, and for these behaviors 
to be reinforced. Additional studies are needed to directly determine whether the 
diminished capacity to experience positive emotion is a root cause of the 
negative symptoms seen in deficit syndrome patients, or whether positive 
emotion abnormalities are simply a result of severe negative symptoms. The 
extensive and comprehensive meta-analysis on positive affect conducted by 
Lyubomirsky, King, and Diener provides a basis for this work, and suggests that 
additional investigations of positive affect and negative symptoms would be 
worthwhile.
From a neurophysiological stand-point, abnormalities in experiencing positive 
emotion may be subsumed by dopaminergic dysfunction. Two previous studies 
have reported that deficit status has been linked to lower dopamine function 
(Ribeyre et al., 1994; Thibaut et al., 1994). Considering that higher dopamine 
levels are known to be key for higher levels of positive emotional experience 
(Ashby, Isen, & Turken, 1999), it is possible that the diminished capacity to 
experience positive emotion may be due to reduced dopamine function. 
Dampened response of the DA system in deficit patients could create 
deficiencies in the normal reward circuitry characterized by diminished DA 
release in the presence of positively reinforcing stimuli. Thus, normal 
associations between positive events and the internal experience of hedonic 
pleasure would not ise formed, leading to a decreased inner experience of 
positive emotion, as well as a decreased drive to engage in pleasaurable events. 
Additional studies using functional neuroimaging procedures could establish a
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direct link between the experience of positive affect and dopaminergic 
dysfunction in deficit and non-deficit patients.
Emotional Perception 
Emotion perception was examined in relation to visual and olfactory 
sensory domains. These results are discussed in facial affect identification and 
olfactory perception sections, respectively.
Facial Affect Identification
Results of the facial affect identification procedure provided some support 
for the hypothesis that deficit syndrome patients would display impairment in 
processing positive facial expressions. In general, results indicated that deficit 
syndrome patients were significantly less accurate and slower at processing 
positive faces than controls. However, these impairments were not specific to 
positive emotions, as deficit patients were also significantly less accurate than 
controls at identifying negative emotions. More specifically, when differences 
were analyzed in relation to individual emotions, results indicated that deficit 
patients were significantly more impaired than non-deficit patients and controls 
for surprise, fear, and neutral faces. The expected finding of decreased accuracy 
on the part of the deficit syndrome groups for identification of happy faces was 
not found. In examining the data for happy faces, it is apparent that ceiling 
effects were present particularly for controls (% correct = 99), but also for the 
non-deficit group (% correct = 89) and the deficit group (% correct = 87). So, 
while the pattern of results was consistent with hypotheses, these ceiling effects
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may have attenuated differences among the groups, differences which would 
have otherwise been present if the task difficulty level was greater. Thus, the 
mixed findings for positive emotions, surprise and joy, may be accounted for by 
this factor.
With regard to prior research, these findings are generally consistent with 
results reported by Bryson et al. (1998) who also found deficit syndrome patients 
to display accuracy impairments for surprise, and neutral. However, unlike 
Bryson et al., deficit syndrome patients in the current study were not significantly 
more impaired than non-deficit patients for displays of sadness. Our findings and 
those of Bryson et al. are also contrary to results reported by Horan and 
Blanchard (2003), who failed to find differences in facial affect identification 
between deficit and non-deficit patient groups. These discrepant findings may be 
due to differences in methodology and analytic strategy, as Horan and Blanchard 
did not examine differences in relation to discrete emotions which may have 
precluded the observation of noticeable differences by compounding variance 
across multiple emotional conditions. It has also been suggested that emotion 
recognition varies based on the manner in which the stimuli are presented (for a 
review see Edwards, Jackson, & Pattison, 2002). The method used here can 
most accurately be called a facial affect labeling task, which assesses controlled 
cognitive processes. Similar tasks have been shown to produce a pattern of 
results in patients with schizophrenia (not examining deficit and non-deficit 
distinctions) that suggest that negative emotions are most significantly impaired, 
particularly fear and sadness. The current findings suggest that negative
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emotions are more significantly impaired for schizoptirenia patients ttian positive 
emotions, and provide further evidence that fear and sadness may be the two 
facial affect displays that are most affected. Additionally, deficit syndrome 
patients do not appear to differ from non-deficit patients with regard to this 
pattern of impairment typically found with labeling tasks. However, they are 
impaired on displays of fear to a significantly greater extent than non-deficit 
patients, suggesting that the facial affect identification abnormalities typically 
seen in patients with schizophrenia are magnified in patients with primary 
negative symptoms.
Mixed support was also found for the hypothesis that deficit patients would 
be significantly slower than non-deficit patients and controls for positive faces. 
Similar to accuracy findings, deficit patients were significantly slower at 
processing positive faces (both happiness and surprise in the case of RT) than 
both non-deficit patients and controls; however, these findings were not specific 
to positive emotions, as deficit patients were slower than non-deficit patients, 
who were in turn significantly slower than controls, for all emotions examined. 
Thus, deficit patients are simply slower at processing faces, a finding that may 
reflect a generalized impairment in attention or processing speed. Although not 
supporting the expected distinction between reaction times for positive and 
negative affect, these findings provide the first data examining differences in RT 
for facial affect perception in patients with deficit and non-deficit schizophrenia.
Qualifications should be placed on facial affect findings reported. The task 
design used in the current study largely tapped into controlled cognitive
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proœsses since facial affect stimuli remained on the computer screen for a 
maximum of 5 seconds or until participants provided a vocal response, whichever 
came first. It is likely that tasks utilizing a faster presentation, which would 
measure automatic processing, would result in different findings (see Edwards, 
Jackson, & Pattison, 2002 for a review of methodological considerations in face 
perception tasks). This is particularly likely considering that controlled and 
automatic emotion processing tasks activate different neural circuits. Additional 
studies could compare controlled and automatic facial affect processing tasks 
among deficit and non-deficit patients. Findings are also limited by the stimulus 
set used. Although widely used in emotion studies, the Matsummoto and Ekman 
(1988) stimulus set presents only intense facial displays of emotion, and does not 
offer variations in emotional intensity afforded by other stimulus sets. These 
intense facial displays undoubtedly accounted for some of the ceiling effects 
noted for happiness. Future studies could examine the possibility of differences 
among high and low intensity emotional faces using other standardized facial 
affect stimulus sets.
Olfactory Perception
Consistent with hypotheses, results indicate that deficit syndrome patients 
evidenced significantly poorer olfactory identification performance than non- 
deficit patients and controls. These findings are in-line with several studies 
indicating decreased olfactory identification in deficit syndrome patients 
(Goudsmit et al., 2003; Malaspina & Coleman, 2003; Malaspina et al., 2002; 
Moberg et al., 2006; Seckinger et al., 2003), and provide additional support for
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the use of the Brief-Smell Identification Test (B-SIT) as a measure capable of 
differentiating deficit and non-deficit schizophrenia (Goudsmit et al., 2004).
Results extend previous studies of olfaction in deficit syndrome patients by 
separating out individual B-SIT items to examine impairments in accurately 
identifying and judging the valence of pleasant and unpleasant odors. Relative to 
non-deficit patients and controls, deficit patients were found to identify both 
positive and negative items with less accuracy. This finding of diminished 
accuracy for both odor categories was specific to deficit patients, as non-deficit 
patients and controls did not differ in relation to identifying either pleasant or 
unpleasant items. Thus, data did not support the hypothesis of a differential 
impairment in identifying pleasant items among deficit syndrome patients.
However, an odor specific impairment was found when individual items 
were examined in relation to valence judgment. When asked to rate individual B- 
SIT items for pleasantness on a 7-point scale, deficit syndrome patients were 
uniquely found to rate pleasant items as significantly more neutral than controls. 
No differences were found with regard to judging negative smells, as deficit, non­
deficit patients and controls were all found to judge unpleasant smells as being 
similarly negative. This finding of a hedonic impairment forjudging pleasantness 
is consistent with previous studies examining olfactory hedonics in patients with 
schizophrenia (Crespo-Facorro et al., 2001; Doop & Park, 2006; Hurdy et al., 
2002), and provides the first evidence suggesting that valence judgment may be 
more impaired in deficit syndrome patients. It is also consistent with our finding of 
decreased trait positive affect, particularly as it relates to a diminished experience
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of positive events being experienced as pleasurable, possibly due to a 
dampening of DA response and a dysfunctional reward circuit.
When evidence for impaired judgment of pleasantness is viewed in 
relation to previous work, results also provide insight into the neural mechanisms 
underlying deficit syndrome classification. Research by Crespo-Facorro et al. 
(2001) examined neural response to pleasant and unpleasant smells using PET, 
to determine whether patients with schizophrenia displayed impairment in rating 
intensity and valence of odors. No differences were found in judging valence of 
unpleasant odors; however, pleasant smells were rated by patients as being less 
pleasant than healthy controls. PET data indicated that the judgment of 
unpleasant smells was associated with less activation in limbic/paralimbic 
regions and increased frontal cortical activation. Hurdy et al. (2002) also found 
patients with schizophrenia to display reduced pleasantness ratings, in addition 
to impaired familiarity and edibility judgments. These impairments were thought 
to be subsumed by temporolimbic and orbitofrontal dysfunction. When the 
current findings are viewed in relation to results reported by previous studies, 
results are consistent with dysfunctional limbic and frontal system contribution to 
olfactory performance in schizophrenia, and suggest that frontal and limbic 
circuitry may be particularly related to the neuropathology inherent to the deficit 
syndrome.
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Cognitive Processing of Emotion
Memory
The current study provides the first data examining emotional memory 
impairment in patients with deficit syndrome schizophrenia. Results provide 
some support for the hypothesis that deficit syndrome patients would display a 
memory impairment for positive information. In comparison to non-deficit patients 
and controls, deficit patients recalled significantly fewer happiness words; 
however, recall impairments were not specific to happiness, as deficit patients 
evidenced poorer performance for sadness and anxiety as well. Although 
memory impairment was not selective to positive information, deficit patients 
failed to display the Pollyanna effect (i.e., superior recall for happiness) displayed 
by both non-deficit patients and healthy controls. Rather, deficit syndrome 
patients showed an equal recall bias for happiness and anger words- a pattern 
not seen in other groups.
In addition to providing the first data on deficit syndrome patients, the 
current study also provides the first comparison of verbal emotional memory for 
multiple discrete emotions. Early studies on emotional memory in schizophrenia 
indicated that patients fail to exhibit the Pollyanna effect (Matlin & Stang, 1978) 
typically found in healthy individuals, both in relation to verbal (Koh, Grinker, 
Marusarz, & Forman, 1981) and visual/facial (Koh et al., 1981) information. Koh 
et al. (1981) also found that patients recognized a significantly greater number of 
negative than positive faces, potentially signifying that patients have a bias 
toward recognizing negative information, a finding supported by Calev and
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Edelist (1996) who reported that patients recalled a greater number of negative 
than positive words and forgot negative words less rapidly after a 2 day delay 
period. Results of the current study are generally consistent with previous 
investigations, as deficit, but not non-deficit patients, failed to display a Pollyanna 
effect, as well as a bias toward recalling anger words at a high rate. Additionally, 
both patient groups recalled significantly less emotional information than healthy 
controls, a finding consistent with the majority of previous studies (see Matthews 
et al. 2005 for contradictory results). The finding of a lack of Pollyanna effect may 
be specific to deficit syndrome patients or more general to those patients who 
experience high levels of negative symptoms. Whatever the case, dividing 
patients into deficit and non-deficit groups may have allowed the current findings 
to emerge, something that was not accomplished in prior studies.
Our findings extend previous work by providing evidence that deficit 
syndrome patients display even more severe emotional memory impairments 
than non-deficit patients. Interestingly, deficit syndrome patients also failed to 
show superior recall for non-emotional words, as was found in both non-deficit 
patients and healthy controls. This finding may reflect that emotional memory 
impairments seen in deficit patients are due to generally poor memory 
performance, or perhaps a failure to use learning strategies when recalling verbal 
material. Alternatively, this difference may suggest that the emotional content of 
the words examined were not as salient for the deficit group, and thus do not 
produce the expected increase in difficulty level in these patients. In other words, 
deficit syndrome patients may process emotional information in a manner similar
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to neutral Information, wfiich is consistent with disturbance in affective memory. 
Additional studies are needed to determine why deficit patients display equivalent 
recall for emotional and nonemotional information, and to extend findings to other 
aspects of memory using multiple sensory domains.
Attention
Results indicate that deficit syndrome schizophrenia is associated with a 
unique pattern of attentional impairments not seen in non-deficit patients. 
Consistent with hypotheses, positive information captured the attention of deficit 
syndrome patients significantly less than non-deficit patients or controls. This 
was indicated by deficit syndrome patients receiving a significantly lower 
difference score (happiness -  neutral) than non-deficit patients and controls for 
high-intensity happiness words on the attention grabbing task. In fact, deficit 
patients did not only evidenced markedly less attentional capture (i.e., 
interference) toward happiness, but they displayed less capture for happiness 
words than for neutral words (i.e., a negative difference score). Importantly, this 
pattern was unique to the deficit syndrome, as non-deficit patients and controls 
displayed an attention bias for happiness (as indicated by a positive difference 
score).
This lack of an attention bias for happiness, which our data suggest is unique 
to deficit syndrome patients in this study, may be explained in several ways.
First, happiness may either be inconsistent with the mood state of deficit patients 
at the time of testing or unrelated to their general cognitive preoccupations. 
Considering that our sample of deficit patients had high symptom ratings for
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measures of anhedonia and avolition (e.g.. curbed interests, diminished social 
drive), this explanation seems plausible. Correlational findings provide further 
support for the role of mood as there was a trend level positive correlation 
between state positive affect and attention bias for happiness, indicating that low 
state positive affect is associated with less attention bias for happiness in 
schizophrenia patients. This finding may suggest that deficit syndrome patients 
display a mood-congruent processing abnormality related to happiness, such that 
diminished capacity to experience positive affect is associated with less of a 
tendency to have attention drawn toward positive information. Thus, findings 
suggest that deficit patients exhibit a failure to attend to positive information at 
the automatic level of cognitive processing, and that this impairment is related to 
core symptoms of the disorder.
Results also indicated that patients with schizophrenia and controls showed 
an attention bias toward negatively valenced material, as has been commonly 
found in healthy individuals (McKenna & Sharma, 2005), other patient groups 
(see Williams, Matthews, & McLeod, 1996), and patients with schizophrenia 
(Epstein et al., 1999) or delusional disorder (Fear et al., 1996). Our findings 
extend previous work in the area by examining attention bias in relation to 
discrete emotions. When attention bias is compared across multiple emotions, 
results indicate that emotional information of all types grabbed the attention of 
non-deficit patients to a greater extent than controls. This may be due to patients 
with schizophrenia having less cognitive resources than healthy individuals, and 
particular impairment in executive functioning, which is required to successfully
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perform the E-Stroop task. Non-deficit patients displayed the greatest attention 
bias for words representing anxiety and sadness, two emotions which are most 
consistent with their clinical presentation. This pattern differed in deficit syndrome 
patients, who showed an attention bias for anxiety, but not sadness. Considering 
that deficit syndrome patients in our sample were lower than non-deficit patients 
on symptoms of depression, this lack of attention bias for sadness may represent 
yet another mood congruent processing impairment. Thus, it is possible that the 
reduced risk for depression and suicide seen in deficit patients may be 
maintained by a failure to have attention captured by sad information.
Another major finding was that deficit patients displayed a significantly greater 
lingering effect for negative information than non-deficit patients, as indicated by 
a positive interference score (neutral word position 2 -  negative word position 1) 
on the E-Stroop lingering effect task. Within our schizophrenia sample, the 
lingering effect was specific to deficit syndrome patients, as non-deficit patients 
failed to display a lingering effect. This lingering effect for negative emotion seen 
in the deficit patients suggests that once negative information captures attention, 
it continues to disrupt on-going cognition, even when negative stimuli are no 
longer present.
Several factors may explain this lingering effect finding. Meta-analytic and 
empirical findings reported by Cohen et al. (2006) suggest that deficit syndrome 
patients display markedly reduced cognitive Amotion in relation to non-deficit 
patients and controls, and indicate that these impairments may reflect a 
generalized abnormality (i.e., no selective neuroanatomical substrates). It is
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possible that the lingering effect seen in deficit syndrome patients results from a 
generally reduced cognitive capacity. They may be less able to disengage 
attentional focus once it has been captured by a salient negative stimulus, and 
have a greater propensity to perseverate on the negative information that initially 
grabbed their attention. Further studies are needed to determine whether deficit 
syndrome patients do in fact perseverate on negative information once it grabs 
their attention, or whether the lingering effect findings reported here may be 
better accounted for by other cognitive processes, such as slower processing 
speed.
Alternatively, the lingering effect seen in deficit patients may reflect either 
hypo or hyper limbic system activation. In healthy individuals, it has been 
documented that once negative information captures attention, it activates 
specific limbic system structures, particularly the amygdala. Deficit syndrome 
patients may have abnormalities in one of the two major amygdala activation 
systems that are associated with negative emotions. However, given that 
negative stimuli have been reported to produce both hyper and hypo-active 
amygdala activation in patients with schizophrenia, neuroimaging studies are 
needed to identify the precise nature of limbic system dysregulation, and to 
determine whether attentional abnormalities noted in deficit syndrome patients 
are associated with amygdala dysfunction.
These findings shed light onto how emotional information processing 
impairments contribute to negative symptoms of schizophrenia, and suggest that 
the failure to have attention captured by positive information may be core to the
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volitional symptoms characteristic of deficit syndrome schizophrenia, whereas 
affective symptoms are associated with a failure to maintain a flexible attentional 
system capable of diverting attention away from negative information and toward 
goal-directed behavior.
General Limitations 
The current study has several general limitations that affect the 
interpretation and generalizability of findings. First, although the total sample size 
of schizophrenia patients is adequate (n = 42), the division of patients into deficit 
(n = 15) and non-deficit (n = 26) groups reduces power. Replication of findings is 
needed to ensure that results generalize to the population of schizophrenia 
patients as a whole. Second, a large number of analyses were conducted to 
analyze differences in emotion processing across a number of cognitive 
domains. The number of analyses conducted raises concerns with inflated Type I 
error. It is therefore possible that some differences found among patient groups 
fail to represent true differences on variables assessed, suggesting further need 
for replication of these results. Third, conclusions drawn regarding the role of 
dopamine in producing diminished positive emotional experience in deficit 
syndrome patients is speculative. Although these conjectures are based on 
research conducted on healthy individuals showing that higher levels of positive 
emotional experience are associated with higher dopamine levels, dopamine was 
not directly assessed in the current study and it is therefore impossible to know 
whether lower dopamine levels contribute to affective disturbances found.
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Additionally, given that the majority of patients were stably medicated with 
antipsychotics, it is impossible to determine how medication effects influenced 
dopamine levels within our sample of deficit patients. Future studies could 
address this issue by studying medication naive first episode psychotic patients 
with and without deficit syndrome schizophrenia.
Summary and Conclusions 
The purpose of the present study was to evaluate the hypothesis that deficit 
syndrome schizophrenia is associated with a unique pattern of affective 
disturbance. The majority of previous work examining emotional abnormalities in 
deficit syndrome patients has focused on understanding affective experience. 
Findings from several studies appear consistent with the notion that deficit 
syndrome patients experience diminished levels of both positive and negative 
emotions (i.e., there is not a differential affective experience impairment). Our 
findings provide mixed support for this idea. Similar to previous studies, our 
deficit patients reported higher levels of anhedonia as measured through clinical 
interview, received less severe clinical ratings of anxiety, guilt, and hostility, and 
reported less depression, suicidality, and suspicion than non-deficit patients. 
However, we did not find evidence for generalized diminished emotional 
experience, as was originally conceptualized by Kirkpatrick et al. (1989). Rather, 
findings point to a selective impairment in experiencing positive, but not negative 
emotion, which is specific to trait measures of emotional experience. Considering 
that frequent experience of positive affect has been found to precede and cause
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a number of desirable functional outcomes (Lyubomirsky et al., 2005), which are 
deficient in deficit syndrome patients, it is possible that diminished positive 
emotional experience is at the core of primary negative symptoms in 
schizophrenia. Additionally, considering that deficit syndrome patients have been 
reported to exhibit decreased dopamine levels, and higher dopamine levels have 
t>een linked to both reward and the experience of positive emotion (Ashby, Isen, 
& Turken, 1999), it is possible that dopaminergic system dysfunction may 
underlie both clinical negative symptoms and the diminished capacity to 
experience positive affect.
Relatively fewer studies have examined emotional information processing in 
patients with deficit syndrome schizophrenia. Although previous findings have 
been mixed (Horan & Blanchard, 2003), there is some evidence that deficit 
syndrome patients display poorer facial affect identification performance than 
non-deficit patients, particularly for the emotions of surprise, fear, disgust, 
sadness, and neutral (Bryson et al., 1998). Our findings provide support for the 
view that deficit patients display abnormalities in emotion perception, as deficit 
patients evidenced decreased accuracy for several facial affect displays, 
including fear, surprise, and neutral. Deficit patients also processed emotional 
faces more slowly than non-deficit patients; however, it is likely that these delays 
are due to a generalized processing speed impairment, rather than an emotion 
specific abnormality.
Emotion perception abnormalities were also found in relation to olfactory 
identification. Similar to previous studies indicating that smell identification
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deficits may represent one of the most stable neurocognitive impairments in 
deficit syndrome schizophrenia, findings indicate that deficit patients were 
significantly poorer than non-deficit patients at identifying common odors. When 
these olfactory performance impairments were analyzed in relation to pleasant 
and unpleasant affective conditions, deficit syndrome patients displayed a unique 
tendency to rate pleasant smells as significantly more neutral than controls. 
Differences were not found in relation to judging the valence of negative smells, 
suggesting that these perceptual abnormalities may be unique to positive 
emotion.
A similar pattern of impairment for positive information was found in relation to 
attention and memory. In comparison to non-deficit patients and controls, deficit 
patients displayed a unique failure to have attention captured by positive 
information. Correlational analyses indicated that less attention bias for 
happiness was associated with greater state ratings of diminished positive affect, 
potentially implicating a mood-congruent processing abnormality. Deficit patients 
were also found to display a significantly greater lingering effect for negative 
information than non-deficit patients or controls, suggesting that once negative 
information captures their attention, it continues to disrupt on-going cognitive 
processes, even when the negative stimulus is no longer present. Together, 
these attention findings reflect that deficit syndrome patients display impairment 
at the automatic level of emotion processing, such that they are less drawn 
toward positive information and find it more difficult to disengage fom negative 
information once it captures their attention. Such difficulties may reflect a failure
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to maintain a flexible attentional system that is capable of shifting between 
rewarding and threatening information in response to environmental 
contingencies, which is essential for adaptive functioning.
Deficit syndrome patients also displayed significant memory impairment for 
emotional information. Relative to non-deficit patients and controls, deficit 
patients displayed markedly reduced emotional memory and learning. However, 
these differences may reflect a generalized neurocognitive impairment, as deficit 
patients were also significantly more impaired on recall for non-emotional 
information and failed to exhibit beneficial recall for non-emotional information as 
found in non-deficit patients and controls. As hypothesized, deficit patients also 
failed to display the Pollyanna effect of superior recall for positive information that 
has been consistently found in healthy individuals (Matlin & Stang, 1978). Similar 
to attentional findings, this positive emotion memory impairment may reflect that 
deficit syndrome patients evidence a mood-congruent memory impairment, 
considering that they reported higher levels of anhedonia and trait positive affect.
When findings from the multiple emotion domains examined are viewed 
together, results provide some indication that deficit syndrome patients evidence 
more severe affective disturbance in relation to positive emotion. In comparison 
to non-deficit patients and controls, deficit patients reported less frequent and 
intense experience of positive emotion, recalled significantly fewer positive 
words, and displayed an impaired ability to accurately identify and judge the 
valence of pleasant odors. Additionally, deficit patients demonstrated a unique 
failure to have their attention captured by positive information, as well as less
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accurate and efficient labeling of positive faces (surprise) than non-deficit 
patients or controls. Thus, results provide support for the notion that the deficit 
syndrome is uniquely associated with abnormalities in the experience and 
processing of positive emotion.
However, affective abnormalities were not entirely specific to positive 
emotion, and it should be noted that deficit syndrome patients displayed cognitive 
and perceptual disturbances for negative emotions as well. For example, deficit 
patients were significantly more impaired than non-deficit patients at identifying 
fear faces, and displayed a lingering effect in attention for negative words that 
was not seen in non-deficit patients. They also exhibited a bias toward recalling 
anger words at a high rate, which was not seen in non-deficit patients, and 
impairment on accurately identifying, negative, as well as positive, odors. Thus, 
although deficit syndrome patients display a more consistent pattern of 
impairment toward positive emotion, which is unique to their clinical presentation, 
they also evidence impairment in relation to the processing of some negative 
information.
In conclusion, the present findings provide support for the suggestion that 
deficit syndrome schizophrenia is a disorder characterized by impairments in 
emotional experience, perception, and information processing. Furthermore, this 
abnormality is not global in nature, but is characterized most notably by deficits 
that are specific to positive emotions. Such findings are consistent with 
characteristic functional deficits in these patients, as well as neurophysiological 
findings implicating dysfunction within dopaminergic and reward-system circuits.
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Additional studies are needed to determine the extent to which emotional 
abnormalities reported in the current study are due to generalized cognitive 
impairment and to identify the specific neural circuits that contribute to this 
dysfunction. Using a matched task for our measure of emotional memory, the 
CVLT, results provide some suggestion that general emotional memory 
impairments displayed by deficit syndrome patients may be due to global recall 
difficulties. Paradigms using matched emotional and non-emotional tasks could 
determine the extent to which emotional abnormalities are caused by general 
neurocognitive impairment. Our findings also point to some potential 
neuroanatomical substrates for the emotion dysfunction seen in deficit patients, 
when findings are viewed in relation to previous work on schizophrenia, most 
notably dysfunctional limbic and frontal circuitry. Future neuroimaging studies 
could further explore the potential contributions of these circuits to deficit 
syndrome symptomatology.
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APPENDIX A
TABLES
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Table 1.
Patient and Contrai Demographic Characteristics.
Deficit
(n=15)
Non- 
Deficit 
(n = 26)
Controls 
(n = 22)
Age 45.8 39.6 40.0
(12.5) (10.9) (12.1)
Education 12.4 12.1 (1.9) 12.8 (1.0)
(1.7)
Vocabulary SS 5.2 (1.8) 7.1 (3.3) 9.6 (2.3)
Information SS 5.1 (1.7) 8.2 (2.7) 9.6 (1.7)
Block Design SS 5.5 (1.8) 7.5 (1.9) 9.5 (1.9)
% Maie 60.0% 69.2% 18.2%
% Female 40.0% 30.8% 81.8%
% Left 06.7% 15.4% 4.5%
% Right 93.3% 84.6% 95.5%
% African-American 60.0% 26.9% 04.5%
% Asian 00.0% 07.7% 04.5%
% Biracial 13.3% 03.8% 13.6%
% Caucasian 26.7% 53.8% 68.2%
% Hispanic/Latino 00.0% 07.7% 09.1%
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Table 2.
Patient and Contrai Sociai Demographic Characteristics.
Deficit 
(n = 15)
Non- 
Deficit 
(n = 26)
Control 
(n = 22)
Homelessness
% Never 66.70% 57.70% 100.0%
% Lifetime 33.30% 42.30% 00.00%
Marital Status
% Divorced 00.00% 11.50% 09.10%
% Married 00.00% 00.00% 77.30%
% Never 93.30% 80.80% 09.10%
Married
% Separated 00.00% 03.80% 04.50%
% Widowed 06.70% 00.00% 00.00%
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Table 3.
Patient and Control Smoking Characteristics.
Deficit Non-Deficit Control
(n = 15) (n =26) (n = 22)
% Who Currently 
Smoke
73.30% 46.20% 40.90%
# Cigarettes 
Smoked
16.82 (11.46) 16.55 (5.13) 10.11 (4.76)
per Day
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Table 4.
Descriptive Statistics for Patient Medication use, Clinical Variables, and 
Extrapyramidal Symptoms.
Deficit Non-Deficit
Chlorpromazine Equivalent Dosage ® 
Depakote Dosage
861.4 705.2
450.0 480.0
Mood Stabilizer Dosage 74.3 83.3
% Prescribed Medication at Testing
Clozaril 33.3% 15.4%
Halodol 13.3% 11.5%
Risperdal 46.7% 34.6%
Zyprexa 40.0% 38.5%
Seroquel 20.0% 19.2%
Geodon 13.3% 26.9%
Ability 33.3% 19.2%
Depakote 46.7% 42.3%
Mood Stabilizer 46.7% 46.2%
Anti-Parkinsonian 06.7% 03.8%
EPS Medication 33.3% 19.2%
Extrapyramidal Symptoms
Rockland Rating Scale- Total “ 18.1 21.1
AIMS -  Total ® 7.5 6.5
EPS Scale- Total ^ 11.5 9.0
Clinical Variables
Psychotic Onset ^ 17.3 15.1
Illness Length ^ 28.5 24.5
* F (1.39) = 0.63, p = .43 
b F(1. 39) = 0.03, p = .87 
c F (1.39) = 0.04, p = .85 
d F(1. 39)= 1.89, p = .18 
® F(1. 39) = 0.20, p = .66 
\F (1 . 39) = 1.69, p = .20 
9 F(1. 39) = 0.59, p = .45 
F(1. 39) = 0.73, p = .40
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Table 5.
Brief Psychiatrie Rating Scale Clinical Symptom Characteristics.
Deficit ( n = 15) Non-Deficit (n = 26)
Individual Items
1. Somatic Concern 02.5(01.1) 02.4 01.6)
2. Anxiety 01.7(01.0) 02.7 01.4)
3. Emotional Withdrawal 04.0 (01.9) 02.5 01.6)
4. Conceptual Disorganization 01.9(01.4) 02.5 01.9)
5. Guilt Feelings 01.1 (00.5) 02.2 01.3)
6. Tension 02.1 (01.5) 01.9 01.3)
7. Mannerisms and Posturing 02.4 (01.8) 02.0 01.2)
8. Grandiosity 01.5(01.1) 02.2 01.6)
9. Depressive Mood 01.1 (00.3) 01.8 01.1)
10. Hostility 01.3 (00.6) 01.9 01.2)
11. Suspiciousness 01.8 (01.2) 03.2 01.8)
12. Hallucinatory Behavior 02.8 (01.7) 03.5 01.8)
13. Motor Retardation 02.8 (01.6) 01.9 01.4)
14. Uncooperativeness 02.3 (01.6) 01.4 01.0)
15. Unusual Thought Content 03.5(01.3) 03.4 01.7)
16. Blunted Affect 05.1 (01.6) 03.0 01.9)
17. Excitement 01.1 (00.5) 01.4 00.8)
18. Disorientation 01.7(01.0) 01.4 00.8)
BPRS Positive Syndrome 07.6 (02.5) 09.5 03.7)
BPRS Negative Syndrome 12.0(04.1) 07.3 03.6)
BPRS Disorganized Syndrome 07.3 (02.5) 07.5 03.3)
BPRS Total 40.9 (06.3) 41.0 08.4)
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Table 6.
Patient Clinical Characteristics for Depression
Deficit NonDeficit
( n = 15) (n = 26)
Individual Items
1. Depression 0.13(0.35) 0.27 (0.45)
2. Hopelessness 0.13(0.35) 0.27 (0.45)
3. Self Deprication 0.20 (0.78) 0.35 (0.69)
4. Guilty Ideas of Reference 0.13(0.35) 0.27 (0.60)
5. Patfiological Guilt 0.13(0.35) 0.38 (0.64)
6. Morning Depression 0.00 (0.00) 0.23 (0.59)
7. Early Wakening 0.13(0.52) 0.58 (0.99)
8. Suicide 0.00 (0.00) 0.27 (0.32)
9. Observed Depression 0.07 (0.26) 0.12 (0.33)
Calgary Depression Scale Total® 0.93 (1.34) 2.73 (3.45)
a. F(1, 39) = 3.70, p = .062
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Table 7.
Scale for the Assessment of Positive Symptoms Clinical Symptom 
Characteristics.
Deficit 
(n  = 15)
Non-Deficit 
(n = 26)
Individual Items
1. Auditory Hallucinations 1.47 (1.69) 2.35 1.67)
2. Voices Commenting 0.47 (1.25) 0.31 0.93)
3. Voices Conversing 0.20 (0.78) 0.69 1.29)
4. Somatic or Tactile Hallucinations 0.53 (1.19) 0.50 0.95)
5. Olfactory Hallucinations 0.00 (0.00) 0.00 0.00)
6. Visual Hallucinations 0.47 (0.99) 0.35 0.80)
7. Global Rating of Haliucinations 1.80 (1.61) 2.31 1.64)
8. Persecutory Delusions 1.27 (1.39) 2.27 1.51)
9. Delusions of Jealousy 0.13(0.52) 0.19 0.63)
10. Delusions of Guilt or Sin 0.13(0.52) 0.81 1.06)
11. Grandiose Delusions 0.47 (0.99) 1.12 1.48)
12. Religious Delusions 0.40 (1.12) 0.81 1.42)
13. Somatic Delusions 0.73(1.28) 1.00 1.50)
14. Delusions of Reference 0.93(1.34) 1.46 1.50)
15. Delusions of Being Controlled 0.13(0.52) 0.31 0.88)
16. Delusions of Mind Reading 0.53 (1.13) 0.50 1.30)
17. Thought Broadcasting 0.47 (1.00) 0.62 1.20)
18. Thought Insertion 0.07 (0.26) 0.31 0.88)
19. Thought Withdrawal 0.20 (0.56) 0.12 0.59)
20. Global Rating of Delusions 2.60 (0.99) 2.88 1.14)
21. Clothing and Appearance 1.67 (1.59) 0.62 1.06)
22. Social and Sexual Behavior 0.27 (0.70) 0.62 1.02)
23. Aggressive and Agitated Behavior 0.27 (0.70) 0.92 1.26)
24. Repetitive or Stereotyped Behavior 0.40 (0.91) 0.35 0.89)
25. Global rating of Bizarre Behavior 1.40 (1.18) 1.42 1.23)
26. Derailment 0.87(1.36) 1.23 1.80)
27. Tangentiality 0.93(1.22) 1.54 1.92)
28. Incoherence 0.40 (0.91) 0.23 0.86)
29. Illogicality 0.13(0.52) 1.12 1.51)
30. Circumstantiality 0.53 (0.92) 1.12 1.68)
31. Pressure of Speech 0.00 (0.00) 0.23 0.82)
32. Distractible Speech 0.87(1.46) 0.85 1.52)
33. Clanging 0.00 (0.00) 0.00 0.00)
34. Global Rating of Formal Thought Disorder 1.20 (1.08) 1.88 1.75)
SAPS Total 21.93
(11.34)
31.00(14.04)
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Table 8.
Scale for the Assessment of Negative Symptoms Clinical Symptom 
Characteristics.
Deficit 
( n = 15)
Non-Deficit 
(n = 26)
Individual Items
1. Unchanging Facial Expression 3.40(1.18) 2.00 1.63)
2. Decreased Spontaneous Movements 2.40 (1.68) 1.12 1.51)
3. Paucity of Expressive Gestures 3.13(1.25) 1.85 1.59)
4. Poor Eye Contact 2.53(1.19) 1.19 1.32)
5. Affective Nonresponsivity 2.67 (1.88) 1.00 1.47)
6. Inappropriate Affect 0.53(1.41) 0.62 1.17)
7. Lack of Vocal Inflections 2.73(1.39) 1.65 1.62)
8. Subjective Complaints of Emotional 2.53 (2.00) 0.58 1.30)
Emptiness
9. Global Rating of Affective Flattening 3.67 (0.72) 2.19 1.60)
10. Poverty of Speech 1.73(1.58) 0.54 0.95)
11. Poverty of Content of Speech 1.67 (1.35) 1.23 1.45)
12. Blocking 1.40 (1.68) 0.62 1.30)
13. Increased Latency of Response 1.93(1.44) 1.15 1.45)
14. Subjective Rating of Alogia 1.57 (1.68) 0.58 1.14)
15. Global Rating of Alogia 2.67 (1.18) 1.58 1.30)
16. Grooming and Hygiene 2.73(1.34) 1.23 1.31)
17. Impersistence at School and Work 2.93 (1.67) 1.23 1.63)
18. Physical Anergia 2.93(1.67) 0.85 1.15)
19. Subjective Complaints of Avolition 2.07(1.71) 0.46 0.86)
20. Global Rating of Avolition 3.40 (0.74) 1.31 1.26)
21. Recreational Interests and Activities 2.93 (1.49) 1.04 1.14)
22. Sexual Interests and Activity 1.40(1.77) 1.04 1.76)
23. Ability to Feel Intimacy and Closeness 2.87(1.60) 1.31 1.52)
24. Relationships with Friends and Peers 3.00 (1.77) 1.50 1.61)
25. Subjective Awareness of Anhedonia 2.60(1.45) 0.77 1.18)
26. Global Rating of Anhedonia/Asociality 3.33 (0.90) 1.42 1.53)
27. Social Inattentiveness 2.53(1.55) 1.15 1.19)
28. Inattentiveness During Mental Testing 3.87 (1.06) 1.65 1.50)
29. Subjective Complaints of Inattentiveness 1.53 (1.92) 1.54 1.48)
30. Global Rating of Inattention 3.53 (0.92) 2.00 1.06)
SANS Total 76.33 36.38
(23.26) (19.84)
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Table 9.
Characteristics and Distribution of Schedule for the Deficit Syndrome Symptoms 
Based Upon Symptom Severity
Severity % with Symptom
Symptom M SD
%
Moderate 
or >
Severity®
% with
primary
Symptoms*'
% with 
Enduring 
' Symptoms'^
Restricted Affect 2.53 0.99 93.3% 78.6% 66.7%
Diminished Emotional 1.87 1.06 66.7% 66.7% 66.7%
Range
Poverty of Speech 1.67 1.29 53.3% 53.3% 53.3%
Curbing of Interests 2.47 0.92 93.3% 93.3% 93.3%
Diminished Sense of 2.67 1.11 86.7% 93.3% 93.3%
Purpose
Diminished Social Drive 2.67 0.90 93.3% 86.7% 93.3%
Note, n = 15 deficit syndrome patients
® Percentage of participants in wtiich symptom severity is moderate or greater. 
Moderate or higher severity is required on at least two symptom domains.
 ^Percentage of participants in which symptom was not caused by neuroleptic 
akinesia, depression, anxiety, paranoia, or other psychotic symptoms and had at 
least moderate severity. At least two symptom domains must meet primary 
criteria to be considered deficit.
 ^Percentage of participants in which symptom was present during the proceeding 
12 months, including during periods of clinical stability. At least two symptom 
domains must meet these stability criteria to be considered deficit.
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Table 10.
Intensity and Frequency of Emotional Experience in patient and control subjects.
Deficit (1) Non-Deficit (2) Control (3)
M SD M SD M SD
PANAS
Trait PA 26.07 10.33 33.58 08.59 33.18 04.97
Trait NA 17.60 09.00 16.42 06.41 15.47 05.64
State PA 28.87 11.29 32.69 10.34 28.06 07.68
State NA 16.27 08.13 14.92 06.21 10.29 01.90
DES
Interest 02.69 01.23 03.38 00.69 03.44 00.57
Joy 02.71 01.32 03.65 01.02 03.91 00.53
Surprise 02.81 00.82 02.73 00.86 02.47 00.50
Sadness 02.11 01.15 02.26 00.95 02.05 00.79
Anger 02.18 01.15 02.12 00.78 02.51 00.68
Disgust 01.98 01.08 01.94 00.85 01.68 00.66
Contempt 01.91 00.84 02.00 01.00 01.79 00.83
Hostility 02.44 01.06 02.65 00.81 02.61 00.46
Fear 02.38 01.20 02.40 01.00 01.75 00.67
Shame 01.96 00.85 02.46 00.95 01.82 00.76
Shyness 01.96 00.92 02.14 01.06 01.81 00.66
Guilt 02.02 01.12 02.28 01.01 02.19 00.71
Note. The numbers in parentheses in column heads refer to the numbers used 
for illustrating significant differences in the last column titled “Post Hoc.” PANAS 
= Positive and Negative Affect Scale; PA = Positive Affect; NA = Negative Affect; 
PANAS scores represent totals (range = 0-50); DES = Differential Emotions 
Scale; DES means represent averages (range = 0-5), rather than totals.
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Table 11.
Facial affect labeling RT in patient and control subjects.
Deficit (1) Non-Deficit (2) Control (3)
M SD M SD M SD
Anger 1976 490 1491 413 1143 208
Fear 2517 483 1827 633 1090 176
Happiness 1478 311 1243 298 824 120
Neutral 2303 602 1544 458 1024 171
Sadness 2289 696 1689 519 1202 222
Surprise 2051 538 1616 402 1016 166
Note. The numbers in parentheses in column heads refer to the numbers used 
for illustrating significant differences in the last column titled “Post Hoc.”
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Table 12.
Differences in olfactory perception among patient and control subjects.
Deficit (1)________ Non-Deficit (2)______ Control(3)
M SD M SD M SD
Accuracy
Positive Item 65.56 12.75 80.57 20.15 88.89 12.54
% Correct 
Negative 53.33 23.50 78.40 17.24 84.17 13.08
ltem% Correct 
Total Correct 07.20 01.78 09.56 01.94 10.17 01.04
(0-12)
Valence
Positive Item 03.09 01.12 02.45 01.18 02.35 00.53
Valence
Negative Item 04.43 01.36 04.30 01.43 05.21 00.89
Valence
Total Valence 03.64 00.92 03.22 01.06 03.54 00.42
Mean
Note. Tfie numbers in parentfieses in column heads refer to the numbers used 
for illustrating significant differences in the last column titled “Post Hoc.”
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APPENDIX B
FIGURES
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Figure 1.
Differences in intensity of state and trait emotional experience among patient 
and control subjects.
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Figure 2.
Differences in frequency ofemotionai experience among patients and 
controi subjects
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Figure 3.
Differences in facial affect labeling accuracy among patient and control subjects.
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Figure 4.
Differences in facial affect labeling RT among patient and control subjects.
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Figure 5.
Differences in total olfactory identification among patient and control
subjects.
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Figure 6.
Differences in olfactory identification within pleasant and unpleasant
conditions among patient and control subjects.
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Figure 7.
Differences in pleasant and unpleasant olfactory valence judgments among
patient and control subjects.
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Figure 8.
Differences in emotional memory bias for discrete emotional categories between
patient and control subjects
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Figure 9.
Differences in emotional word recall for discrete emotional categories between
patient and control subjects
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Figure 10.
Differences In emotional and non-emotional word learning among
patient and control subjects.
14
12
.2  10
0)Q.
■o
0) 8
15
g
P 6
i
JS.O X
D eficit_EVLT
- - D 6ficit_C VLT
— B—  Non-Deftcit_EVLT
- O  - Non-Deficit_CVLT  
-© —  Control_EVLT
- -O  - Control C V L T
3
Trial
160
Figure 11.
Differences in emotional and non-emotional word learning using estimated
marginal means adjusted for IQ among patient and control subjects.
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Figure 12.
Differences in attention bias for individual emotions among patient and
control subjects.
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Figure 13.
Differences in E-Stroop Emotional Lingering Effects for positive and 
negative words in patient and control groups.
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